AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|ICCC_GROUP|POPULATION|AGE|RACE|SEX|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
142.3|148.5|145.4|8498|All ICCC Groups Combined|58588724|0-14|All Races|Male and Female|1999|||
43.5|47.0|45.3|2648|I Leukemias, myeloproliferative & myelodysplastic diseases|58588724|0-14|All Races|Male and Female|1999|||
34.0|37.1|35.5|2079|I(a) Lymphoid leukemias|58588724|0-14|All Races|Male and Female|1999|||
6.8|8.3|7.5|440|I(b) Acute myeloid leukemias|58588724|0-14|All Races|Male and Female|1999|||
0.4|0.9|0.6|36|I(c) Chronic myeloproliferative diseases|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|58588724|0-14|All Races|Male and Female|1999|||
1.1|1.7|1.4|82|I(e) Unspecified and other specified leukemias|58588724|0-14|All Races|Male and Female|1999|||
14.3|16.3|15.3|896|II Lymphomas and reticuloendothelial neoplasms|58588724|0-14|All Races|Male and Female|1999|||
4.9|6.1|5.5|320|II(a) Hodgkin lymphomas|58588724|0-14|All Races|Male and Female|1999|||
5.4|6.6|6.0|349|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|58588724|0-14|All Races|Male and Female|1999|||
2.1|3.0|2.5|148|II(c) Burkitt lymphoma|58588724|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|51|II(d) Miscellaneous lymphoreticular neoplasms|58588724|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|28|II(e) Unspecified lymphomas|58588724|0-14|All Races|Male and Female|1999|||
30.2|33.1|31.7|1856|III CNS and misc intracranial and intraspinal neoplasms|58588724|0-14|All Races|Male and Female|1999|||
2.6|3.5|3.0|176|III(a) Ependymomas and choroid plexus tumor|58588724|0-14|All Races|Male and Female|1999|||
13.5|15.5|14.5|847|III(b) Astrocytomas|58588724|0-14|All Races|Male and Female|1999|||
7.1|8.6|7.8|460|III(c) Intracranial and intraspinal embryonal tumors|58588724|0-14|All Races|Male and Female|1999|||
4.6|5.8|5.1|302|III(d) Other gliomas|58588724|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|30|III(e) Other specified intracranial & intraspinal neoplasms|58588724|0-14|All Races|Male and Female|1999|||
0.5|1.0|0.7|41|III(f) Unspecified intracranial and intraspinal neoplasms|58588724|0-14|All Races|Male and Female|1999|||
9.8|11.5|10.6|617|IV Neuroblastoma and other peripheral nervous cell tumors|58588724|0-14|All Races|Male and Female|1999|||
9.6|11.3|10.4|607|IV(a) Neuroblastoma and ganglioneuroblastoma|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|58588724|0-14|All Races|Male and Female|1999|||
8.7|10.3|9.5|553|IX Soft tissue and other extraosseous sarcomas|58588724|0-14|All Races|Male and Female|1999|||
4.4|5.5|4.9|288|IX(a) Rhabdomyosarcomas|58588724|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|55|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|IX(c) Kaposi sarcoma|58588724|0-14|All Races|Male and Female|1999|||
2.3|3.1|2.7|156|IX(d) Other specified soft tissue sarcomas|58588724|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|53|IX(e) Unspecified soft tissue sarcomas|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.4|0.3|16|Not classified by ICCC|58588724|0-14|All Races|Male and Female|1999|||
3.7|4.8|4.2|245|V Retinoblastoma|58588724|0-14|All Races|Male and Female|1999|||
7.3|8.8|8.0|467|VI Renal tumors|58588724|0-14|All Races|Male and Female|1999|||
6.9|8.3|7.6|442|VI(a) Nephroblastoma and other nonepithelial renal tumors|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|22|VI(b) Renal carcinomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|58588724|0-14|All Races|Male and Female|1999|||
1.8|2.5|2.1|123|VII Hepatic tumors|58588724|0-14|All Races|Male and Female|1999|||
1.4|2.1|1.7|101|VII(a) Hepatoblastoma|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|22|VII(b) Hepatic carcinomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|58588724|0-14|All Races|Male and Female|1999|||
6.5|7.9|7.2|419|VIII Malignant bone tumors|58588724|0-14|All Races|Male and Female|1999|||
3.7|4.8|4.2|246|VIII(a) Osteosarcomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|VIII(b) Chondrosarcomas|58588724|0-14|All Races|Male and Female|1999|||
2.0|2.8|2.3|136|VIII(c) Ewing tumor and related sarcomas of bone|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|19|VIII(d) Other specified malignant bone tumors|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|58588724|0-14|All Races|Male and Female|1999|||
4.4|5.6|5.0|289|X Germ cell, trophoblastic tumors & neoplasms of gonads|58588724|0-14|All Races|Male and Female|1999|||
1.0|1.6|1.3|75|X(a) Intracranial & intraspinal germ cell tumors|58588724|0-14|All Races|Male and Female|1999|||
1.1|1.7|1.3|78|X(b) Malignant extracranial & extragonadal germ cell tumors|58588724|0-14|All Races|Male and Female|1999|||
1.8|2.5|2.1|124|X(c) Malignant gonadal germ cell tumors|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|X(d) Gonadal carcinomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|58588724|0-14|All Races|Male and Female|1999|||
5.2|6.5|5.8|339|XI Other malignant epithelial neoplasms and malignant melanomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|XI(a) Adrenocortical carcinomas|58588724|0-14|All Races|Male and Female|1999|||
1.5|2.2|1.9|109|XI(b) Thyroid carcinomas|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|22|XI(c) Nasopharyngeal carcinomas|58588724|0-14|All Races|Male and Female|1999|||
1.4|2.1|1.8|102|XI(d) Malignant melanomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|XI(e) Skin carcinomas|58588724|0-14|All Races|Male and Female|1999|||
1.2|1.9|1.5|89|XI(f) Other and unspecified carcinomas|58588724|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|30|XII Other and unspecified malignant neoplasms|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|XII(a) Other specified malignant tumors|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|58588724|0-14|All Races|Male and Female|1999|||
146.8|153.0|149.9|8809|All ICCC Groups Combined|58914904|0-14|All Races|Male and Female|2000|||
44.2|47.7|45.9|2695|I Leukemias, myeloproliferative & myelodysplastic diseases|58914904|0-14|All Races|Male and Female|2000|||
35.5|38.7|37.1|2174|I(a) Lymphoid leukemias|58914904|0-14|All Races|Male and Female|2000|||
5.9|7.3|6.6|387|I(b) Acute myeloid leukemias|58914904|0-14|All Races|Male and Female|2000|||
0.5|1.0|0.7|44|I(c) Chronic myeloproliferative diseases|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|58914904|0-14|All Races|Male and Female|2000|||
1.1|1.7|1.4|81|I(e) Unspecified and other specified leukemias|58914904|0-14|All Races|Male and Female|2000|||
15.5|17.6|16.5|976|II Lymphomas and reticuloendothelial neoplasms|58914904|0-14|All Races|Male and Female|2000|||
5.2|6.5|5.8|345|II(a) Hodgkin lymphomas|58914904|0-14|All Races|Male and Female|2000|||
5.4|6.6|6.0|353|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|58914904|0-14|All Races|Male and Female|2000|||
2.4|3.3|2.8|166|II(c) Burkitt lymphoma|58914904|0-14|All Races|Male and Female|2000|||
1.0|1.6|1.3|75|II(d) Miscellaneous lymphoreticular neoplasms|58914904|0-14|All Races|Male and Female|2000|||
0.4|0.9|0.6|37|II(e) Unspecified lymphomas|58914904|0-14|All Races|Male and Female|2000|||
31.7|34.7|33.2|1954|III CNS and misc intracranial and intraspinal neoplasms|58914904|0-14|All Races|Male and Female|2000|||
2.3|3.1|2.7|157|III(a) Ependymomas and choroid plexus tumor|58914904|0-14|All Races|Male and Female|2000|||
16.1|18.2|17.2|1010|III(b) Astrocytomas|58914904|0-14|All Races|Male and Female|2000|||
6.8|8.3|7.5|443|III(c) Intracranial and intraspinal embryonal tumors|58914904|0-14|All Races|Male and Female|2000|||
4.1|5.3|4.7|275|III(d) Other gliomas|58914904|0-14|All Races|Male and Female|2000|||
0.3|0.7|0.5|27|III(e) Other specified intracranial & intraspinal neoplasms|58914904|0-14|All Races|Male and Female|2000|||
0.5|1.0|0.7|42|III(f) Unspecified intracranial and intraspinal neoplasms|58914904|0-14|All Races|Male and Female|2000|||
9.3|10.9|10.1|588|IV Neuroblastoma and other peripheral nervous cell tumors|58914904|0-14|All Races|Male and Female|2000|||
9.1|10.8|9.9|580|IV(a) Neuroblastoma and ganglioneuroblastoma|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|58914904|0-14|All Races|Male and Female|2000|||
9.7|11.3|10.5|616|IX Soft tissue and other extraosseous sarcomas|58914904|0-14|All Races|Male and Female|2000|||
4.7|5.9|5.3|309|IX(a) Rhabdomyosarcomas|58914904|0-14|All Races|Male and Female|2000|||
0.7|1.2|1.0|56|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|IX(c) Kaposi sarcoma|58914904|0-14|All Races|Male and Female|2000|||
2.8|3.7|3.2|189|IX(d) Other specified soft tissue sarcomas|58914904|0-14|All Races|Male and Female|2000|||
0.8|1.3|1.0|61|IX(e) Unspecified soft tissue sarcomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|Not classified by ICCC|58914904|0-14|All Races|Male and Female|2000|||
3.9|5.0|4.4|256|V Retinoblastoma|58914904|0-14|All Races|Male and Female|2000|||
8.1|9.6|8.8|515|VI Renal tumors|58914904|0-14|All Races|Male and Female|2000|||
7.7|9.2|8.4|492|VI(a) Nephroblastoma and other nonepithelial renal tumors|58914904|0-14|All Races|Male and Female|2000|||
0.2|0.6|0.4|22|VI(b) Renal carcinomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|58914904|0-14|All Races|Male and Female|2000|||
1.8|2.6|2.2|129|VII Hepatic tumors|58914904|0-14|All Races|Male and Female|2000|||
1.6|2.3|1.9|113|VII(a) Hepatoblastoma|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VII(b) Hepatic carcinomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|58914904|0-14|All Races|Male and Female|2000|||
5.9|7.2|6.5|387|VIII Malignant bone tumors|58914904|0-14|All Races|Male and Female|2000|||
3.1|4.1|3.6|211|VIII(a) Osteosarcomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(b) Chondrosarcomas|58914904|0-14|All Races|Male and Female|2000|||
2.2|3.1|2.6|156|VIII(c) Ewing tumor and related sarcomas of bone|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|58914904|0-14|All Races|Male and Female|2000|||
4.4|5.5|4.9|291|X Germ cell, trophoblastic tumors & neoplasms of gonads|58914904|0-14|All Races|Male and Female|2000|||
1.2|1.8|1.5|86|X(a) Intracranial & intraspinal germ cell tumors|58914904|0-14|All Races|Male and Female|2000|||
0.9|1.4|1.1|66|X(b) Malignant extracranial & extragonadal germ cell tumors|58914904|0-14|All Races|Male and Female|2000|||
1.8|2.6|2.2|128|X(c) Malignant gonadal germ cell tumors|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|X(d) Gonadal carcinomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|58914904|0-14|All Races|Male and Female|2000|||
5.2|6.5|5.8|344|XI Other malignant epithelial neoplasms and malignant melanomas|58914904|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|18|XI(a) Adrenocortical carcinomas|58914904|0-14|All Races|Male and Female|2000|||
1.6|2.3|1.9|114|XI(b) Thyroid carcinomas|58914904|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|58914904|0-14|All Races|Male and Female|2000|||
1.5|2.2|1.8|105|XI(d) Malignant melanomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|XI(e) Skin carcinomas|58914904|0-14|All Races|Male and Female|2000|||
1.1|1.8|1.4|85|XI(f) Other and unspecified carcinomas|58914904|0-14|All Races|Male and Female|2000|||
0.5|1.0|0.7|44|XII Other and unspecified malignant neoplasms|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|XII(a) Other specified malignant tumors|58914904|0-14|All Races|Male and Female|2000|||
0.4|0.7|0.5|31|XII(b) Other unspecified malignant tumors|58914904|0-14|All Races|Male and Female|2000|||
153.0|159.3|156.1|9331|All ICCC Groups Combined|59815030|0-14|All Races|Male and Female|2001|||
48.7|52.3|50.5|3002|I Leukemias, myeloproliferative & myelodysplastic diseases|59815030|0-14|All Races|Male and Female|2001|||
37.1|40.3|38.7|2294|I(a) Lymphoid leukemias|59815030|0-14|All Races|Male and Female|2001|||
6.6|8.0|7.3|437|I(b) Acute myeloid leukemias|59815030|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.7|100|I(c) Chronic myeloproliferative diseases|59815030|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.6|96|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|59815030|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|75|I(e) Unspecified and other specified leukemias|59815030|0-14|All Races|Male and Female|2001|||
15.0|17.1|16.0|964|II Lymphomas and reticuloendothelial neoplasms|59815030|0-14|All Races|Male and Female|2001|||
5.3|6.5|5.9|356|II(a) Hodgkin lymphomas|59815030|0-14|All Races|Male and Female|2001|||
5.8|7.1|6.5|388|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|59815030|0-14|All Races|Male and Female|2001|||
1.9|2.7|2.3|135|II(c) Burkitt lymphoma|59815030|0-14|All Races|Male and Female|2001|||
0.8|1.3|1.0|61|II(d) Miscellaneous lymphoreticular neoplasms|59815030|0-14|All Races|Male and Female|2001|||
0.3|0.6|0.4|24|II(e) Unspecified lymphomas|59815030|0-14|All Races|Male and Female|2001|||
31.4|34.3|32.9|1960|III CNS and misc intracranial and intraspinal neoplasms|59815030|0-14|All Races|Male and Female|2001|||
2.4|3.2|2.8|166|III(a) Ependymomas and choroid plexus tumor|59815030|0-14|All Races|Male and Female|2001|||
15.3|17.4|16.3|975|III(b) Astrocytomas|59815030|0-14|All Races|Male and Female|2001|||
6.6|8.0|7.3|435|III(c) Intracranial and intraspinal embryonal tumors|59815030|0-14|All Races|Male and Female|2001|||
4.8|6.0|5.4|321|III(d) Other gliomas|59815030|0-14|All Races|Male and Female|2001|||
0.5|0.9|0.7|42|III(e) Other specified intracranial & intraspinal neoplasms|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|21|III(f) Unspecified intracranial and intraspinal neoplasms|59815030|0-14|All Races|Male and Female|2001|||
10.7|12.5|11.6|693|IV Neuroblastoma and other peripheral nervous cell tumors|59815030|0-14|All Races|Male and Female|2001|||
10.6|12.3|11.4|685|IV(a) Neuroblastoma and ganglioneuroblastoma|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|59815030|0-14|All Races|Male and Female|2001|||
9.7|11.3|10.5|629|IX Soft tissue and other extraosseous sarcomas|59815030|0-14|All Races|Male and Female|2001|||
4.6|5.8|5.2|308|IX(a) Rhabdomyosarcomas|59815030|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|76|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|IX(c) Kaposi sarcoma|59815030|0-14|All Races|Male and Female|2001|||
2.6|3.5|3.1|185|IX(d) Other specified soft tissue sarcomas|59815030|0-14|All Races|Male and Female|2001|||
0.8|1.3|1.0|60|IX(e) Unspecified soft tissue sarcomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|Not classified by ICCC|59815030|0-14|All Races|Male and Female|2001|||
3.9|5.0|4.4|266|V Retinoblastoma|59815030|0-14|All Races|Male and Female|2001|||
7.9|9.4|8.6|510|VI Renal tumors|59815030|0-14|All Races|Male and Female|2001|||
7.5|9.0|8.2|488|VI(a) Nephroblastoma and other nonepithelial renal tumors|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|59815030|0-14|All Races|Male and Female|2001|||
1.8|2.5|2.1|126|VII Hepatic tumors|59815030|0-14|All Races|Male and Female|2001|||
1.4|2.0|1.7|100|VII(a) Hepatoblastoma|59815030|0-14|All Races|Male and Female|2001|||
0.3|0.6|0.4|25|VII(b) Hepatic carcinomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|59815030|0-14|All Races|Male and Female|2001|||
6.3|7.7|7.0|422|VIII Malignant bone tumors|59815030|0-14|All Races|Male and Female|2001|||
3.3|4.3|3.8|231|VIII(a) Osteosarcomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(b) Chondrosarcomas|59815030|0-14|All Races|Male and Female|2001|||
2.3|3.1|2.7|160|VIII(c) Ewing tumor and related sarcomas of bone|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|59815030|0-14|All Races|Male and Female|2001|||
4.5|5.6|5.0|303|X Germ cell, trophoblastic tumors & neoplasms of gonads|59815030|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|79|X(a) Intracranial & intraspinal germ cell tumors|59815030|0-14|All Races|Male and Female|2001|||
1.1|1.7|1.4|84|X(b) Malignant extracranial & extragonadal germ cell tumors|59815030|0-14|All Races|Male and Female|2001|||
1.7|2.4|2.0|121|X(c) Malignant gonadal germ cell tumors|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|X(d) Gonadal carcinomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|59815030|0-14|All Races|Male and Female|2001|||
6.0|7.3|6.6|400|XI Other malignant epithelial neoplasms and malignant melanomas|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|17|XI(a) Adrenocortical carcinomas|59815030|0-14|All Races|Male and Female|2001|||
1.9|2.7|2.3|140|XI(b) Thyroid carcinomas|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|59815030|0-14|All Races|Male and Female|2001|||
1.7|2.4|2.0|121|XI(d) Malignant melanomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|XI(e) Skin carcinomas|59815030|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.7|100|XI(f) Other and unspecified carcinomas|59815030|0-14|All Races|Male and Female|2001|||
0.5|1.0|0.7|43|XII Other and unspecified malignant neoplasms|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.6|0.4|22|XII(a) Other specified malignant tumors|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.4|21|XII(b) Other unspecified malignant tumors|59815030|0-14|All Races|Male and Female|2001|||
152.0|158.3|155.1|9296|All ICCC Groups Combined|59931314|0-14|All Races|Male and Female|2002|||
47.7|51.2|49.4|2950|I Leukemias, myeloproliferative & myelodysplastic diseases|59931314|0-14|All Races|Male and Female|2002|||
35.5|38.6|37.0|2204|I(a) Lymphoid leukemias|59931314|0-14|All Races|Male and Female|2002|||
7.2|8.6|7.9|475|I(b) Acute myeloid leukemias|59931314|0-14|All Races|Male and Female|2002|||
1.3|1.9|1.6|95|I(c) Chronic myeloproliferative diseases|59931314|0-14|All Races|Male and Female|2002|||
1.3|2.0|1.6|96|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|59931314|0-14|All Races|Male and Female|2002|||
1.1|1.7|1.3|80|I(e) Unspecified and other specified leukemias|59931314|0-14|All Races|Male and Female|2002|||
14.7|16.7|15.7|947|II Lymphomas and reticuloendothelial neoplasms|59931314|0-14|All Races|Male and Female|2002|||
4.9|6.1|5.5|336|II(a) Hodgkin lymphomas|59931314|0-14|All Races|Male and Female|2002|||
5.5|6.7|6.1|366|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|59931314|0-14|All Races|Male and Female|2002|||
2.3|3.2|2.7|164|II(c) Burkitt lymphoma|59931314|0-14|All Races|Male and Female|2002|||
0.9|1.5|1.1|69|II(d) Miscellaneous lymphoreticular neoplasms|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|II(e) Unspecified lymphomas|59931314|0-14|All Races|Male and Female|2002|||
33.1|36.1|34.6|2064|III CNS and misc intracranial and intraspinal neoplasms|59931314|0-14|All Races|Male and Female|2002|||
3.1|4.1|3.6|215|III(a) Ependymomas and choroid plexus tumor|59931314|0-14|All Races|Male and Female|2002|||
15.4|17.5|16.4|983|III(b) Astrocytomas|59931314|0-14|All Races|Male and Female|2002|||
6.8|8.2|7.4|443|III(c) Intracranial and intraspinal embryonal tumors|59931314|0-14|All Races|Male and Female|2002|||
5.4|6.6|6.0|355|III(d) Other gliomas|59931314|0-14|All Races|Male and Female|2002|||
0.5|1.0|0.7|43|III(e) Other specified intracranial & intraspinal neoplasms|59931314|0-14|All Races|Male and Female|2002|||
0.3|0.6|0.4|25|III(f) Unspecified intracranial and intraspinal neoplasms|59931314|0-14|All Races|Male and Female|2002|||
10.2|11.9|11.1|662|IV Neuroblastoma and other peripheral nervous cell tumors|59931314|0-14|All Races|Male and Female|2002|||
10.1|11.8|10.9|654|IV(a) Neuroblastoma and ganglioneuroblastoma|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|59931314|0-14|All Races|Male and Female|2002|||
10.0|11.7|10.8|649|IX Soft tissue and other extraosseous sarcomas|59931314|0-14|All Races|Male and Female|2002|||
4.8|6.0|5.3|319|IX(a) Rhabdomyosarcomas|59931314|0-14|All Races|Male and Female|2002|||
0.9|1.4|1.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|IX(c) Kaposi sarcoma|59931314|0-14|All Races|Male and Female|2002|||
3.0|3.9|3.4|207|IX(d) Other specified soft tissue sarcomas|59931314|0-14|All Races|Male and Female|2002|||
0.7|1.2|0.9|54|IX(e) Unspecified soft tissue sarcomas|59931314|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.4|21|Not classified by ICCC|59931314|0-14|All Races|Male and Female|2002|||
3.3|4.3|3.8|225|V Retinoblastoma|59931314|0-14|All Races|Male and Female|2002|||
7.6|9.1|8.3|493|VI Renal tumors|59931314|0-14|All Races|Male and Female|2002|||
7.3|8.8|8.1|479|VI(a) Nephroblastoma and other nonepithelial renal tumors|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|VI(b) Renal carcinomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|59931314|0-14|All Races|Male and Female|2002|||
1.6|2.3|1.9|114|VII Hepatic tumors|59931314|0-14|All Races|Male and Female|2002|||
1.2|1.9|1.5|92|VII(a) Hepatoblastoma|59931314|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|21|VII(b) Hepatic carcinomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|59931314|0-14|All Races|Male and Female|2002|||
6.2|7.5|6.8|415|VIII Malignant bone tumors|59931314|0-14|All Races|Male and Female|2002|||
3.2|4.2|3.6|222|VIII(a) Osteosarcomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|VIII(b) Chondrosarcomas|59931314|0-14|All Races|Male and Female|2002|||
2.2|3.0|2.6|157|VIII(c) Ewing tumor and related sarcomas of bone|59931314|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|21|VIII(d) Other specified malignant bone tumors|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|59931314|0-14|All Races|Male and Female|2002|||
4.7|5.9|5.2|318|X Germ cell, trophoblastic tumors & neoplasms of gonads|59931314|0-14|All Races|Male and Female|2002|||
1.1|1.7|1.4|85|X(a) Intracranial & intraspinal germ cell tumors|59931314|0-14|All Races|Male and Female|2002|||
1.2|1.8|1.5|88|X(b) Malignant extracranial & extragonadal germ cell tumors|59931314|0-14|All Races|Male and Female|2002|||
1.9|2.6|2.2|134|X(c) Malignant gonadal germ cell tumors|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|X(d) Gonadal carcinomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|59931314|0-14|All Races|Male and Female|2002|||
6.0|7.3|6.6|402|XI Other malignant epithelial neoplasms and malignant melanomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(a) Adrenocortical carcinomas|59931314|0-14|All Races|Male and Female|2002|||
1.7|2.4|2.0|124|XI(b) Thyroid carcinomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|59931314|0-14|All Races|Male and Female|2002|||
2.0|2.7|2.3|141|XI(d) Malignant melanomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(e) Skin carcinomas|59931314|0-14|All Races|Male and Female|2002|||
1.4|2.0|1.7|103|XI(f) Other and unspecified carcinomas|59931314|0-14|All Races|Male and Female|2002|||
0.4|0.8|0.6|36|XII Other and unspecified malignant neoplasms|59931314|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|21|XII(a) Other specified malignant tumors|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|XII(b) Other unspecified malignant tumors|59931314|0-14|All Races|Male and Female|2002|||
149.2|155.4|152.3|9254|All ICCC Groups Combined|60628650|0-14|All Races|Male and Female|2003|||
46.0|49.5|47.7|2884|I Leukemias, myeloproliferative & myelodysplastic diseases|60628650|0-14|All Races|Male and Female|2003|||
34.5|37.5|36.0|2167|I(a) Lymphoid leukemias|60628650|0-14|All Races|Male and Female|2003|||
6.8|8.2|7.5|457|I(b) Acute myeloid leukemias|60628650|0-14|All Races|Male and Female|2003|||
1.2|1.8|1.5|90|I(c) Chronic myeloproliferative diseases|60628650|0-14|All Races|Male and Female|2003|||
1.5|2.2|1.8|111|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60628650|0-14|All Races|Male and Female|2003|||
0.7|1.3|1.0|59|I(e) Unspecified and other specified leukemias|60628650|0-14|All Races|Male and Female|2003|||
15.2|17.2|16.2|987|II Lymphomas and reticuloendothelial neoplasms|60628650|0-14|All Races|Male and Female|2003|||
5.3|6.5|5.9|363|II(a) Hodgkin lymphomas|60628650|0-14|All Races|Male and Female|2003|||
5.7|7.0|6.3|385|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60628650|0-14|All Races|Male and Female|2003|||
2.3|3.2|2.7|163|II(c) Burkitt lymphoma|60628650|0-14|All Races|Male and Female|2003|||
0.9|1.5|1.2|70|II(d) Miscellaneous lymphoreticular neoplasms|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|II(e) Unspecified lymphomas|60628650|0-14|All Races|Male and Female|2003|||
31.5|34.4|32.9|1989|III CNS and misc intracranial and intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003|||
2.1|2.9|2.5|151|III(a) Ependymomas and choroid plexus tumor|60628650|0-14|All Races|Male and Female|2003|||
15.3|17.4|16.3|990|III(b) Astrocytomas|60628650|0-14|All Races|Male and Female|2003|||
6.6|7.9|7.2|435|III(c) Intracranial and intraspinal embryonal tumors|60628650|0-14|All Races|Male and Female|2003|||
5.0|6.2|5.6|340|III(d) Other gliomas|60628650|0-14|All Races|Male and Female|2003|||
0.6|1.1|0.9|52|III(e) Other specified intracranial & intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|21|III(f) Unspecified intracranial and intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003|||
9.9|11.6|10.7|653|IV Neuroblastoma and other peripheral nervous cell tumors|60628650|0-14|All Races|Male and Female|2003|||
9.8|11.4|10.6|643|IV(a) Neuroblastoma and ganglioneuroblastoma|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60628650|0-14|All Races|Male and Female|2003|||
9.9|11.5|10.7|651|IX Soft tissue and other extraosseous sarcomas|60628650|0-14|All Races|Male and Female|2003|||
4.5|5.7|5.1|306|IX(a) Rhabdomyosarcomas|60628650|0-14|All Races|Male and Female|2003|||
0.8|1.3|1.1|64|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|IX(c) Kaposi sarcoma|60628650|0-14|All Races|Male and Female|2003|||
3.1|4.1|3.6|221|IX(d) Other specified soft tissue sarcomas|60628650|0-14|All Races|Male and Female|2003|||
0.7|1.2|0.9|58|IX(e) Unspecified soft tissue sarcomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|Not classified by ICCC|60628650|0-14|All Races|Male and Female|2003|||
3.6|4.6|4.1|250|V Retinoblastoma|60628650|0-14|All Races|Male and Female|2003|||
7.8|9.3|8.6|517|VI Renal tumors|60628650|0-14|All Races|Male and Female|2003|||
7.4|8.9|8.2|492|VI(a) Nephroblastoma and other nonepithelial renal tumors|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|21|VI(b) Renal carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60628650|0-14|All Races|Male and Female|2003|||
2.1|2.9|2.5|152|VII Hepatic tumors|60628650|0-14|All Races|Male and Female|2003|||
1.7|2.4|2.0|124|VII(a) Hepatoblastoma|60628650|0-14|All Races|Male and Female|2003|||
0.3|0.7|0.5|28|VII(b) Hepatic carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60628650|0-14|All Races|Male and Female|2003|||
6.0|7.3|6.6|408|VIII Malignant bone tumors|60628650|0-14|All Races|Male and Female|2003|||
3.2|4.2|3.7|227|VIII(a) Osteosarcomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VIII(b) Chondrosarcomas|60628650|0-14|All Races|Male and Female|2003|||
1.9|2.6|2.2|137|VIII(c) Ewing tumor and related sarcomas of bone|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.4|0.3|17|VIII(d) Other specified malignant bone tumors|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60628650|0-14|All Races|Male and Female|2003|||
4.5|5.7|5.1|313|X Germ cell, trophoblastic tumors & neoplasms of gonads|60628650|0-14|All Races|Male and Female|2003|||
0.9|1.5|1.2|73|X(a) Intracranial & intraspinal germ cell tumors|60628650|0-14|All Races|Male and Female|2003|||
1.2|1.8|1.4|88|X(b) Malignant extracranial & extragonadal germ cell tumors|60628650|0-14|All Races|Male and Female|2003|||
1.8|2.6|2.2|136|X(c) Malignant gonadal germ cell tumors|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|X(d) Gonadal carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60628650|0-14|All Races|Male and Female|2003|||
5.7|6.9|6.3|390|XI Other malignant epithelial neoplasms and malignant melanomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60628650|0-14|All Races|Male and Female|2003|||
1.8|2.6|2.2|134|XI(b) Thyroid carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60628650|0-14|All Races|Male and Female|2003|||
1.6|2.3|1.9|119|XI(d) Malignant melanomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(e) Skin carcinomas|60628650|0-14|All Races|Male and Female|2003|||
1.5|2.1|1.8|110|XI(f) Other and unspecified carcinomas|60628650|0-14|All Races|Male and Female|2003|||
0.6|1.0|0.8|47|XII Other and unspecified malignant neoplasms|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|60628650|0-14|All Races|Male and Female|2003|||
0.3|0.6|0.4|27|XII(b) Other unspecified malignant tumors|60628650|0-14|All Races|Male and Female|2003|||
156.8|163.2|159.9|9742|All ICCC Groups Combined|60651802|0-14|All Races|Male and Female|2004|||
49.4|53.1|51.2|3107|I Leukemias, myeloproliferative & myelodysplastic diseases|60651802|0-14|All Races|Male and Female|2004|||
37.3|40.4|38.8|2350|I(a) Lymphoid leukemias|60651802|0-14|All Races|Male and Female|2004|||
7.2|8.7|7.9|485|I(b) Acute myeloid leukemias|60651802|0-14|All Races|Male and Female|2004|||
1.3|1.9|1.6|96|I(c) Chronic myeloproliferative diseases|60651802|0-14|All Races|Male and Female|2004|||
1.2|1.9|1.5|93|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.7|1.4|83|I(e) Unspecified and other specified leukemias|60651802|0-14|All Races|Male and Female|2004|||
15.1|17.1|16.1|982|II Lymphomas and reticuloendothelial neoplasms|60651802|0-14|All Races|Male and Female|2004|||
4.7|5.9|5.3|324|II(a) Hodgkin lymphomas|60651802|0-14|All Races|Male and Female|2004|||
6.2|7.6|6.9|419|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60651802|0-14|All Races|Male and Female|2004|||
2.1|2.9|2.4|147|II(c) Burkitt lymphoma|60651802|0-14|All Races|Male and Female|2004|||
1.0|1.6|1.3|80|II(d) Miscellaneous lymphoreticular neoplasms|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|II(e) Unspecified lymphomas|60651802|0-14|All Races|Male and Female|2004|||
33.6|36.6|35.1|2124|III CNS and misc intracranial and intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
2.6|3.4|3.0|181|III(a) Ependymomas and choroid plexus tumor|60651802|0-14|All Races|Male and Female|2004|||
16.5|18.7|17.6|1064|III(b) Astrocytomas|60651802|0-14|All Races|Male and Female|2004|||
7.1|8.5|7.8|471|III(c) Intracranial and intraspinal embryonal tumors|60651802|0-14|All Races|Male and Female|2004|||
4.8|6.0|5.4|324|III(d) Other gliomas|60651802|0-14|All Races|Male and Female|2004|||
0.6|1.1|0.8|49|III(e) Other specified intracranial & intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
0.4|0.8|0.6|35|III(f) Unspecified intracranial and intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
10.2|11.9|11.1|678|IV Neuroblastoma and other peripheral nervous cell tumors|60651802|0-14|All Races|Male and Female|2004|||
10.0|11.7|10.8|663|IV(a) Neuroblastoma and ganglioneuroblastoma|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60651802|0-14|All Races|Male and Female|2004|||
9.8|11.4|10.6|646|IX Soft tissue and other extraosseous sarcomas|60651802|0-14|All Races|Male and Female|2004|||
4.1|5.2|4.6|282|IX(a) Rhabdomyosarcomas|60651802|0-14|All Races|Male and Female|2004|||
1.0|1.5|1.2|76|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|IX(c) Kaposi sarcoma|60651802|0-14|All Races|Male and Female|2004|||
3.2|4.2|3.6|224|IX(d) Other specified soft tissue sarcomas|60651802|0-14|All Races|Male and Female|2004|||
0.8|1.3|1.0|62|IX(e) Unspecified soft tissue sarcomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|Not classified by ICCC|60651802|0-14|All Races|Male and Female|2004|||
3.8|4.9|4.3|266|V Retinoblastoma|60651802|0-14|All Races|Male and Female|2004|||
7.4|8.9|8.1|495|VI Renal tumors|60651802|0-14|All Races|Male and Female|2004|||
7.1|8.5|7.8|472|VI(a) Nephroblastoma and other nonepithelial renal tumors|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.6|0.4|23|VI(b) Renal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60651802|0-14|All Races|Male and Female|2004|||
2.3|3.1|2.7|163|VII Hepatic tumors|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.8|2.3|144|VII(a) Hepatoblastoma|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VII(b) Hepatic carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60651802|0-14|All Races|Male and Female|2004|||
6.5|7.8|7.1|437|VIII Malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
3.6|4.7|4.1|254|VIII(a) Osteosarcomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|17|VIII(b) Chondrosarcomas|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.7|2.3|143|VIII(c) Ewing tumor and related sarcomas of bone|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
5.0|6.2|5.6|347|X Germ cell, trophoblastic tumors & neoplasms of gonads|60651802|0-14|All Races|Male and Female|2004|||
1.3|1.9|1.6|96|X(a) Intracranial & intraspinal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.7|1.3|83|X(b) Malignant extracranial & extragonadal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.8|2.4|148|X(c) Malignant gonadal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|X(d) Gonadal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60651802|0-14|All Races|Male and Female|2004|||
6.5|7.9|7.2|440|XI Other malignant epithelial neoplasms and malignant melanomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|16|XI(a) Adrenocortical carcinomas|60651802|0-14|All Races|Male and Female|2004|||
2.2|3.1|2.6|161|XI(b) Thyroid carcinomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.6|0.4|24|XI(c) Nasopharyngeal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
2.1|2.9|2.4|150|XI(d) Malignant melanomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|XI(e) Skin carcinomas|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.7|1.4|83|XI(f) Other and unspecified carcinomas|60651802|0-14|All Races|Male and Female|2004|||
0.5|0.9|0.7|43|XII Other and unspecified malignant neoplasms|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.3|18|XII(a) Other specified malignant tumors|60651802|0-14|All Races|Male and Female|2004|||
0.3|0.6|0.4|25|XII(b) Other unspecified malignant tumors|60651802|0-14|All Races|Male and Female|2004|||
152.8|159.1|155.9|9489|All ICCC Groups Combined|60519046|0-14|All Races|Male and Female|2005|||
47.5|51.0|49.2|2991|I Leukemias, myeloproliferative & myelodysplastic diseases|60519046|0-14|All Races|Male and Female|2005|||
35.9|39.0|37.5|2272|I(a) Lymphoid leukemias|60519046|0-14|All Races|Male and Female|2005|||
6.6|8.0|7.3|445|I(b) Acute myeloid leukemias|60519046|0-14|All Races|Male and Female|2005|||
1.1|1.8|1.4|87|I(c) Chronic myeloproliferative diseases|60519046|0-14|All Races|Male and Female|2005|||
1.4|2.0|1.7|101|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60519046|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|86|I(e) Unspecified and other specified leukemias|60519046|0-14|All Races|Male and Female|2005|||
15.6|17.7|16.6|1013|II Lymphomas and reticuloendothelial neoplasms|60519046|0-14|All Races|Male and Female|2005|||
5.3|6.5|5.9|360|II(a) Hodgkin lymphomas|60519046|0-14|All Races|Male and Female|2005|||
5.8|7.1|6.4|391|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60519046|0-14|All Races|Male and Female|2005|||
2.2|3.0|2.6|155|II(c) Burkitt lymphoma|60519046|0-14|All Races|Male and Female|2005|||
1.2|1.9|1.5|93|II(d) Miscellaneous lymphoreticular neoplasms|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|II(e) Unspecified lymphomas|60519046|0-14|All Races|Male and Female|2005|||
31.7|34.6|33.1|2001|III CNS and misc intracranial and intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
2.9|3.8|3.3|200|III(a) Ependymomas and choroid plexus tumor|60519046|0-14|All Races|Male and Female|2005|||
15.7|17.7|16.7|1009|III(b) Astrocytomas|60519046|0-14|All Races|Male and Female|2005|||
6.3|7.7|7.0|422|III(c) Intracranial and intraspinal embryonal tumors|60519046|0-14|All Races|Male and Female|2005|||
4.5|5.7|5.1|306|III(d) Other gliomas|60519046|0-14|All Races|Male and Female|2005|||
0.4|0.8|0.6|35|III(e) Other specified intracranial & intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
0.3|0.7|0.5|29|III(f) Unspecified intracranial and intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
11.0|12.7|11.8|726|IV Neuroblastoma and other peripheral nervous cell tumors|60519046|0-14|All Races|Male and Female|2005|||
10.8|12.5|11.7|717|IV(a) Neuroblastoma and ganglioneuroblastoma|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60519046|0-14|All Races|Male and Female|2005|||
9.8|11.5|10.6|644|IX Soft tissue and other extraosseous sarcomas|60519046|0-14|All Races|Male and Female|2005|||
4.7|5.9|5.3|320|IX(a) Rhabdomyosarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.9|1.4|1.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|IX(c) Kaposi sarcoma|60519046|0-14|All Races|Male and Female|2005|||
2.9|3.8|3.3|203|IX(d) Other specified soft tissue sarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.6|1.1|0.8|50|IX(e) Unspecified soft tissue sarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|18|Not classified by ICCC|60519046|0-14|All Races|Male and Female|2005|||
3.4|4.4|3.9|241|V Retinoblastoma|60519046|0-14|All Races|Male and Female|2005|||
7.5|9.0|8.2|500|VI Renal tumors|60519046|0-14|All Races|Male and Female|2005|||
7.1|8.6|7.8|477|VI(a) Nephroblastoma and other nonepithelial renal tumors|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60519046|0-14|All Races|Male and Female|2005|||
2.0|2.8|2.4|145|VII Hepatic tumors|60519046|0-14|All Races|Male and Female|2005|||
1.6|2.3|1.9|116|VII(a) Hepatoblastoma|60519046|0-14|All Races|Male and Female|2005|||
0.3|0.6|0.4|27|VII(b) Hepatic carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60519046|0-14|All Races|Male and Female|2005|||
6.2|7.5|6.8|415|VIII Malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
3.3|4.2|3.7|227|VIII(a) Osteosarcomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VIII(b) Chondrosarcomas|60519046|0-14|All Races|Male and Female|2005|||
2.0|2.8|2.4|147|VIII(c) Ewing tumor and related sarcomas of bone|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
4.9|6.1|5.5|338|X Germ cell, trophoblastic tumors & neoplasms of gonads|60519046|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|83|X(a) Intracranial & intraspinal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
1.3|2.0|1.6|100|X(b) Malignant extracranial & extragonadal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
1.9|2.6|2.2|138|X(c) Malignant gonadal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|X(d) Gonadal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60519046|0-14|All Races|Male and Female|2005|||
6.2|7.6|6.9|421|XI Other malignant epithelial neoplasms and malignant melanomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60519046|0-14|All Races|Male and Female|2005|||
1.9|2.6|2.2|137|XI(b) Thyroid carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
2.0|2.8|2.4|147|XI(d) Malignant melanomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(e) Skin carcinomas|60519046|0-14|All Races|Male and Female|2005|||
1.5|2.2|1.9|114|XI(f) Other and unspecified carcinomas|60519046|0-14|All Races|Male and Female|2005|||
0.4|0.8|0.6|36|XII Other and unspecified malignant neoplasms|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|19|XII(a) Other specified malignant tumors|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|17|XII(b) Other unspecified malignant tumors|60519046|0-14|All Races|Male and Female|2005|||
155.8|162.1|158.9|9672|All ICCC Groups Combined|60516709|0-14|All Races|Male and Female|2006|||
49.8|53.5|51.6|3138|I Leukemias, myeloproliferative & myelodysplastic diseases|60516709|0-14|All Races|Male and Female|2006|||
37.3|40.5|38.9|2359|I(a) Lymphoid leukemias|60516709|0-14|All Races|Male and Female|2006|||
7.2|8.6|7.9|481|I(b) Acute myeloid leukemias|60516709|0-14|All Races|Male and Female|2006|||
1.4|2.1|1.8|107|I(c) Chronic myeloproliferative diseases|60516709|0-14|All Races|Male and Female|2006|||
1.5|2.2|1.8|109|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60516709|0-14|All Races|Male and Female|2006|||
1.1|1.7|1.3|82|I(e) Unspecified and other specified leukemias|60516709|0-14|All Races|Male and Female|2006|||
15.7|17.8|16.8|1017|II Lymphomas and reticuloendothelial neoplasms|60516709|0-14|All Races|Male and Female|2006|||
5.5|6.8|6.2|374|II(a) Hodgkin lymphomas|60516709|0-14|All Races|Male and Female|2006|||
5.8|7.1|6.4|390|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60516709|0-14|All Races|Male and Female|2006|||
2.1|2.9|2.5|151|II(c) Burkitt lymphoma|60516709|0-14|All Races|Male and Female|2006|||
1.2|1.8|1.5|90|II(d) Miscellaneous lymphoreticular neoplasms|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|II(e) Unspecified lymphomas|60516709|0-14|All Races|Male and Female|2006|||
32.6|35.6|34.1|2063|III CNS and misc intracranial and intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
2.6|3.5|3.1|186|III(a) Ependymomas and choroid plexus tumor|60516709|0-14|All Races|Male and Female|2006|||
15.4|17.5|16.4|995|III(b) Astrocytomas|60516709|0-14|All Races|Male and Female|2006|||
7.0|8.4|7.7|466|III(c) Intracranial and intraspinal embryonal tumors|60516709|0-14|All Races|Male and Female|2006|||
5.1|6.4|5.7|344|III(d) Other gliomas|60516709|0-14|All Races|Male and Female|2006|||
0.3|0.7|0.5|31|III(e) Other specified intracranial & intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
0.5|0.9|0.7|41|III(f) Unspecified intracranial and intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
9.5|11.2|10.3|636|IV Neuroblastoma and other peripheral nervous cell tumors|60516709|0-14|All Races|Male and Female|2006|||
9.4|11.1|10.2|630|IV(a) Neuroblastoma and ganglioneuroblastoma|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60516709|0-14|All Races|Male and Female|2006|||
9.8|11.5|10.6|646|IX Soft tissue and other extraosseous sarcomas|60516709|0-14|All Races|Male and Female|2006|||
4.4|5.5|4.9|297|IX(a) Rhabdomyosarcomas|60516709|0-14|All Races|Male and Female|2006|||
0.8|1.4|1.1|67|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|IX(c) Kaposi sarcoma|60516709|0-14|All Races|Male and Female|2006|||
3.1|4.0|3.5|214|IX(d) Other specified soft tissue sarcomas|60516709|0-14|All Races|Male and Female|2006|||
0.8|1.4|1.1|66|IX(e) Unspecified soft tissue sarcomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|Not classified by ICCC|60516709|0-14|All Races|Male and Female|2006|||
3.6|4.6|4.1|253|V Retinoblastoma|60516709|0-14|All Races|Male and Female|2006|||
7.6|9.0|8.3|505|VI Renal tumors|60516709|0-14|All Races|Male and Female|2006|||
7.2|8.6|7.9|480|VI(a) Nephroblastoma and other nonepithelial renal tumors|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60516709|0-14|All Races|Male and Female|2006|||
2.2|3.0|2.6|160|VII Hepatic tumors|60516709|0-14|All Races|Male and Female|2006|||
1.8|2.5|2.1|133|VII(a) Hepatoblastoma|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.6|0.4|23|VII(b) Hepatic carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60516709|0-14|All Races|Male and Female|2006|||
6.4|7.7|7.0|424|VIII Malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
3.5|4.5|4.0|242|VIII(a) Osteosarcomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VIII(b) Chondrosarcomas|60516709|0-14|All Races|Male and Female|2006|||
2.0|2.9|2.4|146|VIII(c) Ewing tumor and related sarcomas of bone|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
4.6|5.7|5.1|314|X Germ cell, trophoblastic tumors & neoplasms of gonads|60516709|0-14|All Races|Male and Female|2006|||
1.0|1.6|1.3|77|X(a) Intracranial & intraspinal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
1.2|1.9|1.5|95|X(b) Malignant extracranial & extragonadal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
1.7|2.5|2.1|126|X(c) Malignant gonadal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|X(d) Gonadal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60516709|0-14|All Races|Male and Female|2006|||
6.9|8.3|7.5|460|XI Other malignant epithelial neoplasms and malignant melanomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60516709|0-14|All Races|Male and Female|2006|||
2.3|3.1|2.7|163|XI(b) Thyroid carcinomas|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|XI(c) Nasopharyngeal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
2.0|2.8|2.4|147|XI(d) Malignant melanomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|XI(e) Skin carcinomas|60516709|0-14|All Races|Male and Female|2006|||
1.5|2.2|1.9|113|XI(f) Other and unspecified carcinomas|60516709|0-14|All Races|Male and Female|2006|||
0.5|1.0|0.7|45|XII Other and unspecified malignant neoplasms|60516709|0-14|All Races|Male and Female|2006|||
0.3|0.6|0.4|27|XII(a) Other specified malignant tumors|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|XII(b) Other unspecified malignant tumors|60516709|0-14|All Races|Male and Female|2006|||
159.1|165.5|162.3|9918|All ICCC Groups Combined|60681615|0-14|All Races|Male and Female|2007|||
50.4|54.0|52.2|3183|I Leukemias, myeloproliferative & myelodysplastic diseases|60681615|0-14|All Races|Male and Female|2007|||
38.5|41.7|40.0|2439|I(a) Lymphoid leukemias|60681615|0-14|All Races|Male and Female|2007|||
7.0|8.4|7.7|473|I(b) Acute myeloid leukemias|60681615|0-14|All Races|Male and Female|2007|||
1.4|2.0|1.7|102|I(c) Chronic myeloproliferative diseases|60681615|0-14|All Races|Male and Female|2007|||
1.3|1.9|1.6|97|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60681615|0-14|All Races|Male and Female|2007|||
0.9|1.5|1.2|72|I(e) Unspecified and other specified leukemias|60681615|0-14|All Races|Male and Female|2007|||
15.7|17.8|16.7|1012|II Lymphomas and reticuloendothelial neoplasms|60681615|0-14|All Races|Male and Female|2007|||
4.9|6.1|5.5|332|II(a) Hodgkin lymphomas|60681615|0-14|All Races|Male and Female|2007|||
6.4|7.7|7.0|425|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60681615|0-14|All Races|Male and Female|2007|||
2.3|3.1|2.7|160|II(c) Burkitt lymphoma|60681615|0-14|All Races|Male and Female|2007|||
1.0|1.6|1.3|82|II(d) Miscellaneous lymphoreticular neoplasms|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|II(e) Unspecified lymphomas|60681615|0-14|All Races|Male and Female|2007|||
33.9|36.9|35.4|2150|III CNS and misc intracranial and intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
2.5|3.4|2.9|178|III(a) Ependymomas and choroid plexus tumor|60681615|0-14|All Races|Male and Female|2007|||
15.9|18.0|16.9|1027|III(b) Astrocytomas|60681615|0-14|All Races|Male and Female|2007|||
7.1|8.5|7.7|471|III(c) Intracranial and intraspinal embryonal tumors|60681615|0-14|All Races|Male and Female|2007|||
5.9|7.2|6.5|396|III(d) Other gliomas|60681615|0-14|All Races|Male and Female|2007|||
0.6|1.0|0.8|46|III(e) Other specified intracranial & intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
0.4|0.7|0.5|32|III(f) Unspecified intracranial and intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
10.9|12.7|11.8|735|IV Neuroblastoma and other peripheral nervous cell tumors|60681615|0-14|All Races|Male and Female|2007|||
10.7|12.5|11.6|723|IV(a) Neuroblastoma and ganglioneuroblastoma|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60681615|0-14|All Races|Male and Female|2007|||
10.2|11.9|11.0|672|IX Soft tissue and other extraosseous sarcomas|60681615|0-14|All Races|Male and Female|2007|||
5.1|6.3|5.7|345|IX(a) Rhabdomyosarcomas|60681615|0-14|All Races|Male and Female|2007|||
0.9|1.5|1.2|73|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|IX(c) Kaposi sarcoma|60681615|0-14|All Races|Male and Female|2007|||
2.9|3.8|3.3|202|IX(d) Other specified soft tissue sarcomas|60681615|0-14|All Races|Male and Female|2007|||
0.6|1.1|0.8|51|IX(e) Unspecified soft tissue sarcomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|Not classified by ICCC|60681615|0-14|All Races|Male and Female|2007|||
3.8|4.9|4.3|273|V Retinoblastoma|60681615|0-14|All Races|Male and Female|2007|||
7.9|9.4|8.6|530|VI Renal tumors|60681615|0-14|All Races|Male and Female|2007|||
7.5|8.9|8.2|503|VI(a) Nephroblastoma and other nonepithelial renal tumors|60681615|0-14|All Races|Male and Female|2007|||
0.3|0.6|0.4|26|VI(b) Renal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60681615|0-14|All Races|Male and Female|2007|||
2.2|3.0|2.6|159|VII Hepatic tumors|60681615|0-14|All Races|Male and Female|2007|||
1.9|2.7|2.3|141|VII(a) Hepatoblastoma|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|18|VII(b) Hepatic carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60681615|0-14|All Races|Male and Female|2007|||
6.2|7.5|6.9|415|VIII Malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
3.2|4.2|3.7|223|VIII(a) Osteosarcomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(b) Chondrosarcomas|60681615|0-14|All Races|Male and Female|2007|||
2.1|2.9|2.5|151|VIII(c) Ewing tumor and related sarcomas of bone|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
4.9|6.1|5.5|338|X Germ cell, trophoblastic tumors & neoplasms of gonads|60681615|0-14|All Races|Male and Female|2007|||
1.1|1.7|1.4|86|X(a) Intracranial & intraspinal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
1.0|1.6|1.3|82|X(b) Malignant extracranial & extragonadal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
2.2|3.0|2.6|157|X(c) Malignant gonadal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|X(d) Gonadal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60681615|0-14|All Races|Male and Female|2007|||
5.9|7.2|6.6|399|XI Other malignant epithelial neoplasms and malignant melanomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.9|2.6|2.2|136|XI(b) Thyroid carcinomas|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.8|2.5|2.1|130|XI(d) Malignant melanomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|XI(e) Skin carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.4|2.0|1.7|101|XI(f) Other and unspecified carcinomas|60681615|0-14|All Races|Male and Female|2007|||
0.5|0.9|0.7|42|XII Other and unspecified malignant neoplasms|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|60681615|0-14|All Races|Male and Female|2007|||
161.8|168.3|165.0|10126|All ICCC Groups Combined|60907384|0-14|All Races|Male and Female|2008|||
52.2|55.9|54.0|3318|I Leukemias, myeloproliferative & myelodysplastic diseases|60907384|0-14|All Races|Male and Female|2008|||
39.5|42.8|41.1|2521|I(a) Lymphoid leukemias|60907384|0-14|All Races|Male and Female|2008|||
7.3|8.7|8.0|492|I(b) Acute myeloid leukemias|60907384|0-14|All Races|Male and Female|2008|||
1.8|2.6|2.2|134|I(c) Chronic myeloproliferative diseases|60907384|0-14|All Races|Male and Female|2008|||
1.4|2.0|1.7|104|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60907384|0-14|All Races|Male and Female|2008|||
0.8|1.4|1.1|67|I(e) Unspecified and other specified leukemias|60907384|0-14|All Races|Male and Female|2008|||
16.2|18.3|17.2|1044|II Lymphomas and reticuloendothelial neoplasms|60907384|0-14|All Races|Male and Female|2008|||
5.7|7.0|6.3|383|II(a) Hodgkin lymphomas|60907384|0-14|All Races|Male and Female|2008|||
6.1|7.5|6.8|410|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60907384|0-14|All Races|Male and Female|2008|||
2.3|3.1|2.7|163|II(c) Burkitt lymphoma|60907384|0-14|All Races|Male and Female|2008|||
0.9|1.5|1.2|74|II(d) Miscellaneous lymphoreticular neoplasms|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|II(e) Unspecified lymphomas|60907384|0-14|All Races|Male and Female|2008|||
34.1|37.1|35.6|2174|III CNS and misc intracranial and intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
2.3|3.1|2.7|163|III(a) Ependymomas and choroid plexus tumor|60907384|0-14|All Races|Male and Female|2008|||
16.6|18.8|17.7|1077|III(b) Astrocytomas|60907384|0-14|All Races|Male and Female|2008|||
7.4|8.9|8.1|500|III(c) Intracranial and intraspinal embryonal tumors|60907384|0-14|All Races|Male and Female|2008|||
5.5|6.7|6.1|368|III(d) Other gliomas|60907384|0-14|All Races|Male and Female|2008|||
0.5|1.0|0.7|44|III(e) Other specified intracranial & intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.5|0.4|22|III(f) Unspecified intracranial and intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
10.1|11.8|11.0|686|IV Neuroblastoma and other peripheral nervous cell tumors|60907384|0-14|All Races|Male and Female|2008|||
9.9|11.5|10.7|669|IV(a) Neuroblastoma and ganglioneuroblastoma|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.4|0.3|17|IV(b) Other peripheral nervous cell tumors|60907384|0-14|All Races|Male and Female|2008|||
10.2|11.9|11.1|677|IX Soft tissue and other extraosseous sarcomas|60907384|0-14|All Races|Male and Female|2008|||
4.8|5.9|5.3|326|IX(a) Rhabdomyosarcomas|60907384|0-14|All Races|Male and Female|2008|||
0.8|1.3|1.0|61|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|IX(c) Kaposi sarcoma|60907384|0-14|All Races|Male and Female|2008|||
3.0|3.9|3.4|210|IX(d) Other specified soft tissue sarcomas|60907384|0-14|All Races|Male and Female|2008|||
1.0|1.6|1.3|79|IX(e) Unspecified soft tissue sarcomas|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.4|0.3|17|Not classified by ICCC|60907384|0-14|All Races|Male and Female|2008|||
3.7|4.8|4.2|268|V Retinoblastoma|60907384|0-14|All Races|Male and Female|2008|||
8.3|9.8|9.0|557|VI Renal tumors|60907384|0-14|All Races|Male and Female|2008|||
7.9|9.3|8.6|532|VI(a) Nephroblastoma and other nonepithelial renal tumors|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.6|0.4|23|VI(b) Renal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60907384|0-14|All Races|Male and Female|2008|||
2.2|3.1|2.6|164|VII Hepatic tumors|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.6|2.2|140|VII(a) Hepatoblastoma|60907384|0-14|All Races|Male and Female|2008|||
0.3|0.6|0.4|24|VII(b) Hepatic carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60907384|0-14|All Races|Male and Female|2008|||
6.2|7.6|6.9|415|VIII Malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
3.4|4.4|3.9|233|VIII(a) Osteosarcomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(b) Chondrosarcomas|60907384|0-14|All Races|Male and Female|2008|||
2.1|2.9|2.4|148|VIII(c) Ewing tumor and related sarcomas of bone|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
4.7|5.9|5.3|325|X Germ cell, trophoblastic tumors & neoplasms of gonads|60907384|0-14|All Races|Male and Female|2008|||
1.1|1.7|1.4|83|X(a) Intracranial & intraspinal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
1.1|1.7|1.4|89|X(b) Malignant extracranial & extragonadal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.7|2.3|141|X(c) Malignant gonadal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|X(d) Gonadal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60907384|0-14|All Races|Male and Female|2008|||
6.6|8.0|7.3|442|XI Other malignant epithelial neoplasms and malignant melanomas|60907384|0-14|All Races|Male and Female|2008|||
0.1|0.4|0.3|16|XI(a) Adrenocortical carcinomas|60907384|0-14|All Races|Male and Female|2008|||
2.2|3.0|2.6|158|XI(b) Thyroid carcinomas|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.7|2.3|140|XI(d) Malignant melanomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|XI(e) Skin carcinomas|60907384|0-14|All Races|Male and Female|2008|||
1.5|2.1|1.8|108|XI(f) Other and unspecified carcinomas|60907384|0-14|All Races|Male and Female|2008|||
0.4|0.9|0.6|39|XII Other and unspecified malignant neoplasms|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.6|0.4|24|XII(a) Other specified malignant tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|XII(b) Other unspecified malignant tumors|60907384|0-14|All Races|Male and Female|2008|||
160.3|166.7|163.5|10045|All ICCC Groups Combined|61087581|0-14|All Races|Male and Female|2009|||
50.8|54.5|52.6|3242|I Leukemias, myeloproliferative & myelodysplastic diseases|61087581|0-14|All Races|Male and Female|2009|||
39.5|42.8|41.1|2534|I(a) Lymphoid leukemias|61087581|0-14|All Races|Male and Female|2009|||
6.6|8.0|7.3|448|I(b) Acute myeloid leukemias|61087581|0-14|All Races|Male and Female|2009|||
1.3|1.9|1.6|96|I(c) Chronic myeloproliferative diseases|61087581|0-14|All Races|Male and Female|2009|||
1.2|1.9|1.5|94|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.4|1.1|70|I(e) Unspecified and other specified leukemias|61087581|0-14|All Races|Male and Female|2009|||
15.9|18.0|16.9|1030|II Lymphomas and reticuloendothelial neoplasms|61087581|0-14|All Races|Male and Female|2009|||
5.2|6.4|5.7|348|II(a) Hodgkin lymphomas|61087581|0-14|All Races|Male and Female|2009|||
6.3|7.7|7.0|425|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61087581|0-14|All Races|Male and Female|2009|||
2.0|2.8|2.4|143|II(c) Burkitt lymphoma|61087581|0-14|All Races|Male and Female|2009|||
1.3|2.0|1.6|102|II(d) Miscellaneous lymphoreticular neoplasms|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|II(e) Unspecified lymphomas|61087581|0-14|All Races|Male and Female|2009|||
34.1|37.1|35.6|2181|III CNS and misc intracranial and intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
2.1|3.0|2.5|156|III(a) Ependymomas and choroid plexus tumor|61087581|0-14|All Races|Male and Female|2009|||
16.6|18.8|17.7|1083|III(b) Astrocytomas|61087581|0-14|All Races|Male and Female|2009|||
7.0|8.4|7.6|469|III(c) Intracranial and intraspinal embryonal tumors|61087581|0-14|All Races|Male and Female|2009|||
6.1|7.4|6.7|409|III(d) Other gliomas|61087581|0-14|All Races|Male and Female|2009|||
0.4|0.8|0.6|34|III(e) Other specified intracranial & intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.7|0.5|30|III(f) Unspecified intracranial and intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
10.0|11.7|10.8|673|IV Neuroblastoma and other peripheral nervous cell tumors|61087581|0-14|All Races|Male and Female|2009|||
9.9|11.5|10.6|663|IV(a) Neuroblastoma and ganglioneuroblastoma|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61087581|0-14|All Races|Male and Female|2009|||
9.9|11.6|10.7|657|IX Soft tissue and other extraosseous sarcomas|61087581|0-14|All Races|Male and Female|2009|||
4.0|5.1|4.5|276|IX(a) Rhabdomyosarcomas|61087581|0-14|All Races|Male and Female|2009|||
1.0|1.6|1.3|78|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|IX(c) Kaposi sarcoma|61087581|0-14|All Races|Male and Female|2009|||
3.3|4.3|3.8|231|IX(d) Other specified soft tissue sarcomas|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.5|1.2|72|IX(e) Unspecified soft tissue sarcomas|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.5|0.3|20|Not classified by ICCC|61087581|0-14|All Races|Male and Female|2009|||
4.0|5.1|4.5|284|V Retinoblastoma|61087581|0-14|All Races|Male and Female|2009|||
8.5|10.0|9.2|574|VI Renal tumors|61087581|0-14|All Races|Male and Female|2009|||
7.9|9.4|8.6|536|VI(a) Nephroblastoma and other nonepithelial renal tumors|61087581|0-14|All Races|Male and Female|2009|||
0.4|0.8|0.6|36|VI(b) Renal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61087581|0-14|All Races|Male and Female|2009|||
1.8|2.6|2.2|137|VII Hepatic tumors|61087581|0-14|All Races|Male and Female|2009|||
1.5|2.2|1.9|116|VII(a) Hepatoblastoma|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.5|0.3|19|VII(b) Hepatic carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61087581|0-14|All Races|Male and Female|2009|||
6.4|7.7|7.0|427|VIII Malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
3.5|4.5|4.0|241|VIII(a) Osteosarcomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VIII(b) Chondrosarcomas|61087581|0-14|All Races|Male and Female|2009|||
2.0|2.8|2.4|144|VIII(c) Ewing tumor and related sarcomas of bone|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.6|0.4|24|VIII(d) Other specified malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
4.9|6.1|5.5|334|X Germ cell, trophoblastic tumors & neoplasms of gonads|61087581|0-14|All Races|Male and Female|2009|||
1.1|1.7|1.4|85|X(a) Intracranial & intraspinal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.5|1.2|74|X(b) Malignant extracranial & extragonadal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
2.2|3.0|2.6|160|X(c) Malignant gonadal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|X(d) Gonadal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61087581|0-14|All Races|Male and Female|2009|||
6.5|7.9|7.2|437|XI Other malignant epithelial neoplasms and malignant melanomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61087581|0-14|All Races|Male and Female|2009|||
2.5|3.4|2.9|177|XI(b) Thyroid carcinomas|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.6|0.4|25|XI(c) Nasopharyngeal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
1.3|2.0|1.6|100|XI(d) Malignant melanomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|XI(e) Skin carcinomas|61087581|0-14|All Races|Male and Female|2009|||
1.6|2.3|1.9|115|XI(f) Other and unspecified carcinomas|61087581|0-14|All Races|Male and Female|2009|||
0.6|1.0|0.8|49|XII Other and unspecified malignant neoplasms|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.5|0.3|21|XII(a) Other specified malignant tumors|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.7|0.5|28|XII(b) Other unspecified malignant tumors|61087581|0-14|All Races|Male and Female|2009|||
167.3|173.8|170.5|10483|All ICCC Groups Combined|61200686|0-14|All Races|Male and Female|2010|||
52.5|56.2|54.3|3347|I Leukemias, myeloproliferative & myelodysplastic diseases|61200686|0-14|All Races|Male and Female|2010|||
39.4|42.6|41.0|2528|I(a) Lymphoid leukemias|61200686|0-14|All Races|Male and Female|2010|||
7.1|8.5|7.7|476|I(b) Acute myeloid leukemias|61200686|0-14|All Races|Male and Female|2010|||
1.6|2.3|1.9|118|I(c) Chronic myeloproliferative diseases|61200686|0-14|All Races|Male and Female|2010|||
1.6|2.3|1.9|118|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61200686|0-14|All Races|Male and Female|2010|||
1.4|2.1|1.7|107|I(e) Unspecified and other specified leukemias|61200686|0-14|All Races|Male and Female|2010|||
18.9|21.2|20.0|1222|II Lymphomas and reticuloendothelial neoplasms|61200686|0-14|All Races|Male and Female|2010|||
4.7|5.9|5.3|322|II(a) Hodgkin lymphomas|61200686|0-14|All Races|Male and Female|2010|||
6.5|7.8|7.1|435|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61200686|0-14|All Races|Male and Female|2010|||
2.1|2.9|2.5|151|II(c) Burkitt lymphoma|61200686|0-14|All Races|Male and Female|2010|||
4.4|5.5|4.9|304|II(d) Miscellaneous lymphoreticular neoplasms|61200686|0-14|All Races|Male and Female|2010|||
~|~|~|~|II(e) Unspecified lymphomas|61200686|0-14|All Races|Male and Female|2010|||
35.1|38.1|36.6|2246|III CNS and misc intracranial and intraspinal neoplasms|61200686|0-14|All Races|Male and Female|2010|||
2.9|3.8|3.3|205|III(a) Ependymomas and choroid plexus tumor|61200686|0-14|All Races|Male and Female|2010|||
17.7|19.8|18.7|1149|III(b) Astrocytomas|61200686|0-14|All Races|Male and Female|2010|||
6.7|8.1|7.4|454|III(c) Intracranial and intraspinal embryonal tumors|61200686|0-14|All Races|Male and Female|2010|||
5.6|6.8|6.2|376|III(d) Other gliomas|61200686|0-14|All Races|Male and Female|2010|||
0.5|0.9|0.6|39|III(e) Other specified intracranial & intraspinal neoplasms|61200686|0-14|All Races|Male and Female|2010|||
0.2|0.6|0.4|23|III(f) Unspecified intracranial and intraspinal neoplasms|61200686|0-14|All Races|Male and Female|2010|||
10.4|12.0|11.2|694|IV Neuroblastoma and other peripheral nervous cell tumors|61200686|0-14|All Races|Male and Female|2010|||
10.2|11.9|11.0|684|IV(a) Neuroblastoma and ganglioneuroblastoma|61200686|0-14|All Races|Male and Female|2010|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61200686|0-14|All Races|Male and Female|2010|||
10.7|12.5|11.6|709|IX Soft tissue and other extraosseous sarcomas|61200686|0-14|All Races|Male and Female|2010|||
5.0|6.2|5.6|343|IX(a) Rhabdomyosarcomas|61200686|0-14|All Races|Male and Female|2010|||
0.6|1.1|0.8|49|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61200686|0-14|All Races|Male and Female|2010|||
~|~|~|~|IX(c) Kaposi sarcoma|61200686|0-14|All Races|Male and Female|2010|||
3.4|4.4|3.9|238|IX(d) Other specified soft tissue sarcomas|61200686|0-14|All Races|Male and Female|2010|||
1.0|1.6|1.3|79|IX(e) Unspecified soft tissue sarcomas|61200686|0-14|All Races|Male and Female|2010|||
~|~|~|~|Not classified by ICCC|61200686|0-14|All Races|Male and Female|2010|||
4.0|5.1|4.6|283|V Retinoblastoma|61200686|0-14|All Races|Male and Female|2010|||
7.8|9.2|8.5|527|VI Renal tumors|61200686|0-14|All Races|Male and Female|2010|||
7.4|8.9|8.1|506|VI(a) Nephroblastoma and other nonepithelial renal tumors|61200686|0-14|All Races|Male and Female|2010|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|61200686|0-14|All Races|Male and Female|2010|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61200686|0-14|All Races|Male and Female|2010|||
2.6|3.5|3.0|187|VII Hepatic tumors|61200686|0-14|All Races|Male and Female|2010|||
2.1|2.9|2.5|157|VII(a) Hepatoblastoma|61200686|0-14|All Races|Male and Female|2010|||
0.3|0.7|0.5|29|VII(b) Hepatic carcinomas|61200686|0-14|All Races|Male and Female|2010|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61200686|0-14|All Races|Male and Female|2010|||
6.1|7.4|6.7|408|VIII Malignant bone tumors|61200686|0-14|All Races|Male and Female|2010|||
3.2|4.2|3.7|225|VIII(a) Osteosarcomas|61200686|0-14|All Races|Male and Female|2010|||
~|~|~|~|VIII(b) Chondrosarcomas|61200686|0-14|All Races|Male and Female|2010|||
2.0|2.8|2.4|143|VIII(c) Ewing tumor and related sarcomas of bone|61200686|0-14|All Races|Male and Female|2010|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|61200686|0-14|All Races|Male and Female|2010|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61200686|0-14|All Races|Male and Female|2010|||
5.6|6.8|6.2|378|X Germ cell, trophoblastic tumors & neoplasms of gonads|61200686|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.8|111|X(a) Intracranial & intraspinal germ cell tumors|61200686|0-14|All Races|Male and Female|2010|||
1.1|1.7|1.4|84|X(b) Malignant extracranial & extragonadal germ cell tumors|61200686|0-14|All Races|Male and Female|2010|||
2.2|3.0|2.6|159|X(c) Malignant gonadal germ cell tumors|61200686|0-14|All Races|Male and Female|2010|||
~|~|~|~|X(d) Gonadal carcinomas|61200686|0-14|All Races|Male and Female|2010|||
0.2|0.4|0.3|16|X(e) Other and unspecified malignant gonadal tumors|61200686|0-14|All Races|Male and Female|2010|||
6.4|7.7|7.0|427|XI Other malignant epithelial neoplasms and malignant melanomas|61200686|0-14|All Races|Male and Female|2010|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61200686|0-14|All Races|Male and Female|2010|||
2.4|3.3|2.8|172|XI(b) Thyroid carcinomas|61200686|0-14|All Races|Male and Female|2010|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|61200686|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.8|110|XI(d) Malignant melanomas|61200686|0-14|All Races|Male and Female|2010|||
~|~|~|~|XI(e) Skin carcinomas|61200686|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.8|109|XI(f) Other and unspecified carcinomas|61200686|0-14|All Races|Male and Female|2010|||
0.5|0.9|0.6|40|XII Other and unspecified malignant neoplasms|61200686|0-14|All Races|Male and Female|2010|||
0.3|0.6|0.4|25|XII(a) Other specified malignant tumors|61200686|0-14|All Races|Male and Female|2010|||
~|~|~|~|XII(b) Other unspecified malignant tumors|61200686|0-14|All Races|Male and Female|2010|||
167.0|173.6|170.3|10457|All ICCC Groups Combined|61168631|0-14|All Races|Male and Female|2011|||
52.5|56.2|54.3|3341|I Leukemias, myeloproliferative & myelodysplastic diseases|61168631|0-14|All Races|Male and Female|2011|||
40.3|43.6|41.9|2581|I(a) Lymphoid leukemias|61168631|0-14|All Races|Male and Female|2011|||
7.0|8.4|7.7|473|I(b) Acute myeloid leukemias|61168631|0-14|All Races|Male and Female|2011|||
1.5|2.2|1.8|112|I(c) Chronic myeloproliferative diseases|61168631|0-14|All Races|Male and Female|2011|||
1.1|1.7|1.3|83|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61168631|0-14|All Races|Male and Female|2011|||
1.2|1.8|1.5|92|I(e) Unspecified and other specified leukemias|61168631|0-14|All Races|Male and Female|2011|||
19.2|21.5|20.3|1240|II Lymphomas and reticuloendothelial neoplasms|61168631|0-14|All Races|Male and Female|2011|||
4.6|5.8|5.2|316|II(a) Hodgkin lymphomas|61168631|0-14|All Races|Male and Female|2011|||
5.8|7.1|6.4|390|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61168631|0-14|All Races|Male and Female|2011|||
2.3|3.1|2.7|162|II(c) Burkitt lymphoma|61168631|0-14|All Races|Male and Female|2011|||
5.2|6.5|5.8|358|II(d) Miscellaneous lymphoreticular neoplasms|61168631|0-14|All Races|Male and Female|2011|||
~|~|~|~|II(e) Unspecified lymphomas|61168631|0-14|All Races|Male and Female|2011|||
34.4|37.4|35.9|2198|III CNS and misc intracranial and intraspinal neoplasms|61168631|0-14|All Races|Male and Female|2011|||
3.0|3.9|3.4|212|III(a) Ependymomas and choroid plexus tumor|61168631|0-14|All Races|Male and Female|2011|||
17.0|19.2|18.1|1106|III(b) Astrocytomas|61168631|0-14|All Races|Male and Female|2011|||
6.4|7.7|7.0|433|III(c) Intracranial and intraspinal embryonal tumors|61168631|0-14|All Races|Male and Female|2011|||
5.7|7.0|6.3|385|III(d) Other gliomas|61168631|0-14|All Races|Male and Female|2011|||
0.4|0.8|0.5|33|III(e) Other specified intracranial & intraspinal neoplasms|61168631|0-14|All Races|Male and Female|2011|||
0.3|0.7|0.5|29|III(f) Unspecified intracranial and intraspinal neoplasms|61168631|0-14|All Races|Male and Female|2011|||
10.4|12.1|11.2|695|IV Neuroblastoma and other peripheral nervous cell tumors|61168631|0-14|All Races|Male and Female|2011|||
10.2|11.9|11.0|682|IV(a) Neuroblastoma and ganglioneuroblastoma|61168631|0-14|All Races|Male and Female|2011|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61168631|0-14|All Races|Male and Female|2011|||
10.3|12.0|11.1|681|IX Soft tissue and other extraosseous sarcomas|61168631|0-14|All Races|Male and Female|2011|||
4.7|5.8|5.2|321|IX(a) Rhabdomyosarcomas|61168631|0-14|All Races|Male and Female|2011|||
0.8|1.3|1.0|64|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61168631|0-14|All Races|Male and Female|2011|||
~|~|~|~|IX(c) Kaposi sarcoma|61168631|0-14|All Races|Male and Female|2011|||
3.3|4.3|3.7|228|IX(d) Other specified soft tissue sarcomas|61168631|0-14|All Races|Male and Female|2011|||
0.8|1.4|1.1|66|IX(e) Unspecified soft tissue sarcomas|61168631|0-14|All Races|Male and Female|2011|||
~|~|~|~|Not classified by ICCC|61168631|0-14|All Races|Male and Female|2011|||
3.7|4.8|4.2|262|V Retinoblastoma|61168631|0-14|All Races|Male and Female|2011|||
8.3|9.8|9.0|557|VI Renal tumors|61168631|0-14|All Races|Male and Female|2011|||
7.9|9.4|8.6|534|VI(a) Nephroblastoma and other nonepithelial renal tumors|61168631|0-14|All Races|Male and Female|2011|||
0.2|0.5|0.4|22|VI(b) Renal carcinomas|61168631|0-14|All Races|Male and Female|2011|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61168631|0-14|All Races|Male and Female|2011|||
2.7|3.6|3.2|196|VII Hepatic tumors|61168631|0-14|All Races|Male and Female|2011|||
2.3|3.1|2.7|167|VII(a) Hepatoblastoma|61168631|0-14|All Races|Male and Female|2011|||
0.3|0.6|0.4|25|VII(b) Hepatic carcinomas|61168631|0-14|All Races|Male and Female|2011|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61168631|0-14|All Races|Male and Female|2011|||
6.8|8.1|7.4|452|VIII Malignant bone tumors|61168631|0-14|All Races|Male and Female|2011|||
3.6|4.6|4.1|249|VIII(a) Osteosarcomas|61168631|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(b) Chondrosarcomas|61168631|0-14|All Races|Male and Female|2011|||
2.4|3.3|2.8|173|VIII(c) Ewing tumor and related sarcomas of bone|61168631|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|61168631|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61168631|0-14|All Races|Male and Female|2011|||
4.6|5.7|5.1|313|X Germ cell, trophoblastic tumors & neoplasms of gonads|61168631|0-14|All Races|Male and Female|2011|||
1.2|1.9|1.5|94|X(a) Intracranial & intraspinal germ cell tumors|61168631|0-14|All Races|Male and Female|2011|||
0.9|1.5|1.2|74|X(b) Malignant extracranial & extragonadal germ cell tumors|61168631|0-14|All Races|Male and Female|2011|||
1.8|2.6|2.2|132|X(c) Malignant gonadal germ cell tumors|61168631|0-14|All Races|Male and Female|2011|||
~|~|~|~|X(d) Gonadal carcinomas|61168631|0-14|All Races|Male and Female|2011|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61168631|0-14|All Races|Male and Female|2011|||
7.1|8.5|7.7|471|XI Other malignant epithelial neoplasms and malignant melanomas|61168631|0-14|All Races|Male and Female|2011|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61168631|0-14|All Races|Male and Female|2011|||
2.9|3.8|3.3|202|XI(b) Thyroid carcinomas|61168631|0-14|All Races|Male and Female|2011|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|61168631|0-14|All Races|Male and Female|2011|||
1.7|2.5|2.1|127|XI(d) Malignant melanomas|61168631|0-14|All Races|Male and Female|2011|||
~|~|~|~|XI(e) Skin carcinomas|61168631|0-14|All Races|Male and Female|2011|||
1.4|2.1|1.7|106|XI(f) Other and unspecified carcinomas|61168631|0-14|All Races|Male and Female|2011|||
0.5|0.9|0.6|39|XII Other and unspecified malignant neoplasms|61168631|0-14|All Races|Male and Female|2011|||
0.2|0.4|0.3|17|XII(a) Other specified malignant tumors|61168631|0-14|All Races|Male and Female|2011|||
0.2|0.5|0.4|22|XII(b) Other unspecified malignant tumors|61168631|0-14|All Races|Male and Female|2011|||
166.4|172.9|169.6|10396|All ICCC Groups Combined|61113314|0-14|All Races|Male and Female|2012|||
50.6|54.3|52.4|3221|I Leukemias, myeloproliferative & myelodysplastic diseases|61113314|0-14|All Races|Male and Female|2012|||
38.6|41.8|40.2|2470|I(a) Lymphoid leukemias|61113314|0-14|All Races|Male and Female|2012|||
6.5|7.9|7.2|440|I(b) Acute myeloid leukemias|61113314|0-14|All Races|Male and Female|2012|||
1.4|2.0|1.7|103|I(c) Chronic myeloproliferative diseases|61113314|0-14|All Races|Male and Female|2012|||
1.4|2.0|1.7|102|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61113314|0-14|All Races|Male and Female|2012|||
1.4|2.1|1.7|106|I(e) Unspecified and other specified leukemias|61113314|0-14|All Races|Male and Female|2012|||
20.6|22.9|21.7|1327|II Lymphomas and reticuloendothelial neoplasms|61113314|0-14|All Races|Male and Female|2012|||
5.2|6.4|5.8|353|II(a) Hodgkin lymphomas|61113314|0-14|All Races|Male and Female|2012|||
6.8|8.2|7.4|454|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61113314|0-14|All Races|Male and Female|2012|||
2.0|2.8|2.3|143|II(c) Burkitt lymphoma|61113314|0-14|All Races|Male and Female|2012|||
5.2|6.4|5.8|353|II(d) Miscellaneous lymphoreticular neoplasms|61113314|0-14|All Races|Male and Female|2012|||
0.3|0.6|0.4|24|II(e) Unspecified lymphomas|61113314|0-14|All Races|Male and Female|2012|||
33.9|36.9|35.3|2165|III CNS and misc intracranial and intraspinal neoplasms|61113314|0-14|All Races|Male and Female|2012|||
2.5|3.4|3.0|182|III(a) Ependymomas and choroid plexus tumor|61113314|0-14|All Races|Male and Female|2012|||
17.7|19.9|18.8|1148|III(b) Astrocytomas|61113314|0-14|All Races|Male and Female|2012|||
6.5|7.8|7.1|436|III(c) Intracranial and intraspinal embryonal tumors|61113314|0-14|All Races|Male and Female|2012|||
4.6|5.8|5.2|318|III(d) Other gliomas|61113314|0-14|All Races|Male and Female|2012|||
0.4|0.8|0.6|36|III(e) Other specified intracranial & intraspinal neoplasms|61113314|0-14|All Races|Male and Female|2012|||
0.5|1.0|0.7|45|III(f) Unspecified intracranial and intraspinal neoplasms|61113314|0-14|All Races|Male and Female|2012|||
10.6|12.3|11.4|705|IV Neuroblastoma and other peripheral nervous cell tumors|61113314|0-14|All Races|Male and Female|2012|||
10.4|12.1|11.2|691|IV(a) Neuroblastoma and ganglioneuroblastoma|61113314|0-14|All Races|Male and Female|2012|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61113314|0-14|All Races|Male and Female|2012|||
10.3|12.0|11.1|679|IX Soft tissue and other extraosseous sarcomas|61113314|0-14|All Races|Male and Female|2012|||
4.5|5.6|5.0|309|IX(a) Rhabdomyosarcomas|61113314|0-14|All Races|Male and Female|2012|||
0.9|1.5|1.2|72|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61113314|0-14|All Races|Male and Female|2012|||
~|~|~|~|IX(c) Kaposi sarcoma|61113314|0-14|All Races|Male and Female|2012|||
3.2|4.1|3.6|221|IX(d) Other specified soft tissue sarcomas|61113314|0-14|All Races|Male and Female|2012|||
1.0|1.5|1.2|75|IX(e) Unspecified soft tissue sarcomas|61113314|0-14|All Races|Male and Female|2012|||
~|~|~|~|Not classified by ICCC|61113314|0-14|All Races|Male and Female|2012|||
3.9|5.0|4.4|272|V Retinoblastoma|61113314|0-14|All Races|Male and Female|2012|||
7.9|9.4|8.6|530|VI Renal tumors|61113314|0-14|All Races|Male and Female|2012|||
7.5|8.9|8.2|505|VI(a) Nephroblastoma and other nonepithelial renal tumors|61113314|0-14|All Races|Male and Female|2012|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|61113314|0-14|All Races|Male and Female|2012|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61113314|0-14|All Races|Male and Female|2012|||
2.9|3.8|3.3|205|VII Hepatic tumors|61113314|0-14|All Races|Male and Female|2012|||
2.4|3.3|2.8|175|VII(a) Hepatoblastoma|61113314|0-14|All Races|Male and Female|2012|||
0.3|0.7|0.5|28|VII(b) Hepatic carcinomas|61113314|0-14|All Races|Male and Female|2012|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61113314|0-14|All Races|Male and Female|2012|||
6.6|8.0|7.3|444|VIII Malignant bone tumors|61113314|0-14|All Races|Male and Female|2012|||
3.9|5.0|4.4|268|VIII(a) Osteosarcomas|61113314|0-14|All Races|Male and Female|2012|||
~|~|~|~|VIII(b) Chondrosarcomas|61113314|0-14|All Races|Male and Female|2012|||
1.9|2.7|2.2|137|VIII(c) Ewing tumor and related sarcomas of bone|61113314|0-14|All Races|Male and Female|2012|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|61113314|0-14|All Races|Male and Female|2012|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61113314|0-14|All Races|Male and Female|2012|||
4.6|5.8|5.2|317|X Germ cell, trophoblastic tumors & neoplasms of gonads|61113314|0-14|All Races|Male and Female|2012|||
1.1|1.7|1.4|84|X(a) Intracranial & intraspinal germ cell tumors|61113314|0-14|All Races|Male and Female|2012|||
1.2|1.9|1.5|93|X(b) Malignant extracranial & extragonadal germ cell tumors|61113314|0-14|All Races|Male and Female|2012|||
1.7|2.5|2.1|126|X(c) Malignant gonadal germ cell tumors|61113314|0-14|All Races|Male and Female|2012|||
~|~|~|~|X(d) Gonadal carcinomas|61113314|0-14|All Races|Male and Female|2012|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61113314|0-14|All Races|Male and Female|2012|||
7.0|8.4|7.7|467|XI Other malignant epithelial neoplasms and malignant melanomas|61113314|0-14|All Races|Male and Female|2012|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61113314|0-14|All Races|Male and Female|2012|||
2.8|3.8|3.3|199|XI(b) Thyroid carcinomas|61113314|0-14|All Races|Male and Female|2012|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|61113314|0-14|All Races|Male and Female|2012|||
1.6|2.3|2.0|119|XI(d) Malignant melanomas|61113314|0-14|All Races|Male and Female|2012|||
~|~|~|~|XI(e) Skin carcinomas|61113314|0-14|All Races|Male and Female|2012|||
1.6|2.3|1.9|118|XI(f) Other and unspecified carcinomas|61113314|0-14|All Races|Male and Female|2012|||
0.6|1.1|0.8|52|XII Other and unspecified malignant neoplasms|61113314|0-14|All Races|Male and Female|2012|||
0.3|0.6|0.4|25|XII(a) Other specified malignant tumors|61113314|0-14|All Races|Male and Female|2012|||
0.3|0.6|0.4|27|XII(b) Other unspecified malignant tumors|61113314|0-14|All Races|Male and Female|2012|||
168.9|175.5|172.2|10532|All ICCC Groups Combined|61067866|0-14|All Races|Male and Female|2013|||
49.4|53.0|51.2|3136|I Leukemias, myeloproliferative & myelodysplastic diseases|61067866|0-14|All Races|Male and Female|2013|||
36.5|39.6|38.0|2330|I(a) Lymphoid leukemias|61067866|0-14|All Races|Male and Female|2013|||
7.1|8.6|7.8|479|I(b) Acute myeloid leukemias|61067866|0-14|All Races|Male and Female|2013|||
1.4|2.0|1.7|103|I(c) Chronic myeloproliferative diseases|61067866|0-14|All Races|Male and Female|2013|||
1.2|1.8|1.5|92|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61067866|0-14|All Races|Male and Female|2013|||
1.8|2.6|2.2|132|I(e) Unspecified and other specified leukemias|61067866|0-14|All Races|Male and Female|2013|||
20.6|23.0|21.8|1328|II Lymphomas and reticuloendothelial neoplasms|61067866|0-14|All Races|Male and Female|2013|||
5.0|6.2|5.5|337|II(a) Hodgkin lymphomas|61067866|0-14|All Races|Male and Female|2013|||
6.7|8.1|7.3|448|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61067866|0-14|All Races|Male and Female|2013|||
1.9|2.7|2.3|140|II(c) Burkitt lymphoma|61067866|0-14|All Races|Male and Female|2013|||
5.7|7.0|6.4|389|II(d) Miscellaneous lymphoreticular neoplasms|61067866|0-14|All Races|Male and Female|2013|||
~|~|~|~|II(e) Unspecified lymphomas|61067866|0-14|All Races|Male and Female|2013|||
35.3|38.3|36.8|2248|III CNS and misc intracranial and intraspinal neoplasms|61067866|0-14|All Races|Male and Female|2013|||
2.7|3.6|3.2|193|III(a) Ependymomas and choroid plexus tumor|61067866|0-14|All Races|Male and Female|2013|||
18.3|20.5|19.4|1183|III(b) Astrocytomas|61067866|0-14|All Races|Male and Female|2013|||
6.2|7.6|6.9|421|III(c) Intracranial and intraspinal embryonal tumors|61067866|0-14|All Races|Male and Female|2013|||
5.6|6.8|6.2|378|III(d) Other gliomas|61067866|0-14|All Races|Male and Female|2013|||
0.5|1.0|0.7|44|III(e) Other specified intracranial & intraspinal neoplasms|61067866|0-14|All Races|Male and Female|2013|||
0.3|0.7|0.5|29|III(f) Unspecified intracranial and intraspinal neoplasms|61067866|0-14|All Races|Male and Female|2013|||
11.3|13.1|12.2|748|IV Neuroblastoma and other peripheral nervous cell tumors|61067866|0-14|All Races|Male and Female|2013|||
11.0|12.8|11.9|730|IV(a) Neuroblastoma and ganglioneuroblastoma|61067866|0-14|All Races|Male and Female|2013|||
0.2|0.5|0.3|18|IV(b) Other peripheral nervous cell tumors|61067866|0-14|All Races|Male and Female|2013|||
10.4|12.1|11.2|683|IX Soft tissue and other extraosseous sarcomas|61067866|0-14|All Races|Male and Female|2013|||
4.7|5.9|5.3|323|IX(a) Rhabdomyosarcomas|61067866|0-14|All Races|Male and Female|2013|||
1.0|1.5|1.2|74|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61067866|0-14|All Races|Male and Female|2013|||
~|~|~|~|IX(c) Kaposi sarcoma|61067866|0-14|All Races|Male and Female|2013|||
3.2|4.2|3.7|224|IX(d) Other specified soft tissue sarcomas|61067866|0-14|All Races|Male and Female|2013|||
0.8|1.3|1.0|61|IX(e) Unspecified soft tissue sarcomas|61067866|0-14|All Races|Male and Female|2013|||
0.1|0.4|0.3|16|Not classified by ICCC|61067866|0-14|All Races|Male and Female|2013|||
3.8|4.9|4.3|266|V Retinoblastoma|61067866|0-14|All Races|Male and Female|2013|||
8.3|9.8|9.0|552|VI Renal tumors|61067866|0-14|All Races|Male and Female|2013|||
7.8|9.3|8.5|525|VI(a) Nephroblastoma and other nonepithelial renal tumors|61067866|0-14|All Races|Male and Female|2013|||
0.3|0.6|0.4|24|VI(b) Renal carcinomas|61067866|0-14|All Races|Male and Female|2013|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61067866|0-14|All Races|Male and Female|2013|||
2.5|3.3|2.9|177|VII Hepatic tumors|61067866|0-14|All Races|Male and Female|2013|||
2.1|2.8|2.4|149|VII(a) Hepatoblastoma|61067866|0-14|All Races|Male and Female|2013|||
0.3|0.6|0.4|26|VII(b) Hepatic carcinomas|61067866|0-14|All Races|Male and Female|2013|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61067866|0-14|All Races|Male and Female|2013|||
6.7|8.1|7.4|448|VIII Malignant bone tumors|61067866|0-14|All Races|Male and Female|2013|||
3.3|4.3|3.8|229|VIII(a) Osteosarcomas|61067866|0-14|All Races|Male and Female|2013|||
~|~|~|~|VIII(b) Chondrosarcomas|61067866|0-14|All Races|Male and Female|2013|||
2.4|3.3|2.9|174|VIII(c) Ewing tumor and related sarcomas of bone|61067866|0-14|All Races|Male and Female|2013|||
0.3|0.6|0.4|27|VIII(d) Other specified malignant bone tumors|61067866|0-14|All Races|Male and Female|2013|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61067866|0-14|All Races|Male and Female|2013|||
5.2|6.4|5.8|353|X Germ cell, trophoblastic tumors & neoplasms of gonads|61067866|0-14|All Races|Male and Female|2013|||
1.4|2.1|1.7|103|X(a) Intracranial & intraspinal germ cell tumors|61067866|0-14|All Races|Male and Female|2013|||
1.1|1.6|1.3|81|X(b) Malignant extracranial & extragonadal germ cell tumors|61067866|0-14|All Races|Male and Female|2013|||
2.1|2.9|2.4|148|X(c) Malignant gonadal germ cell tumors|61067866|0-14|All Races|Male and Female|2013|||
~|~|~|~|X(d) Gonadal carcinomas|61067866|0-14|All Races|Male and Female|2013|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61067866|0-14|All Races|Male and Female|2013|||
8.1|9.6|8.8|538|XI Other malignant epithelial neoplasms and malignant melanomas|61067866|0-14|All Races|Male and Female|2013|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61067866|0-14|All Races|Male and Female|2013|||
3.1|4.1|3.6|218|XI(b) Thyroid carcinomas|61067866|0-14|All Races|Male and Female|2013|||
0.2|0.6|0.4|23|XI(c) Nasopharyngeal carcinomas|61067866|0-14|All Races|Male and Female|2013|||
1.8|2.6|2.1|131|XI(d) Malignant melanomas|61067866|0-14|All Races|Male and Female|2013|||
~|~|~|~|XI(e) Skin carcinomas|61067866|0-14|All Races|Male and Female|2013|||
2.1|2.9|2.5|153|XI(f) Other and unspecified carcinomas|61067866|0-14|All Races|Male and Female|2013|||
0.5|0.9|0.6|39|XII Other and unspecified malignant neoplasms|61067866|0-14|All Races|Male and Female|2013|||
0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|61067866|0-14|All Races|Male and Female|2013|||
0.1|0.4|0.3|16|XII(b) Other unspecified malignant tumors|61067866|0-14|All Races|Male and Female|2013|||
172.1|175.1|173.6|53060|All ICCC Groups Combined|305059222|0-14|All Races|Male and Female|2013-2017|||
51.8|53.4|52.6|16103|I Leukemias, myeloproliferative & myelodysplastic diseases|305059222|0-14|All Races|Male and Female|2013-2017|||
38.8|40.2|39.5|12090|I(a) Lymphoid leukemias|305059222|0-14|All Races|Male and Female|2013-2017|||
7.5|8.2|7.8|2399|I(b) Acute myeloid leukemias|305059222|0-14|All Races|Male and Female|2013-2017|||
1.6|1.9|1.8|537|I(c) Chronic myeloproliferative diseases|305059222|0-14|All Races|Male and Female|2013-2017|||
1.3|1.6|1.5|447|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|305059222|0-14|All Races|Male and Female|2013-2017|||
1.9|2.2|2.1|630|I(e) Unspecified and other specified leukemias|305059222|0-14|All Races|Male and Female|2013-2017|||
22.0|23.0|22.5|6853|II Lymphomas and reticuloendothelial neoplasms|305059222|0-14|All Races|Male and Female|2013-2017|||
5.4|6.0|5.7|1731|II(a) Hodgkin lymphomas|305059222|0-14|All Races|Male and Female|2013-2017|||
7.4|8.0|7.7|2353|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|305059222|0-14|All Races|Male and Female|2013-2017|||
2.3|2.7|2.5|766|II(c) Burkitt lymphoma|305059222|0-14|All Races|Male and Female|2013-2017|||
6.0|6.6|6.3|1933|II(d) Miscellaneous lymphoreticular neoplasms|305059222|0-14|All Races|Male and Female|2013-2017|||
0.2|0.3|0.2|70|II(e) Unspecified lymphomas|305059222|0-14|All Races|Male and Female|2013-2017|||
35.0|36.3|35.7|10894|III CNS and misc intracranial and intraspinal neoplasms|305059222|0-14|All Races|Male and Female|2013-2017|||
2.9|3.3|3.1|959|III(a) Ependymomas and choroid plexus tumor|305059222|0-14|All Races|Male and Female|2013-2017|||
17.6|18.6|18.1|5521|III(b) Astrocytomas|305059222|0-14|All Races|Male and Female|2013-2017|||
6.7|7.3|7.0|2143|III(c) Intracranial and intraspinal embryonal tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
5.9|6.5|6.2|1884|III(d) Other gliomas|305059222|0-14|All Races|Male and Female|2013-2017|||
0.6|0.8|0.7|222|III(e) Other specified intracranial & intraspinal neoplasms|305059222|0-14|All Races|Male and Female|2013-2017|||
0.5|0.6|0.5|165|III(f) Unspecified intracranial and intraspinal neoplasms|305059222|0-14|All Races|Male and Female|2013-2017|||
11.2|12.0|11.6|3563|IV Neuroblastoma and other peripheral nervous cell tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
11.0|11.8|11.4|3505|IV(a) Neuroblastoma and ganglioneuroblastoma|305059222|0-14|All Races|Male and Female|2013-2017|||
0.1|0.2|0.2|58|IV(b) Other peripheral nervous cell tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
10.7|11.5|11.1|3387|IX Soft tissue and other extraosseous sarcomas|305059222|0-14|All Races|Male and Female|2013-2017|||
5.0|5.5|5.2|1602|IX(a) Rhabdomyosarcomas|305059222|0-14|All Races|Male and Female|2013-2017|||
1.0|1.2|1.1|325|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|305059222|0-14|All Races|Male and Female|2013-2017|||
~|~|~|~|IX(c) Kaposi sarcoma|305059222|0-14|All Races|Male and Female|2013-2017|||
3.4|3.8|3.6|1099|IX(d) Other specified soft tissue sarcomas|305059222|0-14|All Races|Male and Female|2013-2017|||
1.1|1.3|1.2|357|IX(e) Unspecified soft tissue sarcomas|305059222|0-14|All Races|Male and Female|2013-2017|||
0.2|0.3|0.2|76|Not classified by ICCC|305059222|0-14|All Races|Male and Female|2013-2017|||
4.1|4.6|4.4|1341|V Retinoblastoma|305059222|0-14|All Races|Male and Female|2013-2017|||
8.6|9.3|8.9|2742|VI Renal tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
8.1|8.8|8.5|2598|VI(a) Nephroblastoma and other nonepithelial renal tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
0.4|0.5|0.4|132|VI(b) Renal carcinomas|305059222|0-14|All Races|Male and Female|2013-2017|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
2.8|3.2|3.0|923|VII Hepatic tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
2.4|2.8|2.6|806|VII(a) Hepatoblastoma|305059222|0-14|All Races|Male and Female|2013-2017|||
0.3|0.4|0.4|110|VII(b) Hepatic carcinomas|305059222|0-14|All Races|Male and Female|2013-2017|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
7.3|8.0|7.6|2321|VIII Malignant bone tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
3.9|4.4|4.1|1257|VIII(a) Osteosarcomas|305059222|0-14|All Races|Male and Female|2013-2017|||
0.2|0.3|0.2|60|VIII(b) Chondrosarcomas|305059222|0-14|All Races|Male and Female|2013-2017|||
2.5|2.9|2.7|825|VIII(c) Ewing tumor and related sarcomas of bone|305059222|0-14|All Races|Male and Female|2013-2017|||
0.4|0.5|0.5|138|VIII(d) Other specified malignant bone tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
0.1|0.2|0.1|41|VIII(e) Unspecified malignant bone tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
5.5|6.1|5.8|1762|X Germ cell, trophoblastic tumors & neoplasms of gonads|305059222|0-14|All Races|Male and Female|2013-2017|||
1.6|1.8|1.7|516|X(a) Intracranial & intraspinal germ cell tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
1.3|1.5|1.4|431|X(b) Malignant extracranial & extragonadal germ cell tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
2.2|2.5|2.3|712|X(c) Malignant gonadal germ cell tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
0.1|0.1|0.1|31|X(d) Gonadal carcinomas|305059222|0-14|All Races|Male and Female|2013-2017|||
0.2|0.3|0.2|72|X(e) Other and unspecified malignant gonadal tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
9.0|9.7|9.4|2852|XI Other malignant epithelial neoplasms and malignant melanomas|305059222|0-14|All Races|Male and Female|2013-2017|||
0.1|0.2|0.2|49|XI(a) Adrenocortical carcinomas|305059222|0-14|All Races|Male and Female|2013-2017|||
3.3|3.7|3.5|1066|XI(b) Thyroid carcinomas|305059222|0-14|All Races|Male and Female|2013-2017|||
0.2|0.3|0.2|69|XI(c) Nasopharyngeal carcinomas|305059222|0-14|All Races|Male and Female|2013-2017|||
1.8|2.1|2.0|598|XI(d) Malignant melanomas|305059222|0-14|All Races|Male and Female|2013-2017|||
~|~|~|~|XI(e) Skin carcinomas|305059222|0-14|All Races|Male and Female|2013-2017|||
3.3|3.7|3.5|1055|XI(f) Other and unspecified carcinomas|305059222|0-14|All Races|Male and Female|2013-2017|||
0.7|0.9|0.8|243|XII Other and unspecified malignant neoplasms|305059222|0-14|All Races|Male and Female|2013-2017|||
0.4|0.6|0.5|148|XII(a) Other specified malignant tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
0.3|0.4|0.3|95|XII(b) Other unspecified malignant tumors|305059222|0-14|All Races|Male and Female|2013-2017|||
172.6|179.2|175.9|10756|All ICCC Groups Combined|61053482|0-14|All Races|Male and Female|2014|||
50.4|54.0|52.2|3196|I Leukemias, myeloproliferative & myelodysplastic diseases|61053482|0-14|All Races|Male and Female|2014|||
37.5|40.6|39.0|2390|I(a) Lymphoid leukemias|61053482|0-14|All Races|Male and Female|2014|||
7.2|8.7|7.9|485|I(b) Acute myeloid leukemias|61053482|0-14|All Races|Male and Female|2014|||
1.3|1.9|1.6|95|I(c) Chronic myeloproliferative diseases|61053482|0-14|All Races|Male and Female|2014|||
1.3|2.0|1.6|98|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61053482|0-14|All Races|Male and Female|2014|||
1.7|2.5|2.1|128|I(e) Unspecified and other specified leukemias|61053482|0-14|All Races|Male and Female|2014|||
22.3|24.8|23.5|1435|II Lymphomas and reticuloendothelial neoplasms|61053482|0-14|All Races|Male and Female|2014|||
5.0|6.2|5.5|337|II(a) Hodgkin lymphomas|61053482|0-14|All Races|Male and Female|2014|||
7.7|9.2|8.4|514|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61053482|0-14|All Races|Male and Female|2014|||
2.4|3.2|2.8|170|II(c) Burkitt lymphoma|61053482|0-14|All Races|Male and Female|2014|||
5.8|7.1|6.5|396|II(d) Miscellaneous lymphoreticular neoplasms|61053482|0-14|All Races|Male and Female|2014|||
0.2|0.5|0.3|18|II(e) Unspecified lymphomas|61053482|0-14|All Races|Male and Female|2014|||
35.0|38.0|36.5|2230|III CNS and misc intracranial and intraspinal neoplasms|61053482|0-14|All Races|Male and Female|2014|||
2.8|3.7|3.2|198|III(a) Ependymomas and choroid plexus tumor|61053482|0-14|All Races|Male and Female|2014|||
17.7|19.9|18.8|1146|III(b) Astrocytomas|61053482|0-14|All Races|Male and Female|2014|||
6.7|8.1|7.4|451|III(c) Intracranial and intraspinal embryonal tumors|61053482|0-14|All Races|Male and Female|2014|||
5.1|6.3|5.7|348|III(d) Other gliomas|61053482|0-14|All Races|Male and Female|2014|||
0.6|1.1|0.8|51|III(e) Other specified intracranial & intraspinal neoplasms|61053482|0-14|All Races|Male and Female|2014|||
0.4|0.8|0.6|36|III(f) Unspecified intracranial and intraspinal neoplasms|61053482|0-14|All Races|Male and Female|2014|||
11.1|12.9|12.0|736|IV Neuroblastoma and other peripheral nervous cell tumors|61053482|0-14|All Races|Male and Female|2014|||
10.9|12.6|11.8|723|IV(a) Neuroblastoma and ganglioneuroblastoma|61053482|0-14|All Races|Male and Female|2014|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61053482|0-14|All Races|Male and Female|2014|||
10.4|12.1|11.2|683|IX Soft tissue and other extraosseous sarcomas|61053482|0-14|All Races|Male and Female|2014|||
4.4|5.5|4.9|302|IX(a) Rhabdomyosarcomas|61053482|0-14|All Races|Male and Female|2014|||
0.9|1.5|1.2|73|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61053482|0-14|All Races|Male and Female|2014|||
~|~|~|~|IX(c) Kaposi sarcoma|61053482|0-14|All Races|Male and Female|2014|||
3.4|4.4|3.9|235|IX(d) Other specified soft tissue sarcomas|61053482|0-14|All Races|Male and Female|2014|||
0.9|1.5|1.2|72|IX(e) Unspecified soft tissue sarcomas|61053482|0-14|All Races|Male and Female|2014|||
0.2|0.5|0.3|20|Not classified by ICCC|61053482|0-14|All Races|Male and Female|2014|||
3.8|4.9|4.3|267|V Retinoblastoma|61053482|0-14|All Races|Male and Female|2014|||
8.4|10.0|9.2|563|VI Renal tumors|61053482|0-14|All Races|Male and Female|2014|||
8.0|9.5|8.7|535|VI(a) Nephroblastoma and other nonepithelial renal tumors|61053482|0-14|All Races|Male and Female|2014|||
0.3|0.6|0.4|26|VI(b) Renal carcinomas|61053482|0-14|All Races|Male and Female|2014|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61053482|0-14|All Races|Male and Female|2014|||
2.6|3.5|3.0|187|VII Hepatic tumors|61053482|0-14|All Races|Male and Female|2014|||
2.2|3.1|2.6|161|VII(a) Hepatoblastoma|61053482|0-14|All Races|Male and Female|2014|||
0.3|0.6|0.4|26|VII(b) Hepatic carcinomas|61053482|0-14|All Races|Male and Female|2014|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61053482|0-14|All Races|Male and Female|2014|||
7.3|8.7|8.0|485|VIII Malignant bone tumors|61053482|0-14|All Races|Male and Female|2014|||
3.9|5.0|4.4|268|VIII(a) Osteosarcomas|61053482|0-14|All Races|Male and Female|2014|||
~|~|~|~|VIII(b) Chondrosarcomas|61053482|0-14|All Races|Male and Female|2014|||
2.3|3.2|2.7|167|VIII(c) Ewing tumor and related sarcomas of bone|61053482|0-14|All Races|Male and Female|2014|||
0.3|0.7|0.5|29|VIII(d) Other specified malignant bone tumors|61053482|0-14|All Races|Male and Female|2014|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61053482|0-14|All Races|Male and Female|2014|||
5.1|6.4|5.7|350|X Germ cell, trophoblastic tumors & neoplasms of gonads|61053482|0-14|All Races|Male and Female|2014|||
1.2|1.8|1.5|89|X(a) Intracranial & intraspinal germ cell tumors|61053482|0-14|All Races|Male and Female|2014|||
1.3|2.0|1.6|101|X(b) Malignant extracranial & extragonadal germ cell tumors|61053482|0-14|All Races|Male and Female|2014|||
1.9|2.7|2.3|138|X(c) Malignant gonadal germ cell tumors|61053482|0-14|All Races|Male and Female|2014|||
~|~|~|~|X(d) Gonadal carcinomas|61053482|0-14|All Races|Male and Female|2014|||
0.2|0.4|0.3|16|X(e) Other and unspecified malignant gonadal tumors|61053482|0-14|All Races|Male and Female|2014|||
8.6|10.1|9.3|566|XI Other malignant epithelial neoplasms and malignant melanomas|61053482|0-14|All Races|Male and Female|2014|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61053482|0-14|All Races|Male and Female|2014|||
3.4|4.4|3.9|234|XI(b) Thyroid carcinomas|61053482|0-14|All Races|Male and Female|2014|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|61053482|0-14|All Races|Male and Female|2014|||
1.9|2.7|2.2|137|XI(d) Malignant melanomas|61053482|0-14|All Races|Male and Female|2014|||
~|~|~|~|XI(e) Skin carcinomas|61053482|0-14|All Races|Male and Female|2014|||
2.4|3.3|2.8|171|XI(f) Other and unspecified carcinomas|61053482|0-14|All Races|Male and Female|2014|||
0.4|0.9|0.6|38|XII Other and unspecified malignant neoplasms|61053482|0-14|All Races|Male and Female|2014|||
0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|61053482|0-14|All Races|Male and Female|2014|||
~|~|~|~|XII(b) Other unspecified malignant tumors|61053482|0-14|All Races|Male and Female|2014|||
174.7|181.4|178.1|10890|All ICCC Groups Combined|60999735|0-14|All Races|Male and Female|2015|||
52.9|56.6|54.7|3353|I Leukemias, myeloproliferative & myelodysplastic diseases|60999735|0-14|All Races|Male and Female|2015|||
39.8|43.0|41.4|2534|I(a) Lymphoid leukemias|60999735|0-14|All Races|Male and Female|2015|||
7.2|8.7|7.9|485|I(b) Acute myeloid leukemias|60999735|0-14|All Races|Male and Female|2015|||
1.6|2.3|1.9|116|I(c) Chronic myeloproliferative diseases|60999735|0-14|All Races|Male and Female|2015|||
1.2|1.8|1.5|92|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60999735|0-14|All Races|Male and Female|2015|||
1.7|2.5|2.1|126|I(e) Unspecified and other specified leukemias|60999735|0-14|All Races|Male and Female|2015|||
22.0|24.4|23.2|1411|II Lymphomas and reticuloendothelial neoplasms|60999735|0-14|All Races|Male and Female|2015|||
5.4|6.6|6.0|361|II(a) Hodgkin lymphomas|60999735|0-14|All Races|Male and Female|2015|||
6.8|8.1|7.4|452|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60999735|0-14|All Races|Male and Female|2015|||
2.2|3.0|2.5|155|II(c) Burkitt lymphoma|60999735|0-14|All Races|Male and Female|2015|||
6.3|7.6|7.0|426|II(d) Miscellaneous lymphoreticular neoplasms|60999735|0-14|All Races|Male and Female|2015|||
0.2|0.4|0.3|17|II(e) Unspecified lymphomas|60999735|0-14|All Races|Male and Female|2015|||
33.8|36.8|35.3|2153|III CNS and misc intracranial and intraspinal neoplasms|60999735|0-14|All Races|Male and Female|2015|||
2.7|3.6|3.1|191|III(a) Ependymomas and choroid plexus tumor|60999735|0-14|All Races|Male and Female|2015|||
16.9|19.1|18.0|1097|III(b) Astrocytomas|60999735|0-14|All Races|Male and Female|2015|||
6.6|8.0|7.3|445|III(c) Intracranial and intraspinal embryonal tumors|60999735|0-14|All Races|Male and Female|2015|||
5.2|6.4|5.8|354|III(d) Other gliomas|60999735|0-14|All Races|Male and Female|2015|||
0.5|0.9|0.7|42|III(e) Other specified intracranial & intraspinal neoplasms|60999735|0-14|All Races|Male and Female|2015|||
0.3|0.6|0.4|24|III(f) Unspecified intracranial and intraspinal neoplasms|60999735|0-14|All Races|Male and Female|2015|||
11.3|13.1|12.2|752|IV Neuroblastoma and other peripheral nervous cell tumors|60999735|0-14|All Races|Male and Female|2015|||
11.1|12.9|12.0|740|IV(a) Neuroblastoma and ganglioneuroblastoma|60999735|0-14|All Races|Male and Female|2015|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60999735|0-14|All Races|Male and Female|2015|||
10.4|12.1|11.3|687|IX Soft tissue and other extraosseous sarcomas|60999735|0-14|All Races|Male and Female|2015|||
4.7|5.9|5.3|322|IX(a) Rhabdomyosarcomas|60999735|0-14|All Races|Male and Female|2015|||
0.9|1.4|1.1|67|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60999735|0-14|All Races|Male and Female|2015|||
~|~|~|~|IX(c) Kaposi sarcoma|60999735|0-14|All Races|Male and Female|2015|||
3.3|4.3|3.7|228|IX(d) Other specified soft tissue sarcomas|60999735|0-14|All Races|Male and Female|2015|||
0.9|1.4|1.1|69|IX(e) Unspecified soft tissue sarcomas|60999735|0-14|All Races|Male and Female|2015|||
~|~|~|~|Not classified by ICCC|60999735|0-14|All Races|Male and Female|2015|||
4.3|5.5|4.9|302|V Retinoblastoma|60999735|0-14|All Races|Male and Female|2015|||
9.0|10.6|9.8|601|VI Renal tumors|60999735|0-14|All Races|Male and Female|2015|||
8.6|10.1|9.3|575|VI(a) Nephroblastoma and other nonepithelial renal tumors|60999735|0-14|All Races|Male and Female|2015|||
0.3|0.6|0.4|24|VI(b) Renal carcinomas|60999735|0-14|All Races|Male and Female|2015|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60999735|0-14|All Races|Male and Female|2015|||
2.8|3.7|3.2|199|VII Hepatic tumors|60999735|0-14|All Races|Male and Female|2015|||
2.4|3.2|2.8|172|VII(a) Hepatoblastoma|60999735|0-14|All Races|Male and Female|2015|||
0.3|0.6|0.4|26|VII(b) Hepatic carcinomas|60999735|0-14|All Races|Male and Female|2015|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60999735|0-14|All Races|Male and Female|2015|||
6.8|8.2|7.5|456|VIII Malignant bone tumors|60999735|0-14|All Races|Male and Female|2015|||
3.4|4.5|3.9|238|VIII(a) Osteosarcomas|60999735|0-14|All Races|Male and Female|2015|||
~|~|~|~|VIII(b) Chondrosarcomas|60999735|0-14|All Races|Male and Female|2015|||
2.3|3.1|2.7|164|VIII(c) Ewing tumor and related sarcomas of bone|60999735|0-14|All Races|Male and Female|2015|||
0.3|0.7|0.5|31|VIII(d) Other specified malignant bone tumors|60999735|0-14|All Races|Male and Female|2015|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60999735|0-14|All Races|Male and Female|2015|||
4.9|6.1|5.5|334|X Germ cell, trophoblastic tumors & neoplasms of gonads|60999735|0-14|All Races|Male and Female|2015|||
1.3|2.0|1.6|99|X(a) Intracranial & intraspinal germ cell tumors|60999735|0-14|All Races|Male and Female|2015|||
1.1|1.7|1.3|83|X(b) Malignant extracranial & extragonadal germ cell tumors|60999735|0-14|All Races|Male and Female|2015|||
1.9|2.6|2.2|135|X(c) Malignant gonadal germ cell tumors|60999735|0-14|All Races|Male and Female|2015|||
~|~|~|~|X(d) Gonadal carcinomas|60999735|0-14|All Races|Male and Female|2015|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60999735|0-14|All Races|Male and Female|2015|||
8.9|10.5|9.7|587|XI Other malignant epithelial neoplasms and malignant melanomas|60999735|0-14|All Races|Male and Female|2015|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60999735|0-14|All Races|Male and Female|2015|||
3.0|4.0|3.5|211|XI(b) Thyroid carcinomas|60999735|0-14|All Races|Male and Female|2015|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60999735|0-14|All Races|Male and Female|2015|||
1.8|2.5|2.1|130|XI(d) Malignant melanomas|60999735|0-14|All Races|Male and Female|2015|||
~|~|~|~|XI(e) Skin carcinomas|60999735|0-14|All Races|Male and Female|2015|||
3.3|4.2|3.7|226|XI(f) Other and unspecified carcinomas|60999735|0-14|All Races|Male and Female|2015|||
0.5|1.0|0.7|45|XII Other and unspecified malignant neoplasms|60999735|0-14|All Races|Male and Female|2015|||
0.3|0.7|0.5|31|XII(a) Other specified malignant tumors|60999735|0-14|All Races|Male and Female|2015|||
~|~|~|~|XII(b) Other unspecified malignant tumors|60999735|0-14|All Races|Male and Female|2015|||
171.7|178.4|175.0|10697|All ICCC Groups Combined|60975441|0-14|All Races|Male and Female|2016|||
52.9|56.6|54.7|3350|I Leukemias, myeloproliferative & myelodysplastic diseases|60975441|0-14|All Races|Male and Female|2016|||
39.5|42.7|41.1|2517|I(a) Lymphoid leukemias|60975441|0-14|All Races|Male and Female|2016|||
7.4|8.8|8.1|493|I(b) Acute myeloid leukemias|60975441|0-14|All Races|Male and Female|2016|||
1.7|2.4|2.0|123|I(c) Chronic myeloproliferative diseases|60975441|0-14|All Races|Male and Female|2016|||
1.2|1.8|1.5|89|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60975441|0-14|All Races|Male and Female|2016|||
1.7|2.5|2.1|128|I(e) Unspecified and other specified leukemias|60975441|0-14|All Races|Male and Female|2016|||
21.0|23.4|22.2|1351|II Lymphomas and reticuloendothelial neoplasms|60975441|0-14|All Races|Male and Female|2016|||
5.2|6.4|5.8|352|II(a) Hodgkin lymphomas|60975441|0-14|All Races|Male and Female|2016|||
7.6|9.1|8.4|508|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60975441|0-14|All Races|Male and Female|2016|||
2.0|2.8|2.4|146|II(c) Burkitt lymphoma|60975441|0-14|All Races|Male and Female|2016|||
4.9|6.1|5.4|333|II(d) Miscellaneous lymphoreticular neoplasms|60975441|0-14|All Races|Male and Female|2016|||
~|~|~|~|II(e) Unspecified lymphomas|60975441|0-14|All Races|Male and Female|2016|||
33.1|36.1|34.6|2113|III CNS and misc intracranial and intraspinal neoplasms|60975441|0-14|All Races|Male and Female|2016|||
2.4|3.3|2.8|173|III(a) Ependymomas and choroid plexus tumor|60975441|0-14|All Races|Male and Female|2016|||
15.7|17.7|16.7|1018|III(b) Astrocytomas|60975441|0-14|All Races|Male and Female|2016|||
6.2|7.5|6.8|418|III(c) Intracranial and intraspinal embryonal tumors|60975441|0-14|All Races|Male and Female|2016|||
6.2|7.5|6.8|415|III(d) Other gliomas|60975441|0-14|All Races|Male and Female|2016|||
0.6|1.1|0.8|51|III(e) Other specified intracranial & intraspinal neoplasms|60975441|0-14|All Races|Male and Female|2016|||
0.4|0.9|0.6|38|III(f) Unspecified intracranial and intraspinal neoplasms|60975441|0-14|All Races|Male and Female|2016|||
10.5|12.2|11.3|697|IV Neuroblastoma and other peripheral nervous cell tumors|60975441|0-14|All Races|Male and Female|2016|||
10.4|12.1|11.2|690|IV(a) Neuroblastoma and ganglioneuroblastoma|60975441|0-14|All Races|Male and Female|2016|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60975441|0-14|All Races|Male and Female|2016|||
10.4|12.1|11.2|685|IX Soft tissue and other extraosseous sarcomas|60975441|0-14|All Races|Male and Female|2016|||
5.0|6.3|5.6|344|IX(a) Rhabdomyosarcomas|60975441|0-14|All Races|Male and Female|2016|||
0.7|1.2|1.0|59|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60975441|0-14|All Races|Male and Female|2016|||
~|~|~|~|IX(c) Kaposi sarcoma|60975441|0-14|All Races|Male and Female|2016|||
3.1|4.1|3.6|218|IX(d) Other specified soft tissue sarcomas|60975441|0-14|All Races|Male and Female|2016|||
0.8|1.3|1.0|63|IX(e) Unspecified soft tissue sarcomas|60975441|0-14|All Races|Male and Female|2016|||
0.2|0.5|0.3|19|Not classified by ICCC|60975441|0-14|All Races|Male and Female|2016|||
3.8|4.8|4.3|263|V Retinoblastoma|60975441|0-14|All Races|Male and Female|2016|||
7.8|9.3|8.6|526|VI Renal tumors|60975441|0-14|All Races|Male and Female|2016|||
7.3|8.8|8.0|493|VI(a) Nephroblastoma and other nonepithelial renal tumors|60975441|0-14|All Races|Male and Female|2016|||
0.3|0.7|0.5|31|VI(b) Renal carcinomas|60975441|0-14|All Races|Male and Female|2016|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60975441|0-14|All Races|Male and Female|2016|||
2.7|3.6|3.1|193|VII Hepatic tumors|60975441|0-14|All Races|Male and Female|2016|||
2.5|3.3|2.9|177|VII(a) Hepatoblastoma|60975441|0-14|All Races|Male and Female|2016|||
~|~|~|~|VII(b) Hepatic carcinomas|60975441|0-14|All Races|Male and Female|2016|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60975441|0-14|All Races|Male and Female|2016|||
7.4|8.8|8.1|489|VIII Malignant bone tumors|60975441|0-14|All Races|Male and Female|2016|||
3.8|4.9|4.3|263|VIII(a) Osteosarcomas|60975441|0-14|All Races|Male and Female|2016|||
~|~|~|~|VIII(b) Chondrosarcomas|60975441|0-14|All Races|Male and Female|2016|||
2.5|3.4|2.9|177|VIII(c) Ewing tumor and related sarcomas of bone|60975441|0-14|All Races|Male and Female|2016|||
0.3|0.7|0.5|31|VIII(d) Other specified malignant bone tumors|60975441|0-14|All Races|Male and Female|2016|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60975441|0-14|All Races|Male and Female|2016|||
5.3|6.5|5.8|357|X Germ cell, trophoblastic tumors & neoplasms of gonads|60975441|0-14|All Races|Male and Female|2016|||
1.5|2.2|1.8|112|X(a) Intracranial & intraspinal germ cell tumors|60975441|0-14|All Races|Male and Female|2016|||
1.0|1.6|1.3|80|X(b) Malignant extracranial & extragonadal germ cell tumors|60975441|0-14|All Races|Male and Female|2016|||
2.1|2.9|2.4|149|X(c) Malignant gonadal germ cell tumors|60975441|0-14|All Races|Male and Female|2016|||
~|~|~|~|X(d) Gonadal carcinomas|60975441|0-14|All Races|Male and Female|2016|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60975441|0-14|All Races|Male and Female|2016|||
9.2|10.8|9.9|603|XI Other malignant epithelial neoplasms and malignant melanomas|60975441|0-14|All Races|Male and Female|2016|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60975441|0-14|All Races|Male and Female|2016|||
3.0|3.9|3.4|207|XI(b) Thyroid carcinomas|60975441|0-14|All Races|Male and Female|2016|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60975441|0-14|All Races|Male and Female|2016|||
1.6|2.3|1.9|116|XI(d) Malignant melanomas|60975441|0-14|All Races|Male and Female|2016|||
~|~|~|~|XI(e) Skin carcinomas|60975441|0-14|All Races|Male and Female|2016|||
3.7|4.8|4.2|255|XI(f) Other and unspecified carcinomas|60975441|0-14|All Races|Male and Female|2016|||
0.6|1.1|0.8|51|XII Other and unspecified malignant neoplasms|60975441|0-14|All Races|Male and Female|2016|||
0.4|0.8|0.5|33|XII(a) Other specified malignant tumors|60975441|0-14|All Races|Male and Female|2016|||
0.2|0.5|0.3|18|XII(b) Other unspecified malignant tumors|60975441|0-14|All Races|Male and Female|2016|||
163.5|170.0|166.7|10185|All ICCC Groups Combined|60962698|0-14|All Races|Male and Female|2017|||
48.4|51.9|50.1|3068|I Leukemias, myeloproliferative & myelodysplastic diseases|60962698|0-14|All Races|Male and Female|2017|||
36.3|39.4|37.8|2319|I(a) Lymphoid leukemias|60962698|0-14|All Races|Male and Female|2017|||
6.8|8.2|7.5|457|I(b) Acute myeloid leukemias|60962698|0-14|All Races|Male and Female|2017|||
1.3|2.0|1.6|100|I(c) Chronic myeloproliferative diseases|60962698|0-14|All Races|Male and Female|2017|||
1.0|1.6|1.2|76|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60962698|0-14|All Races|Male and Female|2017|||
1.6|2.3|1.9|116|I(e) Unspecified and other specified leukemias|60962698|0-14|All Races|Male and Female|2017|||
20.6|23.0|21.8|1328|II Lymphomas and reticuloendothelial neoplasms|60962698|0-14|All Races|Male and Female|2017|||
5.1|6.3|5.7|344|II(a) Hodgkin lymphomas|60962698|0-14|All Races|Male and Female|2017|||
6.4|7.8|7.1|431|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60962698|0-14|All Races|Male and Female|2017|||
2.2|3.0|2.5|155|II(c) Burkitt lymphoma|60962698|0-14|All Races|Male and Female|2017|||
5.8|7.0|6.4|389|II(d) Miscellaneous lymphoreticular neoplasms|60962698|0-14|All Races|Male and Female|2017|||
~|~|~|~|II(e) Unspecified lymphomas|60962698|0-14|All Races|Male and Female|2017|||
33.8|36.8|35.2|2150|III CNS and misc intracranial and intraspinal neoplasms|60962698|0-14|All Races|Male and Female|2017|||
2.9|3.8|3.3|204|III(a) Ependymomas and choroid plexus tumor|60962698|0-14|All Races|Male and Female|2017|||
16.6|18.7|17.6|1077|III(b) Astrocytomas|60962698|0-14|All Races|Male and Female|2017|||
6.1|7.4|6.7|408|III(c) Intracranial and intraspinal embryonal tumors|60962698|0-14|All Races|Male and Female|2017|||
5.8|7.1|6.4|389|III(d) Other gliomas|60962698|0-14|All Races|Male and Female|2017|||
0.4|0.8|0.6|34|III(e) Other specified intracranial & intraspinal neoplasms|60962698|0-14|All Races|Male and Female|2017|||
0.4|0.9|0.6|38|III(f) Unspecified intracranial and intraspinal neoplasms|60962698|0-14|All Races|Male and Female|2017|||
9.5|11.1|10.3|630|IV Neuroblastoma and other peripheral nervous cell tumors|60962698|0-14|All Races|Male and Female|2017|||
9.4|11.0|10.1|622|IV(a) Neuroblastoma and ganglioneuroblastoma|60962698|0-14|All Races|Male and Female|2017|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60962698|0-14|All Races|Male and Female|2017|||
9.8|11.5|10.6|649|IX Soft tissue and other extraosseous sarcomas|60962698|0-14|All Races|Male and Female|2017|||
4.5|5.7|5.1|311|IX(a) Rhabdomyosarcomas|60962698|0-14|All Races|Male and Female|2017|||
0.6|1.1|0.9|52|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60962698|0-14|All Races|Male and Female|2017|||
~|~|~|~|IX(c) Kaposi sarcoma|60962698|0-14|All Races|Male and Female|2017|||
2.8|3.7|3.2|194|IX(d) Other specified soft tissue sarcomas|60962698|0-14|All Races|Male and Female|2017|||
1.2|1.9|1.5|92|IX(e) Unspecified soft tissue sarcomas|60962698|0-14|All Races|Male and Female|2017|||
~|~|~|~|Not classified by ICCC|60962698|0-14|All Races|Male and Female|2017|||
3.5|4.5|4.0|243|V Retinoblastoma|60962698|0-14|All Races|Male and Female|2017|||
7.4|8.9|8.1|500|VI Renal tumors|60962698|0-14|All Races|Male and Female|2017|||
7.0|8.4|7.7|470|VI(a) Nephroblastoma and other nonepithelial renal tumors|60962698|0-14|All Races|Male and Female|2017|||
0.3|0.6|0.4|27|VI(b) Renal carcinomas|60962698|0-14|All Races|Male and Female|2017|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60962698|0-14|All Races|Male and Female|2017|||
2.3|3.2|2.7|167|VII Hepatic tumors|60962698|0-14|All Races|Male and Female|2017|||
2.0|2.8|2.4|147|VII(a) Hepatoblastoma|60962698|0-14|All Races|Male and Female|2017|||
0.2|0.4|0.3|17|VII(b) Hepatic carcinomas|60962698|0-14|All Races|Male and Female|2017|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60962698|0-14|All Races|Male and Female|2017|||
6.6|8.0|7.3|443|VIII Malignant bone tumors|60962698|0-14|All Races|Male and Female|2017|||
3.8|4.8|4.3|259|VIII(a) Osteosarcomas|60962698|0-14|All Races|Male and Female|2017|||
~|~|~|~|VIII(b) Chondrosarcomas|60962698|0-14|All Races|Male and Female|2017|||
2.0|2.8|2.3|143|VIII(c) Ewing tumor and related sarcomas of bone|60962698|0-14|All Races|Male and Female|2017|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|60962698|0-14|All Races|Male and Female|2017|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60962698|0-14|All Races|Male and Female|2017|||
5.4|6.7|6.0|368|X Germ cell, trophoblastic tumors & neoplasms of gonads|60962698|0-14|All Races|Male and Female|2017|||
1.5|2.2|1.9|113|X(a) Intracranial & intraspinal germ cell tumors|60962698|0-14|All Races|Male and Female|2017|||
1.1|1.7|1.4|86|X(b) Malignant extracranial & extragonadal germ cell tumors|60962698|0-14|All Races|Male and Female|2017|||
2.0|2.7|2.3|142|X(c) Malignant gonadal germ cell tumors|60962698|0-14|All Races|Male and Female|2017|||
~|~|~|~|X(d) Gonadal carcinomas|60962698|0-14|All Races|Male and Female|2017|||
0.2|0.5|0.3|21|X(e) Other and unspecified malignant gonadal tumors|60962698|0-14|All Races|Male and Female|2017|||
8.4|10.0|9.2|558|XI Other malignant epithelial neoplasms and malignant melanomas|60962698|0-14|All Races|Male and Female|2017|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60962698|0-14|All Races|Male and Female|2017|||
2.8|3.7|3.2|196|XI(b) Thyroid carcinomas|60962698|0-14|All Races|Male and Female|2017|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60962698|0-14|All Races|Male and Female|2017|||
1.1|1.7|1.4|84|XI(d) Malignant melanomas|60962698|0-14|All Races|Male and Female|2017|||
~|~|~|~|XI(e) Skin carcinomas|60962698|0-14|All Races|Male and Female|2017|||
3.6|4.6|4.1|250|XI(f) Other and unspecified carcinomas|60962698|0-14|All Races|Male and Female|2017|||
0.9|1.4|1.1|70|XII Other and unspecified malignant neoplasms|60962698|0-14|All Races|Male and Female|2017|||
0.4|0.9|0.6|38|XII(a) Other specified malignant tumors|60962698|0-14|All Races|Male and Female|2017|||
0.4|0.7|0.5|32|XII(b) Other unspecified malignant tumors|60962698|0-14|All Races|Male and Female|2017|||
155.8|161.4|158.5|12371|All ICCC Groups Combined|78174581|0-19|All Races|Male and Female|1999|155.5|161.1|158.2
39.2|42.0|40.6|3170|I Leukemias, myeloproliferative & myelodysplastic diseases|78174581|0-19|All Races|Male and Female|1999|39.2|42.0|40.6
28.9|31.3|30.1|2352|I(a) Lymphoid leukemias|78174581|0-19|All Races|Male and Female|1999|28.9|31.3|30.1
7.4|8.6|8.0|623|I(b) Acute myeloid leukemias|78174581|0-19|All Races|Male and Female|1999|7.4|8.6|8.0
0.8|1.2|1.0|78|I(c) Chronic myeloproliferative diseases|78174581|0-19|All Races|Male and Female|1999|0.8|1.2|1.0
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|78174581|0-19|All Races|Male and Female|1999|~|~|~
1.1|1.6|1.3|105|I(e) Unspecified and other specified leukemias|78174581|0-19|All Races|Male and Female|1999|1.1|1.6|1.3
22.2|24.3|23.2|1812|II Lymphomas and reticuloendothelial neoplasms|78174581|0-19|All Races|Male and Female|1999|22.1|24.3|23.2
11.1|12.7|11.9|925|II(a) Hodgkin lymphomas|78174581|0-19|All Races|Male and Female|1999|11.1|12.6|11.8
7.0|8.3|7.6|597|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|78174581|0-19|All Races|Male and Female|1999|7.0|8.3|7.6
2.1|2.8|2.4|188|II(c) Burkitt lymphoma|78174581|0-19|All Races|Male and Female|1999|2.1|2.8|2.4
0.5|0.9|0.7|53|II(d) Miscellaneous lymphoreticular neoplasms|78174581|0-19|All Races|Male and Female|1999|0.5|0.9|0.7
0.5|0.8|0.6|49|II(e) Unspecified lymphomas|78174581|0-19|All Races|Male and Female|1999|0.5|0.8|0.6
27.5|29.9|28.7|2242|III CNS and misc intracranial and intraspinal neoplasms|78174581|0-19|All Races|Male and Female|1999|27.5|29.9|28.7
2.3|3.0|2.6|206|III(a) Ependymomas and choroid plexus tumor|78174581|0-19|All Races|Male and Female|1999|2.3|3.0|2.6
12.8|14.5|13.6|1066|III(b) Astrocytomas|78174581|0-19|All Races|Male and Female|1999|12.8|14.5|13.6
6.1|7.2|6.6|519|III(c) Intracranial and intraspinal embryonal tumors|78174581|0-19|All Races|Male and Female|1999|6.1|7.2|6.6
4.2|5.2|4.7|365|III(d) Other gliomas|78174581|0-19|All Races|Male and Female|1999|4.2|5.2|4.7
0.4|0.7|0.5|39|III(e) Other specified intracranial & intraspinal neoplasms|78174581|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
0.4|0.8|0.6|47|III(f) Unspecified intracranial and intraspinal neoplasms|78174581|0-19|All Races|Male and Female|1999|0.4|0.8|0.6
7.6|8.9|8.2|638|IV Neuroblastoma and other peripheral nervous cell tumors|78174581|0-19|All Races|Male and Female|1999|7.5|8.8|8.2
7.3|8.6|7.9|616|IV(a) Neuroblastoma and ganglioneuroblastoma|78174581|0-19|All Races|Male and Female|1999|7.3|8.5|7.9
0.2|0.4|0.3|22|IV(b) Other peripheral nervous cell tumors|78174581|0-19|All Races|Male and Female|1999|0.2|0.4|0.3
10.2|11.7|10.9|854|IX Soft tissue and other extraosseous sarcomas|78174581|0-19|All Races|Male and Female|1999|10.2|11.7|10.9
4.1|5.0|4.5|355|IX(a) Rhabdomyosarcomas|78174581|0-19|All Races|Male and Female|1999|4.1|5.0|4.5
0.9|1.4|1.1|88|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|78174581|0-19|All Races|Male and Female|1999|0.9|1.4|1.1
~|~|~|~|IX(c) Kaposi sarcoma|78174581|0-19|All Races|Male and Female|1999|~|~|~
3.6|4.5|4.0|311|IX(d) Other specified soft tissue sarcomas|78174581|0-19|All Races|Male and Female|1999|3.5|4.4|4.0
1.0|1.5|1.2|97|IX(e) Unspecified soft tissue sarcomas|78174581|0-19|All Races|Male and Female|1999|1.0|1.5|1.2
0.2|0.4|0.3|22|Not classified by ICCC|78174581|0-19|All Races|Male and Female|1999|0.2|0.4|0.3
2.8|3.6|3.2|246|V Retinoblastoma|78174581|0-19|All Races|Male and Female|1999|2.8|3.6|3.1
5.8|6.9|6.3|494|VI Renal tumors|78174581|0-19|All Races|Male and Female|1999|5.8|6.9|6.3
5.3|6.3|5.8|451|VI(a) Nephroblastoma and other nonepithelial renal tumors|78174581|0-19|All Races|Male and Female|1999|5.2|6.3|5.8
0.4|0.7|0.5|39|VI(b) Renal carcinomas|78174581|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|78174581|0-19|All Races|Male and Female|1999|~|~|~
1.7|2.3|2.0|155|VII Hepatic tumors|78174581|0-19|All Races|Male and Female|1999|1.7|2.3|2.0
1.1|1.6|1.3|102|VII(a) Hepatoblastoma|78174581|0-19|All Races|Male and Female|1999|1.1|1.6|1.3
0.5|0.9|0.7|52|VII(b) Hepatic carcinomas|78174581|0-19|All Races|Male and Female|1999|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|78174581|0-19|All Races|Male and Female|1999|~|~|~
8.2|9.6|8.9|692|VIII Malignant bone tumors|78174581|0-19|All Races|Male and Female|1999|8.2|9.5|8.9
4.6|5.7|5.1|400|VIII(a) Osteosarcomas|78174581|0-19|All Races|Male and Female|1999|4.6|5.6|5.1
0.2|0.5|0.4|28|VIII(b) Chondrosarcomas|78174581|0-19|All Races|Male and Female|1999|0.2|0.5|0.4
2.4|3.1|2.7|212|VIII(c) Ewing tumor and related sarcomas of bone|78174581|0-19|All Races|Male and Female|1999|2.4|3.1|2.7
0.4|0.7|0.5|40|VIII(d) Other specified malignant bone tumors|78174581|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|78174581|0-19|All Races|Male and Female|1999|~|~|~
9.4|10.9|10.1|788|X Germ cell, trophoblastic tumors & neoplasms of gonads|78174581|0-19|All Races|Male and Female|1999|9.4|10.8|10.1
1.1|1.7|1.4|109|X(a) Intracranial & intraspinal germ cell tumors|78174581|0-19|All Races|Male and Female|1999|1.1|1.7|1.4
1.1|1.7|1.4|106|X(b) Malignant extracranial & extragonadal germ cell tumors|78174581|0-19|All Races|Male and Female|1999|1.1|1.6|1.4
6.1|7.3|6.7|522|X(c) Malignant gonadal germ cell tumors|78174581|0-19|All Races|Male and Female|1999|6.1|7.3|6.7
0.3|0.6|0.4|32|X(d) Gonadal carcinomas|78174581|0-19|All Races|Male and Female|1999|0.3|0.6|0.4
0.1|0.4|0.2|19|X(e) Other and unspecified malignant gonadal tumors|78174581|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
14.5|16.2|15.3|1194|XI Other malignant epithelial neoplasms and malignant melanomas|78174581|0-19|All Races|Male and Female|1999|14.4|16.2|15.3
0.1|0.4|0.2|18|XI(a) Adrenocortical carcinomas|78174581|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
5.3|6.4|5.9|457|XI(b) Thyroid carcinomas|78174581|0-19|All Races|Male and Female|1999|5.3|6.4|5.8
0.4|0.7|0.5|41|XI(c) Nasopharyngeal carcinomas|78174581|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
4.3|5.3|4.8|370|XI(d) Malignant melanomas|78174581|0-19|All Races|Male and Female|1999|4.3|5.2|4.7
~|~|~|~|XI(e) Skin carcinomas|78174581|0-19|All Races|Male and Female|1999|~|~|~
3.4|4.3|3.9|301|XI(f) Other and unspecified carcinomas|78174581|0-19|All Races|Male and Female|1999|3.4|4.3|3.9
0.6|1.0|0.8|64|XII Other and unspecified malignant neoplasms|78174581|0-19|All Races|Male and Female|1999|0.6|1.0|0.8
0.1|0.3|0.2|17|XII(a) Other specified malignant tumors|78174581|0-19|All Races|Male and Female|1999|0.1|0.3|0.2
0.4|0.8|0.6|47|XII(b) Other unspecified malignant tumors|78174581|0-19|All Races|Male and Female|1999|0.4|0.8|0.6
161.1|166.8|163.9|12881|All ICCC Groups Combined|78714159|0-19|All Races|Male and Female|2000|160.8|166.5|163.6
40.0|42.8|41.4|3247|I Leukemias, myeloproliferative & myelodysplastic diseases|78714159|0-19|All Races|Male and Female|2000|39.8|42.7|41.3
30.6|33.1|31.8|2496|I(a) Lymphoid leukemias|78714159|0-19|All Races|Male and Female|2000|30.5|33.0|31.7
6.6|7.8|7.1|561|I(b) Acute myeloid leukemias|78714159|0-19|All Races|Male and Female|2000|6.5|7.7|7.1
0.7|1.2|0.9|73|I(c) Chronic myeloproliferative diseases|78714159|0-19|All Races|Male and Female|2000|0.7|1.2|0.9
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|78714159|0-19|All Races|Male and Female|2000|~|~|~
1.1|1.6|1.4|106|I(e) Unspecified and other specified leukemias|78714159|0-19|All Races|Male and Female|2000|1.1|1.6|1.3
23.7|25.9|24.8|1954|II Lymphomas and reticuloendothelial neoplasms|78714159|0-19|All Races|Male and Female|2000|23.7|25.9|24.8
11.5|13.1|12.3|970|II(a) Hodgkin lymphomas|78714159|0-19|All Races|Male and Female|2000|11.6|13.1|12.3
7.5|8.8|8.2|643|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|78714159|0-19|All Races|Male and Female|2000|7.5|8.8|8.2
2.3|3.1|2.7|211|II(c) Burkitt lymphoma|78714159|0-19|All Races|Male and Female|2000|2.3|3.1|2.7
0.8|1.2|1.0|78|II(d) Miscellaneous lymphoreticular neoplasms|78714159|0-19|All Races|Male and Female|2000|0.8|1.2|1.0
0.5|0.9|0.7|52|II(e) Unspecified lymphomas|78714159|0-19|All Races|Male and Female|2000|0.5|0.9|0.7
29.1|31.5|30.3|2380|III CNS and misc intracranial and intraspinal neoplasms|78714159|0-19|All Races|Male and Female|2000|29.0|31.5|30.2
2.0|2.7|2.3|183|III(a) Ependymomas and choroid plexus tumor|78714159|0-19|All Races|Male and Female|2000|2.0|2.7|2.3
14.9|16.7|15.8|1243|III(b) Astrocytomas|78714159|0-19|All Races|Male and Female|2000|14.9|16.7|15.8
5.9|7.0|6.4|506|III(c) Intracranial and intraspinal embryonal tumors|78714159|0-19|All Races|Male and Female|2000|5.9|7.0|6.4
4.1|5.1|4.6|360|III(d) Other gliomas|78714159|0-19|All Races|Male and Female|2000|4.1|5.1|4.6
0.3|0.6|0.5|36|III(e) Other specified intracranial & intraspinal neoplasms|78714159|0-19|All Races|Male and Female|2000|0.3|0.6|0.5
0.5|0.9|0.7|52|III(f) Unspecified intracranial and intraspinal neoplasms|78714159|0-19|All Races|Male and Female|2000|0.5|0.9|0.7
7.1|8.3|7.7|599|IV Neuroblastoma and other peripheral nervous cell tumors|78714159|0-19|All Races|Male and Female|2000|7.0|8.2|7.6
6.9|8.2|7.5|588|IV(a) Neuroblastoma and ganglioneuroblastoma|78714159|0-19|All Races|Male and Female|2000|6.9|8.1|7.5
~|~|~|~|IV(b) Other peripheral nervous cell tumors|78714159|0-19|All Races|Male and Female|2000|~|~|~
11.2|12.7|12.0|941|IX Soft tissue and other extraosseous sarcomas|78714159|0-19|All Races|Male and Female|2000|11.2|12.7|12.0
4.4|5.4|4.9|383|IX(a) Rhabdomyosarcomas|78714159|0-19|All Races|Male and Female|2000|4.4|5.4|4.9
1.0|1.5|1.2|94|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|78714159|0-19|All Races|Male and Female|2000|1.0|1.5|1.2
~|~|~|~|IX(c) Kaposi sarcoma|78714159|0-19|All Races|Male and Female|2000|~|~|~
4.0|5.0|4.5|355|IX(d) Other specified soft tissue sarcomas|78714159|0-19|All Races|Male and Female|2000|4.1|5.0|4.5
1.1|1.6|1.3|105|IX(e) Unspecified soft tissue sarcomas|78714159|0-19|All Races|Male and Female|2000|1.1|1.6|1.3
0.1|0.3|0.2|17|Not classified by ICCC|78714159|0-19|All Races|Male and Female|2000|0.1|0.3|0.2
2.9|3.7|3.3|257|V Retinoblastoma|78714159|0-19|All Races|Male and Female|2000|2.9|3.7|3.3
6.3|7.5|6.9|538|VI Renal tumors|78714159|0-19|All Races|Male and Female|2000|6.3|7.4|6.8
5.8|7.0|6.4|499|VI(a) Nephroblastoma and other nonepithelial renal tumors|78714159|0-19|All Races|Male and Female|2000|5.8|6.9|6.3
0.3|0.6|0.5|37|VI(b) Renal carcinomas|78714159|0-19|All Races|Male and Female|2000|0.3|0.6|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|78714159|0-19|All Races|Male and Female|2000|~|~|~
1.6|2.2|1.8|144|VII Hepatic tumors|78714159|0-19|All Races|Male and Female|2000|1.5|2.2|1.8
1.2|1.7|1.4|113|VII(a) Hepatoblastoma|78714159|0-19|All Races|Male and Female|2000|1.2|1.7|1.4
0.2|0.5|0.4|29|VII(b) Hepatic carcinomas|78714159|0-19|All Races|Male and Female|2000|0.2|0.5|0.4
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|78714159|0-19|All Races|Male and Female|2000|~|~|~
7.7|9.0|8.4|661|VIII Malignant bone tumors|78714159|0-19|All Races|Male and Female|2000|7.8|9.1|8.4
4.2|5.2|4.7|371|VIII(a) Osteosarcomas|78714159|0-19|All Races|Male and Female|2000|4.2|5.2|4.7
~|~|~|~|VIII(b) Chondrosarcomas|78714159|0-19|All Races|Male and Female|2000|~|~|~
2.7|3.5|3.1|241|VIII(c) Ewing tumor and related sarcomas of bone|78714159|0-19|All Races|Male and Female|2000|2.7|3.5|3.1
0.1|0.4|0.2|19|VIII(d) Other specified malignant bone tumors|78714159|0-19|All Races|Male and Female|2000|0.1|0.4|0.2
0.1|0.3|0.2|16|VIII(e) Unspecified malignant bone tumors|78714159|0-19|All Races|Male and Female|2000|0.1|0.3|0.2
10.0|11.5|10.7|845|X Germ cell, trophoblastic tumors & neoplasms of gonads|78714159|0-19|All Races|Male and Female|2000|10.0|11.5|10.7
1.4|2.0|1.6|130|X(a) Intracranial & intraspinal germ cell tumors|78714159|0-19|All Races|Male and Female|2000|1.4|2.0|1.7
1.1|1.7|1.4|109|X(b) Malignant extracranial & extragonadal germ cell tumors|78714159|0-19|All Races|Male and Female|2000|1.1|1.7|1.4
6.4|7.6|7.0|553|X(c) Malignant gonadal germ cell tumors|78714159|0-19|All Races|Male and Female|2000|6.5|7.6|7.0
0.3|0.6|0.4|34|X(d) Gonadal carcinomas|78714159|0-19|All Races|Male and Female|2000|0.3|0.6|0.4
0.1|0.4|0.2|19|X(e) Other and unspecified malignant gonadal tumors|78714159|0-19|All Races|Male and Female|2000|0.1|0.4|0.2
14.8|16.5|15.6|1233|XI Other malignant epithelial neoplasms and malignant melanomas|78714159|0-19|All Races|Male and Female|2000|14.8|16.6|15.7
0.2|0.5|0.3|25|XI(a) Adrenocortical carcinomas|78714159|0-19|All Races|Male and Female|2000|0.2|0.5|0.3
5.1|6.2|5.7|446|XI(b) Thyroid carcinomas|78714159|0-19|All Races|Male and Female|2000|5.2|6.2|5.7
0.4|0.7|0.5|40|XI(c) Nasopharyngeal carcinomas|78714159|0-19|All Races|Male and Female|2000|0.4|0.7|0.5
4.7|5.8|5.2|412|XI(d) Malignant melanomas|78714159|0-19|All Races|Male and Female|2000|4.7|5.8|5.2
~|~|~|~|XI(e) Skin carcinomas|78714159|0-19|All Races|Male and Female|2000|~|~|~
3.4|4.3|3.9|304|XI(f) Other and unspecified carcinomas|78714159|0-19|All Races|Male and Female|2000|3.4|4.3|3.9
0.6|1.1|0.8|65|XII Other and unspecified malignant neoplasms|78714159|0-19|All Races|Male and Female|2000|0.6|1.1|0.8
~|~|~|~|XII(a) Other specified malignant tumors|78714159|0-19|All Races|Male and Female|2000|~|~|~
0.5|0.8|0.6|50|XII(b) Other unspecified malignant tumors|78714159|0-19|All Races|Male and Female|2000|0.5|0.8|0.6
167.6|173.3|170.4|13638|All ICCC Groups Combined|80042731|0-19|All Races|Male and Female|2001|167.5|173.3|170.4
44.2|47.1|45.6|3634|I Leukemias, myeloproliferative & myelodysplastic diseases|80042731|0-19|All Races|Male and Female|2001|43.9|46.9|45.4
31.6|34.2|32.9|2610|I(a) Lymphoid leukemias|80042731|0-19|All Races|Male and Female|2001|31.4|33.9|32.6
7.1|8.4|7.7|620|I(b) Acute myeloid leukemias|80042731|0-19|All Races|Male and Female|2001|7.1|8.4|7.7
1.9|2.6|2.3|182|I(c) Chronic myeloproliferative diseases|80042731|0-19|All Races|Male and Female|2001|2.0|2.6|2.3
1.2|1.8|1.5|118|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|80042731|0-19|All Races|Male and Female|2001|1.2|1.8|1.5
1.1|1.6|1.3|104|I(e) Unspecified and other specified leukemias|80042731|0-19|All Races|Male and Female|2001|1.1|1.6|1.3
23.5|25.7|24.6|1979|II Lymphomas and reticuloendothelial neoplasms|80042731|0-19|All Races|Male and Female|2001|23.6|25.8|24.7
11.7|13.3|12.5|1005|II(a) Hodgkin lymphomas|80042731|0-19|All Races|Male and Female|2001|11.8|13.4|12.6
8.0|9.3|8.7|696|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|80042731|0-19|All Races|Male and Female|2001|8.1|9.4|8.7
1.9|2.5|2.2|174|II(c) Burkitt lymphoma|80042731|0-19|All Races|Male and Female|2001|1.9|2.5|2.2
0.6|1.0|0.8|65|II(d) Miscellaneous lymphoreticular neoplasms|80042731|0-19|All Races|Male and Female|2001|0.6|1.0|0.8
0.3|0.7|0.5|39|II(e) Unspecified lymphomas|80042731|0-19|All Races|Male and Female|2001|0.3|0.7|0.5
28.8|31.2|30.0|2395|III CNS and misc intracranial and intraspinal neoplasms|80042731|0-19|All Races|Male and Female|2001|28.7|31.1|29.9
2.1|2.8|2.5|196|III(a) Ependymomas and choroid plexus tumor|80042731|0-19|All Races|Male and Female|2001|2.1|2.8|2.4
14.2|15.9|15.1|1203|III(b) Astrocytomas|80042731|0-19|All Races|Male and Female|2001|14.2|15.9|15.0
5.9|7.1|6.5|517|III(c) Intracranial and intraspinal embryonal tumors|80042731|0-19|All Races|Male and Female|2001|5.9|7.0|6.5
4.5|5.5|5.0|401|III(d) Other gliomas|80042731|0-19|All Races|Male and Female|2001|4.5|5.5|5.0
0.5|0.8|0.6|49|III(e) Other specified intracranial & intraspinal neoplasms|80042731|0-19|All Races|Male and Female|2001|0.5|0.8|0.6
0.2|0.5|0.4|29|III(f) Unspecified intracranial and intraspinal neoplasms|80042731|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
8.2|9.5|8.9|708|IV Neuroblastoma and other peripheral nervous cell tumors|80042731|0-19|All Races|Male and Female|2001|8.2|9.5|8.8
8.0|9.3|8.7|693|IV(a) Neuroblastoma and ganglioneuroblastoma|80042731|0-19|All Races|Male and Female|2001|8.0|9.3|8.7
~|~|~|~|IV(b) Other peripheral nervous cell tumors|80042731|0-19|All Races|Male and Female|2001|~|~|~
11.2|12.7|11.9|956|IX Soft tissue and other extraosseous sarcomas|80042731|0-19|All Races|Male and Female|2001|11.2|12.7|11.9
4.6|5.6|5.0|401|IX(a) Rhabdomyosarcomas|80042731|0-19|All Races|Male and Female|2001|4.5|5.5|5.0
1.2|1.7|1.4|116|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|80042731|0-19|All Races|Male and Female|2001|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|80042731|0-19|All Races|Male and Female|2001|~|~|~
3.7|4.6|4.1|333|IX(d) Other specified soft tissue sarcomas|80042731|0-19|All Races|Male and Female|2001|3.7|4.6|4.2
1.0|1.5|1.3|103|IX(e) Unspecified soft tissue sarcomas|80042731|0-19|All Races|Male and Female|2001|1.1|1.6|1.3
0.2|0.4|0.2|20|Not classified by ICCC|80042731|0-19|All Races|Male and Female|2001|0.2|0.4|0.2
2.9|3.7|3.3|266|V Retinoblastoma|80042731|0-19|All Races|Male and Female|2001|2.9|3.7|3.3
6.2|7.4|6.8|540|VI Renal tumors|80042731|0-19|All Races|Male and Female|2001|6.2|7.3|6.7
5.7|6.8|6.2|494|VI(a) Nephroblastoma and other nonepithelial renal tumors|80042731|0-19|All Races|Male and Female|2001|5.6|6.7|6.2
0.4|0.7|0.5|43|VI(b) Renal carcinomas|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|80042731|0-19|All Races|Male and Female|2001|~|~|~
1.5|2.1|1.8|145|VII Hepatic tumors|80042731|0-19|All Races|Male and Female|2001|1.5|2.1|1.8
1.0|1.5|1.3|101|VII(a) Hepatoblastoma|80042731|0-19|All Races|Male and Female|2001|1.0|1.5|1.3
0.4|0.7|0.5|43|VII(b) Hepatic carcinomas|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|80042731|0-19|All Races|Male and Female|2001|~|~|~
8.9|10.2|9.5|767|VIII Malignant bone tumors|80042731|0-19|All Races|Male and Female|2001|8.9|10.3|9.6
4.7|5.7|5.2|418|VIII(a) Osteosarcomas|80042731|0-19|All Races|Male and Female|2001|4.7|5.7|5.2
0.2|0.5|0.4|29|VIII(b) Chondrosarcomas|80042731|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
3.0|3.8|3.4|273|VIII(c) Ewing tumor and related sarcomas of bone|80042731|0-19|All Races|Male and Female|2001|3.0|3.8|3.4
0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|80042731|0-19|All Races|Male and Female|2001|0.3|0.6|0.4
~|~|~|~|VIII(e) Unspecified malignant bone tumors|80042731|0-19|All Races|Male and Female|2001|~|~|~
9.7|11.1|10.4|834|X Germ cell, trophoblastic tumors & neoplasms of gonads|80042731|0-19|All Races|Male and Female|2001|9.7|11.2|10.4
1.3|1.9|1.6|128|X(a) Intracranial & intraspinal germ cell tumors|80042731|0-19|All Races|Male and Female|2001|1.3|1.9|1.6
1.3|1.9|1.6|128|X(b) Malignant extracranial & extragonadal germ cell tumors|80042731|0-19|All Races|Male and Female|2001|1.3|1.9|1.6
6.0|7.1|6.6|528|X(c) Malignant gonadal germ cell tumors|80042731|0-19|All Races|Male and Female|2001|6.0|7.2|6.6
0.2|0.5|0.3|26|X(d) Gonadal carcinomas|80042731|0-19|All Races|Male and Female|2001|0.2|0.5|0.3
0.2|0.4|0.3|24|X(e) Other and unspecified malignant gonadal tumors|80042731|0-19|All Races|Male and Female|2001|0.2|0.4|0.3
15.6|17.3|16.4|1323|XI Other malignant epithelial neoplasms and malignant melanomas|80042731|0-19|All Races|Male and Female|2001|15.6|17.4|16.5
0.1|0.4|0.2|18|XI(a) Adrenocortical carcinomas|80042731|0-19|All Races|Male and Female|2001|0.1|0.4|0.2
5.3|6.3|5.8|467|XI(b) Thyroid carcinomas|80042731|0-19|All Races|Male and Female|2001|5.3|6.4|5.8
0.4|0.7|0.5|43|XI(c) Nasopharyngeal carcinomas|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
5.3|6.3|5.8|465|XI(d) Malignant melanomas|80042731|0-19|All Races|Male and Female|2001|5.3|6.4|5.8
~|~|~|~|XI(e) Skin carcinomas|80042731|0-19|All Races|Male and Female|2001|~|~|~
3.6|4.5|4.0|325|XI(f) Other and unspecified carcinomas|80042731|0-19|All Races|Male and Female|2001|3.6|4.5|4.1
0.7|1.1|0.9|71|XII Other and unspecified malignant neoplasms|80042731|0-19|All Races|Male and Female|2001|0.7|1.1|0.9
0.3|0.5|0.4|30|XII(a) Other specified malignant tumors|80042731|0-19|All Races|Male and Female|2001|0.3|0.5|0.4
0.4|0.7|0.5|41|XII(b) Other unspecified malignant tumors|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
167.9|173.6|170.7|13721|All ICCC Groups Combined|80317363|0-19|All Races|Male and Female|2002|168.0|173.7|170.8
43.3|46.2|44.8|3579|I Leukemias, myeloproliferative & myelodysplastic diseases|80317363|0-19|All Races|Male and Female|2002|43.1|46.0|44.6
30.6|33.1|31.8|2538|I(a) Lymphoid leukemias|80317363|0-19|All Races|Male and Female|2002|30.4|32.9|31.6
7.5|8.8|8.1|655|I(b) Acute myeloid leukemias|80317363|0-19|All Races|Male and Female|2002|7.5|8.8|8.2
1.8|2.4|2.1|168|I(c) Chronic myeloproliferative diseases|80317363|0-19|All Races|Male and Female|2002|1.8|2.4|2.1
1.2|1.8|1.5|120|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|80317363|0-19|All Races|Male and Female|2002|1.2|1.8|1.5
1.0|1.5|1.2|98|I(e) Unspecified and other specified leukemias|80317363|0-19|All Races|Male and Female|2002|1.0|1.5|1.2
23.5|25.7|24.6|1988|II Lymphomas and reticuloendothelial neoplasms|80317363|0-19|All Races|Male and Female|2002|23.7|25.9|24.8
11.6|13.2|12.4|1004|II(a) Hodgkin lymphomas|80317363|0-19|All Races|Male and Female|2002|11.7|13.3|12.5
7.6|8.9|8.2|665|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|80317363|0-19|All Races|Male and Female|2002|7.7|8.9|8.3
2.4|3.1|2.7|220|II(c) Burkitt lymphoma|80317363|0-19|All Races|Male and Female|2002|2.4|3.1|2.7
0.7|1.1|0.9|71|II(d) Miscellaneous lymphoreticular neoplasms|80317363|0-19|All Races|Male and Female|2002|0.7|1.1|0.9
0.2|0.5|0.3|28|II(e) Unspecified lymphomas|80317363|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
30.2|32.7|31.4|2514|III CNS and misc intracranial and intraspinal neoplasms|80317363|0-19|All Races|Male and Female|2002|30.1|32.5|31.3
2.6|3.3|2.9|236|III(a) Ependymomas and choroid plexus tumor|80317363|0-19|All Races|Male and Female|2002|2.6|3.3|2.9
14.5|16.3|15.4|1233|III(b) Astrocytomas|80317363|0-19|All Races|Male and Female|2002|14.5|16.2|15.4
5.8|6.9|6.4|508|III(c) Intracranial and intraspinal embryonal tumors|80317363|0-19|All Races|Male and Female|2002|5.8|6.9|6.3
5.1|6.1|5.6|444|III(d) Other gliomas|80317363|0-19|All Races|Male and Female|2002|5.0|6.1|5.5
0.6|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|80317363|0-19|All Races|Male and Female|2002|0.6|0.9|0.7
0.3|0.6|0.4|34|III(f) Unspecified intracranial and intraspinal neoplasms|80317363|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
7.8|9.1|8.5|678|IV Neuroblastoma and other peripheral nervous cell tumors|80317363|0-19|All Races|Male and Female|2002|7.8|9.1|8.4
7.6|8.9|8.2|659|IV(a) Neuroblastoma and ganglioneuroblastoma|80317363|0-19|All Races|Male and Female|2002|7.6|8.9|8.2
0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|80317363|0-19|All Races|Male and Female|2002|0.1|0.4|0.2
11.0|12.5|11.8|947|IX Soft tissue and other extraosseous sarcomas|80317363|0-19|All Races|Male and Female|2002|11.1|12.6|11.8
4.4|5.4|4.9|390|IX(a) Rhabdomyosarcomas|80317363|0-19|All Races|Male and Female|2002|4.4|5.4|4.9
0.9|1.4|1.2|94|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|80317363|0-19|All Races|Male and Female|2002|0.9|1.4|1.2
~|~|~|~|IX(c) Kaposi sarcoma|80317363|0-19|All Races|Male and Female|2002|~|~|~
4.3|5.3|4.8|385|IX(d) Other specified soft tissue sarcomas|80317363|0-19|All Races|Male and Female|2002|4.3|5.3|4.8
0.8|1.2|1.0|78|IX(e) Unspecified soft tissue sarcomas|80317363|0-19|All Races|Male and Female|2002|0.8|1.2|1.0
0.2|0.5|0.3|26|Not classified by ICCC|80317363|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
2.5|3.2|2.8|225|V Retinoblastoma|80317363|0-19|All Races|Male and Female|2002|2.4|3.2|2.8
6.0|7.1|6.5|520|VI Renal tumors|80317363|0-19|All Races|Male and Female|2002|5.9|7.1|6.5
5.5|6.6|6.1|482|VI(a) Nephroblastoma and other nonepithelial renal tumors|80317363|0-19|All Races|Male and Female|2002|5.5|6.6|6.0
0.3|0.6|0.5|37|VI(b) Renal carcinomas|80317363|0-19|All Races|Male and Female|2002|0.3|0.6|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|80317363|0-19|All Races|Male and Female|2002|~|~|~
1.4|2.0|1.7|136|VII Hepatic tumors|80317363|0-19|All Races|Male and Female|2002|1.4|2.0|1.7
0.9|1.4|1.2|93|VII(a) Hepatoblastoma|80317363|0-19|All Races|Male and Female|2002|0.9|1.4|1.2
0.4|0.7|0.5|42|VII(b) Hepatic carcinomas|80317363|0-19|All Races|Male and Female|2002|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|80317363|0-19|All Races|Male and Female|2002|~|~|~
8.5|9.8|9.1|740|VIII Malignant bone tumors|80317363|0-19|All Races|Male and Female|2002|8.6|9.9|9.2
4.4|5.4|4.9|398|VIII(a) Osteosarcomas|80317363|0-19|All Races|Male and Female|2002|4.5|5.5|5.0
0.3|0.6|0.5|38|VIII(b) Chondrosarcomas|80317363|0-19|All Races|Male and Female|2002|0.3|0.6|0.5
2.7|3.5|3.1|250|VIII(c) Ewing tumor and related sarcomas of bone|80317363|0-19|All Races|Male and Female|2002|2.7|3.5|3.1
0.4|0.7|0.5|42|VIII(d) Other specified malignant bone tumors|80317363|0-19|All Races|Male and Female|2002|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|80317363|0-19|All Races|Male and Female|2002|~|~|~
10.3|11.8|11.0|892|X Germ cell, trophoblastic tumors & neoplasms of gonads|80317363|0-19|All Races|Male and Female|2002|10.4|11.9|11.1
1.4|1.9|1.6|132|X(a) Intracranial & intraspinal germ cell tumors|80317363|0-19|All Races|Male and Female|2002|1.4|1.9|1.6
1.3|1.8|1.5|125|X(b) Malignant extracranial & extragonadal germ cell tumors|80317363|0-19|All Races|Male and Female|2002|1.3|1.9|1.6
6.6|7.8|7.2|581|X(c) Malignant gonadal germ cell tumors|80317363|0-19|All Races|Male and Female|2002|6.7|7.8|7.2
0.2|0.5|0.4|29|X(d) Gonadal carcinomas|80317363|0-19|All Races|Male and Female|2002|0.2|0.5|0.4
0.2|0.5|0.3|25|X(e) Other and unspecified malignant gonadal tumors|80317363|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
16.4|18.2|17.3|1403|XI Other malignant epithelial neoplasms and malignant melanomas|80317363|0-19|All Races|Male and Female|2002|16.6|18.4|17.5
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|80317363|0-19|All Races|Male and Female|2002|0.1|0.4|0.2
5.3|6.4|5.8|472|XI(b) Thyroid carcinomas|80317363|0-19|All Races|Male and Female|2002|5.4|6.4|5.9
0.4|0.8|0.6|49|XI(c) Nasopharyngeal carcinomas|80317363|0-19|All Races|Male and Female|2002|0.5|0.8|0.6
6.0|7.1|6.5|527|XI(d) Malignant melanomas|80317363|0-19|All Races|Male and Female|2002|6.0|7.1|6.6
~|~|~|~|XI(e) Skin carcinomas|80317363|0-19|All Races|Male and Female|2002|~|~|~
3.6|4.5|4.0|328|XI(f) Other and unspecified carcinomas|80317363|0-19|All Races|Male and Female|2002|3.7|4.6|4.1
0.7|1.1|0.9|73|XII Other and unspecified malignant neoplasms|80317363|0-19|All Races|Male and Female|2002|0.7|1.1|0.9
0.3|0.6|0.5|37|XII(a) Other specified malignant tumors|80317363|0-19|All Races|Male and Female|2002|0.3|0.6|0.5
0.3|0.6|0.4|36|XII(b) Other unspecified malignant tumors|80317363|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
165.0|170.6|167.8|13700|All ICCC Groups Combined|81425816|0-19|All Races|Male and Female|2003|165.4|171.1|168.3
42.0|44.9|43.5|3525|I Leukemias, myeloproliferative & myelodysplastic diseases|81425816|0-19|All Races|Male and Female|2003|41.9|44.7|43.3
29.5|31.9|30.7|2477|I(a) Lymphoid leukemias|81425816|0-19|All Races|Male and Female|2003|29.2|31.6|30.4
7.2|8.4|7.8|639|I(b) Acute myeloid leukemias|81425816|0-19|All Races|Male and Female|2003|7.3|8.5|7.8
2.0|2.6|2.3|188|I(c) Chronic myeloproliferative diseases|81425816|0-19|All Races|Male and Female|2003|2.0|2.7|2.3
1.4|2.0|1.7|137|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81425816|0-19|All Races|Male and Female|2003|1.4|2.0|1.7
0.8|1.3|1.0|84|I(e) Unspecified and other specified leukemias|81425816|0-19|All Races|Male and Female|2003|0.8|1.3|1.0
23.2|25.3|24.2|1988|II Lymphomas and reticuloendothelial neoplasms|81425816|0-19|All Races|Male and Female|2003|23.4|25.5|24.4
11.7|13.2|12.4|1026|II(a) Hodgkin lymphomas|81425816|0-19|All Races|Male and Female|2003|11.8|13.4|12.6
7.5|8.7|8.1|661|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81425816|0-19|All Races|Male and Female|2003|7.5|8.8|8.1
2.3|3.0|2.6|212|II(c) Burkitt lymphoma|81425816|0-19|All Races|Male and Female|2003|2.3|3.0|2.6
0.7|1.1|0.9|73|II(d) Miscellaneous lymphoreticular neoplasms|81425816|0-19|All Races|Male and Female|2003|0.7|1.1|0.9
0.1|0.3|0.2|16|II(e) Unspecified lymphomas|81425816|0-19|All Races|Male and Female|2003|0.1|0.3|0.2
29.0|31.4|30.2|2447|III CNS and misc intracranial and intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003|28.9|31.3|30.1
2.0|2.7|2.3|188|III(a) Ependymomas and choroid plexus tumor|81425816|0-19|All Races|Male and Female|2003|2.0|2.7|2.3
14.5|16.2|15.3|1243|III(b) Astrocytomas|81425816|0-19|All Races|Male and Female|2003|14.4|16.1|15.3
5.6|6.7|6.1|494|III(c) Intracranial and intraspinal embryonal tumors|81425816|0-19|All Races|Male and Female|2003|5.5|6.6|6.1
4.7|5.7|5.2|424|III(d) Other gliomas|81425816|0-19|All Races|Male and Female|2003|4.7|5.7|5.2
0.7|1.1|0.8|68|III(e) Other specified intracranial & intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003|0.6|1.1|0.8
0.2|0.5|0.4|30|III(f) Unspecified intracranial and intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003|0.2|0.5|0.4
7.6|8.9|8.2|669|IV Neuroblastoma and other peripheral nervous cell tumors|81425816|0-19|All Races|Male and Female|2003|7.6|8.9|8.2
7.4|8.7|8.0|654|IV(a) Neuroblastoma and ganglioneuroblastoma|81425816|0-19|All Races|Male and Female|2003|7.4|8.7|8.0
~|~|~|~|IV(b) Other peripheral nervous cell tumors|81425816|0-19|All Races|Male and Female|2003|~|~|~
11.5|13.0|12.2|1000|IX Soft tissue and other extraosseous sarcomas|81425816|0-19|All Races|Male and Female|2003|11.5|13.1|12.3
4.3|5.3|4.8|389|IX(a) Rhabdomyosarcomas|81425816|0-19|All Races|Male and Female|2003|4.3|5.3|4.8
1.2|1.7|1.5|119|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81425816|0-19|All Races|Male and Female|2003|1.2|1.7|1.5
~|~|~|~|IX(c) Kaposi sarcoma|81425816|0-19|All Races|Male and Female|2003|~|~|~
4.2|5.2|4.7|387|IX(d) Other specified soft tissue sarcomas|81425816|0-19|All Races|Male and Female|2003|4.3|5.3|4.8
1.0|1.5|1.2|102|IX(e) Unspecified soft tissue sarcomas|81425816|0-19|All Races|Male and Female|2003|1.0|1.5|1.3
0.1|0.4|0.2|19|Not classified by ICCC|81425816|0-19|All Races|Male and Female|2003|0.1|0.4|0.2
2.7|3.5|3.1|251|V Retinoblastoma|81425816|0-19|All Races|Male and Female|2003|2.7|3.5|3.1
6.2|7.3|6.7|544|VI Renal tumors|81425816|0-19|All Races|Male and Female|2003|6.1|7.3|6.7
5.6|6.7|6.1|495|VI(a) Nephroblastoma and other nonepithelial renal tumors|81425816|0-19|All Races|Male and Female|2003|5.6|6.6|6.1
0.4|0.7|0.5|45|VI(b) Renal carcinomas|81425816|0-19|All Races|Male and Female|2003|0.4|0.7|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|81425816|0-19|All Races|Male and Female|2003|~|~|~
1.8|2.5|2.1|174|VII Hepatic tumors|81425816|0-19|All Races|Male and Female|2003|1.8|2.5|2.1
1.3|1.8|1.5|124|VII(a) Hepatoblastoma|81425816|0-19|All Races|Male and Female|2003|1.3|1.8|1.5
0.5|0.8|0.6|50|VII(b) Hepatic carcinomas|81425816|0-19|All Races|Male and Female|2003|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81425816|0-19|All Races|Male and Female|2003|~|~|~
8.0|9.3|8.7|714|VIII Malignant bone tumors|81425816|0-19|All Races|Male and Female|2003|8.1|9.4|8.8
4.8|5.8|5.3|436|VIII(a) Osteosarcomas|81425816|0-19|All Races|Male and Female|2003|4.9|5.9|5.4
0.2|0.4|0.3|21|VIII(b) Chondrosarcomas|81425816|0-19|All Races|Male and Female|2003|0.2|0.4|0.3
2.2|2.9|2.6|212|VIII(c) Ewing tumor and related sarcomas of bone|81425816|0-19|All Races|Male and Female|2003|2.3|3.0|2.6
0.2|0.5|0.3|28|VIII(d) Other specified malignant bone tumors|81425816|0-19|All Races|Male and Female|2003|0.2|0.5|0.3
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|81425816|0-19|All Races|Male and Female|2003|0.1|0.3|0.2
9.6|11.0|10.3|849|X Germ cell, trophoblastic tumors & neoplasms of gonads|81425816|0-19|All Races|Male and Female|2003|9.7|11.2|10.4
1.1|1.6|1.4|113|X(a) Intracranial & intraspinal germ cell tumors|81425816|0-19|All Races|Male and Female|2003|1.1|1.7|1.4
1.2|1.8|1.5|121|X(b) Malignant extracranial & extragonadal germ cell tumors|81425816|0-19|All Races|Male and Female|2003|1.2|1.8|1.5
6.2|7.3|6.7|554|X(c) Malignant gonadal germ cell tumors|81425816|0-19|All Races|Male and Female|2003|6.2|7.4|6.8
0.2|0.5|0.3|29|X(d) Gonadal carcinomas|81425816|0-19|All Races|Male and Female|2003|0.2|0.5|0.4
0.3|0.5|0.4|32|X(e) Other and unspecified malignant gonadal tumors|81425816|0-19|All Races|Male and Female|2003|0.3|0.6|0.4
16.4|18.2|17.3|1432|XI Other malignant epithelial neoplasms and malignant melanomas|81425816|0-19|All Races|Male and Female|2003|16.7|18.5|17.6
0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|81425816|0-19|All Races|Male and Female|2003|0.2|0.4|0.2
5.6|6.7|6.2|511|XI(b) Thyroid carcinomas|81425816|0-19|All Races|Male and Female|2003|5.7|6.8|6.3
0.5|0.9|0.7|54|XI(c) Nasopharyngeal carcinomas|81425816|0-19|All Races|Male and Female|2003|0.5|0.9|0.7
5.4|6.5|5.9|491|XI(d) Malignant melanomas|81425816|0-19|All Races|Male and Female|2003|5.5|6.6|6.0
~|~|~|~|XI(e) Skin carcinomas|81425816|0-19|All Races|Male and Female|2003|~|~|~
3.8|4.7|4.2|347|XI(f) Other and unspecified carcinomas|81425816|0-19|All Races|Male and Female|2003|3.8|4.7|4.3
0.9|1.3|1.1|88|XII Other and unspecified malignant neoplasms|81425816|0-19|All Races|Male and Female|2003|0.9|1.3|1.1
0.3|0.7|0.5|40|XII(a) Other specified malignant tumors|81425816|0-19|All Races|Male and Female|2003|0.4|0.7|0.5
0.4|0.8|0.6|48|XII(b) Other unspecified malignant tumors|81425816|0-19|All Races|Male and Female|2003|0.4|0.8|0.6
171.4|177.1|174.3|14318|All ICCC Groups Combined|81754354|0-19|All Races|Male and Female|2004|172.3|178.0|175.1
44.8|47.7|46.2|3770|I Leukemias, myeloproliferative & myelodysplastic diseases|81754354|0-19|All Races|Male and Female|2004|44.7|47.6|46.1
32.0|34.5|33.3|2702|I(a) Lymphoid leukemias|81754354|0-19|All Races|Male and Female|2004|31.8|34.3|33.1
7.6|8.9|8.2|676|I(b) Acute myeloid leukemias|81754354|0-19|All Races|Male and Female|2004|7.7|8.9|8.3
1.9|2.5|2.2|180|I(c) Chronic myeloproliferative diseases|81754354|0-19|All Races|Male and Female|2004|1.9|2.5|2.2
1.1|1.6|1.4|112|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81754354|0-19|All Races|Male and Female|2004|1.1|1.6|1.4
1.0|1.5|1.2|100|I(e) Unspecified and other specified leukemias|81754354|0-19|All Races|Male and Female|2004|1.0|1.5|1.2
23.1|25.2|24.1|1997|II Lymphomas and reticuloendothelial neoplasms|81754354|0-19|All Races|Male and Female|2004|23.4|25.5|24.4
11.1|12.6|11.8|988|II(a) Hodgkin lymphomas|81754354|0-19|All Races|Male and Female|2004|11.3|12.9|12.1
7.9|9.2|8.5|704|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81754354|0-19|All Races|Male and Female|2004|8.0|9.3|8.6
2.0|2.7|2.3|191|II(c) Burkitt lymphoma|81754354|0-19|All Races|Male and Female|2004|2.0|2.7|2.3
0.9|1.3|1.1|87|II(d) Miscellaneous lymphoreticular neoplasms|81754354|0-19|All Races|Male and Female|2004|0.9|1.3|1.1
0.2|0.5|0.3|27|II(e) Unspecified lymphomas|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
30.9|33.4|32.1|2615|III CNS and misc intracranial and intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|30.8|33.2|32.0
2.4|3.1|2.7|224|III(a) Ependymomas and choroid plexus tumor|81754354|0-19|All Races|Male and Female|2004|2.4|3.1|2.7
15.6|17.4|16.5|1345|III(b) Astrocytomas|81754354|0-19|All Races|Male and Female|2004|15.6|17.4|16.5
6.0|7.2|6.6|533|III(c) Intracranial and intraspinal embryonal tumors|81754354|0-19|All Races|Male and Female|2004|6.0|7.1|6.5
4.6|5.6|5.1|411|III(d) Other gliomas|81754354|0-19|All Races|Male and Female|2004|4.6|5.5|5.0
0.5|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|0.5|0.9|0.7
0.4|0.7|0.5|43|III(f) Unspecified intracranial and intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
7.9|9.1|8.5|695|IV Neuroblastoma and other peripheral nervous cell tumors|81754354|0-19|All Races|Male and Female|2004|7.9|9.2|8.5
7.6|8.8|8.2|672|IV(a) Neuroblastoma and ganglioneuroblastoma|81754354|0-19|All Races|Male and Female|2004|7.6|8.9|8.2
0.2|0.4|0.3|23|IV(b) Other peripheral nervous cell tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.4|0.3
11.3|12.8|12.0|991|IX Soft tissue and other extraosseous sarcomas|81754354|0-19|All Races|Male and Female|2004|11.4|12.9|12.1
3.9|4.8|4.3|351|IX(a) Rhabdomyosarcomas|81754354|0-19|All Races|Male and Female|2004|3.9|4.8|4.3
1.1|1.6|1.4|113|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81754354|0-19|All Races|Male and Female|2004|1.1|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|81754354|0-19|All Races|Male and Female|2004|~|~|~
4.6|5.6|5.1|423|IX(d) Other specified soft tissue sarcomas|81754354|0-19|All Races|Male and Female|2004|4.7|5.7|5.2
1.0|1.5|1.2|100|IX(e) Unspecified soft tissue sarcomas|81754354|0-19|All Races|Male and Female|2004|1.0|1.5|1.2
0.2|0.4|0.3|25|Not classified by ICCC|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
2.9|3.6|3.2|266|V Retinoblastoma|81754354|0-19|All Races|Male and Female|2004|2.9|3.7|3.3
6.0|7.1|6.5|530|VI Renal tumors|81754354|0-19|All Races|Male and Female|2004|5.9|7.1|6.5
5.4|6.5|5.9|480|VI(a) Nephroblastoma and other nonepithelial renal tumors|81754354|0-19|All Races|Male and Female|2004|5.4|6.4|5.9
0.4|0.8|0.6|47|VI(b) Renal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
2.1|2.7|2.4|196|VII Hepatic tumors|81754354|0-19|All Races|Male and Female|2004|2.1|2.8|2.4
1.5|2.1|1.8|144|VII(a) Hepatoblastoma|81754354|0-19|All Races|Male and Female|2004|1.5|2.1|1.8
0.4|0.8|0.6|48|VII(b) Hepatic carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
8.4|9.7|9.1|750|VIII Malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|8.5|9.9|9.2
4.7|5.7|5.1|426|VIII(a) Osteosarcomas|81754354|0-19|All Races|Male and Female|2004|4.7|5.7|5.2
0.4|0.7|0.5|42|VIII(b) Chondrosarcomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
2.4|3.1|2.7|227|VIII(c) Ewing tumor and related sarcomas of bone|81754354|0-19|All Races|Male and Female|2004|2.4|3.2|2.8
0.4|0.7|0.5|42|VIII(d) Other specified malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
10.4|11.9|11.1|928|X Germ cell, trophoblastic tumors & neoplasms of gonads|81754354|0-19|All Races|Male and Female|2004|10.6|12.1|11.4
1.5|2.1|1.8|148|X(a) Intracranial & intraspinal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|1.5|2.1|1.8
1.1|1.6|1.3|110|X(b) Malignant extracranial & extragonadal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|1.1|1.6|1.3
6.7|7.9|7.3|609|X(c) Malignant gonadal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|6.9|8.1|7.4
0.3|0.6|0.4|33|X(d) Gonadal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.3|0.6|0.4
0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
16.9|18.7|17.8|1483|XI Other malignant epithelial neoplasms and malignant melanomas|81754354|0-19|All Races|Male and Female|2004|17.2|19.1|18.1
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|81754354|0-19|All Races|Male and Female|2004|0.1|0.4|0.2
6.3|7.4|6.8|567|XI(b) Thyroid carcinomas|81754354|0-19|All Races|Male and Female|2004|6.4|7.5|6.9
0.4|0.7|0.5|46|XI(c) Nasopharyngeal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
5.9|7.0|6.4|536|XI(d) Malignant melanomas|81754354|0-19|All Races|Male and Female|2004|6.0|7.1|6.6
~|~|~|~|XI(e) Skin carcinomas|81754354|0-19|All Races|Male and Female|2004|~|~|~
3.3|4.1|3.7|307|XI(f) Other and unspecified carcinomas|81754354|0-19|All Races|Male and Female|2004|3.3|4.2|3.8
0.7|1.1|0.9|72|XII Other and unspecified malignant neoplasms|81754354|0-19|All Races|Male and Female|2004|0.7|1.1|0.9
0.2|0.5|0.3|28|XII(a) Other specified malignant tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
0.4|0.7|0.5|44|XII(b) Other unspecified malignant tumors|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
169.8|175.5|172.6|14265|All ICCC Groups Combined|82005260|0-19|All Races|Male and Female|2005|171.1|176.8|174.0
43.1|46.1|44.6|3651|I Leukemias, myeloproliferative & myelodysplastic diseases|82005260|0-19|All Races|Male and Female|2005|43.1|46.0|44.5
30.8|33.3|32.0|2614|I(a) Lymphoid leukemias|82005260|0-19|All Races|Male and Female|2005|30.7|33.1|31.9
7.0|8.2|7.6|625|I(b) Acute myeloid leukemias|82005260|0-19|All Races|Male and Female|2005|7.0|8.2|7.6
1.8|2.4|2.1|173|I(c) Chronic myeloproliferative diseases|82005260|0-19|All Races|Male and Female|2005|1.8|2.4|2.1
1.3|1.9|1.6|132|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82005260|0-19|All Races|Male and Female|2005|1.3|1.9|1.6
1.1|1.6|1.3|107|I(e) Unspecified and other specified leukemias|82005260|0-19|All Races|Male and Female|2005|1.1|1.6|1.3
24.7|26.9|25.8|2154|II Lymphomas and reticuloendothelial neoplasms|82005260|0-19|All Races|Male and Female|2005|25.2|27.4|26.3
11.9|13.5|12.7|1068|II(a) Hodgkin lymphomas|82005260|0-19|All Races|Male and Female|2005|12.3|13.8|13.0
8.4|9.7|9.0|748|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82005260|0-19|All Races|Male and Female|2005|8.5|9.8|9.1
2.2|2.9|2.5|205|II(c) Burkitt lymphoma|82005260|0-19|All Races|Male and Female|2005|2.2|2.9|2.5
1.0|1.5|1.3|104|II(d) Miscellaneous lymphoreticular neoplasms|82005260|0-19|All Races|Male and Female|2005|1.0|1.5|1.3
0.2|0.5|0.3|29|II(e) Unspecified lymphomas|82005260|0-19|All Races|Male and Female|2005|0.2|0.5|0.4
29.1|31.5|30.3|2471|III CNS and misc intracranial and intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|29.0|31.3|30.1
2.6|3.3|2.9|241|III(a) Ependymomas and choroid plexus tumor|82005260|0-19|All Races|Male and Female|2005|2.6|3.3|2.9
14.6|16.3|15.4|1263|III(b) Astrocytomas|82005260|0-19|All Races|Male and Female|2005|14.6|16.3|15.4
5.4|6.5|5.9|480|III(c) Intracranial and intraspinal embryonal tumors|82005260|0-19|All Races|Male and Female|2005|5.3|6.4|5.9
4.4|5.4|4.9|397|III(d) Other gliomas|82005260|0-19|All Races|Male and Female|2005|4.4|5.3|4.8
0.5|0.8|0.6|52|III(e) Other specified intracranial & intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|0.5|0.8|0.6
0.3|0.6|0.5|38|III(f) Unspecified intracranial and intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.5
8.4|9.7|9.0|744|IV Neuroblastoma and other peripheral nervous cell tumors|82005260|0-19|All Races|Male and Female|2005|8.4|9.7|9.1
8.2|9.5|8.8|726|IV(a) Neuroblastoma and ganglioneuroblastoma|82005260|0-19|All Races|Male and Female|2005|8.2|9.5|8.9
0.1|0.3|0.2|18|IV(b) Other peripheral nervous cell tumors|82005260|0-19|All Races|Male and Female|2005|0.1|0.3|0.2
11.6|13.1|12.3|1019|IX Soft tissue and other extraosseous sarcomas|82005260|0-19|All Races|Male and Female|2005|11.7|13.2|12.4
4.4|5.4|4.9|399|IX(a) Rhabdomyosarcomas|82005260|0-19|All Races|Male and Female|2005|4.4|5.4|4.9
1.2|1.7|1.4|117|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82005260|0-19|All Races|Male and Female|2005|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82005260|0-19|All Races|Male and Female|2005|~|~|~
4.4|5.4|4.9|408|IX(d) Other specified soft tissue sarcomas|82005260|0-19|All Races|Male and Female|2005|4.5|5.5|5.0
0.9|1.4|1.1|91|IX(e) Unspecified soft tissue sarcomas|82005260|0-19|All Races|Male and Female|2005|0.9|1.4|1.1
0.2|0.4|0.3|23|Not classified by ICCC|82005260|0-19|All Races|Male and Female|2005|0.2|0.4|0.3
2.6|3.3|2.9|243|V Retinoblastoma|82005260|0-19|All Races|Male and Female|2005|2.6|3.4|3.0
6.1|7.3|6.7|547|VI Renal tumors|82005260|0-19|All Races|Male and Female|2005|6.1|7.3|6.7
5.5|6.6|6.0|493|VI(a) Nephroblastoma and other nonepithelial renal tumors|82005260|0-19|All Races|Male and Female|2005|5.5|6.6|6.0
0.4|0.8|0.6|50|VI(b) Renal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.5|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|82005260|0-19|All Races|Male and Female|2005|~|~|~
1.7|2.3|2.0|167|VII Hepatic tumors|82005260|0-19|All Races|Male and Female|2005|1.7|2.4|2.0
1.2|1.7|1.4|117|VII(a) Hepatoblastoma|82005260|0-19|All Races|Male and Female|2005|1.2|1.7|1.4
0.4|0.8|0.6|48|VII(b) Hepatic carcinomas|82005260|0-19|All Races|Male and Female|2005|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82005260|0-19|All Races|Male and Female|2005|~|~|~
8.2|9.5|8.9|736|VIII Malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|8.3|9.6|9.0
4.5|5.5|5.0|417|VIII(a) Osteosarcomas|82005260|0-19|All Races|Male and Female|2005|4.6|5.6|5.1
0.2|0.4|0.3|23|VIII(b) Chondrosarcomas|82005260|0-19|All Races|Male and Female|2005|0.2|0.4|0.3
2.6|3.3|2.9|243|VIII(c) Ewing tumor and related sarcomas of bone|82005260|0-19|All Races|Male and Female|2005|2.6|3.4|3.0
0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|0.1|0.3|0.2
10.7|12.2|11.4|963|X Germ cell, trophoblastic tumors & neoplasms of gonads|82005260|0-19|All Races|Male and Female|2005|11.0|12.5|11.7
1.3|1.9|1.6|133|X(a) Intracranial & intraspinal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|1.4|1.9|1.6
1.3|1.9|1.6|134|X(b) Malignant extracranial & extragonadal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|1.4|1.9|1.6
6.9|8.1|7.5|636|X(c) Malignant gonadal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|7.2|8.4|7.8
0.3|0.5|0.4|32|X(d) Gonadal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|82005260|0-19|All Races|Male and Female|2005|0.2|0.5|0.3
16.6|18.4|17.4|1472|XI Other malignant epithelial neoplasms and malignant melanomas|82005260|0-19|All Races|Male and Female|2005|17.0|18.9|18.0
~|~|~|~|XI(a) Adrenocortical carcinomas|82005260|0-19|All Races|Male and Female|2005|~|~|~
5.6|6.7|6.1|516|XI(b) Thyroid carcinomas|82005260|0-19|All Races|Male and Female|2005|5.8|6.9|6.3
0.3|0.5|0.4|33|XI(c) Nasopharyngeal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
6.0|7.1|6.5|550|XI(d) Malignant melanomas|82005260|0-19|All Races|Male and Female|2005|6.2|7.3|6.7
~|~|~|~|XI(e) Skin carcinomas|82005260|0-19|All Races|Male and Female|2005|~|~|~
3.8|4.7|4.2|354|XI(f) Other and unspecified carcinomas|82005260|0-19|All Races|Male and Female|2005|3.9|4.8|4.3
0.7|1.1|0.9|75|XII Other and unspecified malignant neoplasms|82005260|0-19|All Races|Male and Female|2005|0.7|1.1|0.9
0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.4|0.7|0.5|43|XII(b) Other unspecified malignant tumors|82005260|0-19|All Races|Male and Female|2005|0.4|0.7|0.5
170.3|176.0|173.1|14369|All ICCC Groups Combined|82324418|0-19|All Races|Male and Female|2006|171.7|177.4|174.5
45.5|48.4|46.9|3858|I Leukemias, myeloproliferative & myelodysplastic diseases|82324418|0-19|All Races|Male and Female|2006|45.4|48.4|46.9
32.0|34.6|33.3|2723|I(a) Lymphoid leukemias|82324418|0-19|All Races|Male and Female|2006|31.8|34.3|33.1
7.6|8.8|8.2|680|I(b) Acute myeloid leukemias|82324418|0-19|All Races|Male and Female|2006|7.7|8.9|8.3
2.1|2.8|2.4|201|I(c) Chronic myeloproliferative diseases|82324418|0-19|All Races|Male and Female|2006|2.1|2.8|2.4
1.4|2.0|1.7|138|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82324418|0-19|All Races|Male and Female|2006|1.4|2.0|1.7
1.2|1.7|1.4|116|I(e) Unspecified and other specified leukemias|82324418|0-19|All Races|Male and Female|2006|1.2|1.7|1.4
24.0|26.2|25.1|2105|II Lymphomas and reticuloendothelial neoplasms|82324418|0-19|All Races|Male and Female|2006|24.5|26.7|25.6
11.7|13.3|12.5|1057|II(a) Hodgkin lymphomas|82324418|0-19|All Races|Male and Female|2006|12.1|13.6|12.8
8.1|9.4|8.7|727|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82324418|0-19|All Races|Male and Female|2006|8.2|9.5|8.8
2.1|2.8|2.4|200|II(c) Burkitt lymphoma|82324418|0-19|All Races|Male and Female|2006|2.1|2.8|2.4
1.0|1.5|1.2|98|II(d) Miscellaneous lymphoreticular neoplasms|82324418|0-19|All Races|Male and Female|2006|1.0|1.5|1.2
0.2|0.4|0.3|23|II(e) Unspecified lymphomas|82324418|0-19|All Races|Male and Female|2006|0.2|0.4|0.3
30.1|32.6|31.3|2567|III CNS and misc intracranial and intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|30.0|32.4|31.2
2.5|3.2|2.8|234|III(a) Ependymomas and choroid plexus tumor|82324418|0-19|All Races|Male and Female|2006|2.5|3.2|2.8
14.6|16.4|15.5|1271|III(b) Astrocytomas|82324418|0-19|All Races|Male and Female|2006|14.6|16.3|15.4
5.8|6.9|6.3|517|III(c) Intracranial and intraspinal embryonal tumors|82324418|0-19|All Races|Male and Female|2006|5.8|6.8|6.3
5.0|6.0|5.5|447|III(d) Other gliomas|82324418|0-19|All Races|Male and Female|2006|4.9|6.0|5.4
0.4|0.8|0.6|48|III(e) Other specified intracranial & intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|0.4|0.8|0.6
0.5|0.8|0.6|50|III(f) Unspecified intracranial and intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
7.3|8.5|7.9|652|IV Neuroblastoma and other peripheral nervous cell tumors|82324418|0-19|All Races|Male and Female|2006|7.3|8.6|7.9
7.2|8.4|7.7|638|IV(a) Neuroblastoma and ganglioneuroblastoma|82324418|0-19|All Races|Male and Female|2006|7.2|8.4|7.7
~|~|~|~|IV(b) Other peripheral nervous cell tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
11.0|12.5|11.7|973|IX Soft tissue and other extraosseous sarcomas|82324418|0-19|All Races|Male and Female|2006|11.1|12.6|11.8
4.1|5.1|4.6|376|IX(a) Rhabdomyosarcomas|82324418|0-19|All Races|Male and Female|2006|4.1|5.1|4.6
1.1|1.6|1.3|109|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82324418|0-19|All Races|Male and Female|2006|1.1|1.6|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82324418|0-19|All Races|Male and Female|2006|~|~|~
4.1|5.0|4.5|380|IX(d) Other specified soft tissue sarcomas|82324418|0-19|All Races|Male and Female|2006|4.2|5.1|4.6
1.0|1.5|1.2|103|IX(e) Unspecified soft tissue sarcomas|82324418|0-19|All Races|Male and Female|2006|1.0|1.5|1.3
0.2|0.4|0.3|23|Not classified by ICCC|82324418|0-19|All Races|Male and Female|2006|0.2|0.4|0.3
2.7|3.5|3.1|254|V Retinoblastoma|82324418|0-19|All Races|Male and Female|2006|2.7|3.5|3.1
6.2|7.3|6.7|551|VI Renal tumors|82324418|0-19|All Races|Male and Female|2006|6.1|7.3|6.7
5.5|6.5|6.0|487|VI(a) Nephroblastoma and other nonepithelial renal tumors|82324418|0-19|All Races|Male and Female|2006|5.4|6.5|5.9
0.5|0.9|0.7|58|VI(b) Renal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
2.0|2.7|2.3|192|VII Hepatic tumors|82324418|0-19|All Races|Male and Female|2006|2.0|2.7|2.3
1.4|1.9|1.6|135|VII(a) Hepatoblastoma|82324418|0-19|All Races|Male and Female|2006|1.4|1.9|1.6
0.5|0.8|0.6|53|VII(b) Hepatic carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
8.6|10.0|9.3|775|VIII Malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|8.8|10.1|9.4
4.9|5.9|5.4|449|VIII(a) Osteosarcomas|82324418|0-19|All Races|Male and Female|2006|5.0|6.0|5.5
0.1|0.3|0.2|17|VIII(b) Chondrosarcomas|82324418|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
2.7|3.4|3.0|251|VIII(c) Ewing tumor and related sarcomas of bone|82324418|0-19|All Races|Male and Female|2006|2.7|3.5|3.0
0.4|0.7|0.5|44|VIII(d) Other specified malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
9.6|11.0|10.3|873|X Germ cell, trophoblastic tumors & neoplasms of gonads|82324418|0-19|All Races|Male and Female|2006|9.9|11.3|10.6
1.3|1.8|1.5|126|X(a) Intracranial & intraspinal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|1.3|1.8|1.5
1.3|1.8|1.5|129|X(b) Malignant extracranial & extragonadal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|1.3|1.9|1.6
5.9|6.9|6.4|546|X(c) Malignant gonadal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|6.1|7.2|6.6
0.4|0.7|0.5|42|X(d) Gonadal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.2|0.5|0.4|30|X(e) Other and unspecified malignant gonadal tumors|82324418|0-19|All Races|Male and Female|2006|0.2|0.5|0.4
16.5|18.2|17.3|1473|XI Other malignant epithelial neoplasms and malignant melanomas|82324418|0-19|All Races|Male and Female|2006|17.0|18.8|17.9
0.1|0.3|0.2|16|XI(a) Adrenocortical carcinomas|82324418|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
6.2|7.3|6.8|575|XI(b) Thyroid carcinomas|82324418|0-19|All Races|Male and Female|2006|6.4|7.6|7.0
0.5|0.8|0.6|54|XI(c) Nasopharyngeal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.9|0.7
4.9|5.9|5.4|461|XI(d) Malignant melanomas|82324418|0-19|All Races|Male and Female|2006|5.1|6.1|5.6
~|~|~|~|XI(e) Skin carcinomas|82324418|0-19|All Races|Male and Female|2006|~|~|~
3.8|4.7|4.2|360|XI(f) Other and unspecified carcinomas|82324418|0-19|All Races|Male and Female|2006|3.9|4.8|4.4
0.7|1.1|0.9|73|XII Other and unspecified malignant neoplasms|82324418|0-19|All Races|Male and Female|2006|0.7|1.1|0.9
0.4|0.7|0.5|41|XII(a) Other specified malignant tumors|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.3|0.5|0.4|32|XII(b) Other unspecified malignant tumors|82324418|0-19|All Races|Male and Female|2006|0.3|0.5|0.4
174.2|180.0|177.1|14797|All ICCC Groups Combined|82749431|0-19|All Races|Male and Female|2007|175.9|181.7|178.8
45.9|48.9|47.4|3916|I Leukemias, myeloproliferative & myelodysplastic diseases|82749431|0-19|All Races|Male and Female|2007|45.9|48.8|47.3
33.0|35.6|34.3|2818|I(a) Lymphoid leukemias|82749431|0-19|All Races|Male and Female|2007|32.8|35.3|34.1
7.4|8.6|8.0|667|I(b) Acute myeloid leukemias|82749431|0-19|All Races|Male and Female|2007|7.5|8.7|8.1
2.2|2.9|2.5|214|I(c) Chronic myeloproliferative diseases|82749431|0-19|All Races|Male and Female|2007|2.3|3.0|2.6
1.2|1.8|1.5|123|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82749431|0-19|All Races|Male and Female|2007|1.2|1.8|1.5
0.9|1.4|1.1|94|I(e) Unspecified and other specified leukemias|82749431|0-19|All Races|Male and Female|2007|0.9|1.4|1.1
24.0|26.1|25.0|2111|II Lymphomas and reticuloendothelial neoplasms|82749431|0-19|All Races|Male and Female|2007|24.4|26.6|25.5
11.4|12.9|12.1|1037|II(a) Hodgkin lymphomas|82749431|0-19|All Races|Male and Female|2007|11.8|13.3|12.5
8.1|9.4|8.8|733|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82749431|0-19|All Races|Male and Female|2007|8.2|9.5|8.9
2.3|3.0|2.6|214|II(c) Burkitt lymphoma|82749431|0-19|All Races|Male and Female|2007|2.3|3.0|2.6
0.9|1.4|1.1|92|II(d) Miscellaneous lymphoreticular neoplasms|82749431|0-19|All Races|Male and Female|2007|0.9|1.4|1.1
0.3|0.6|0.4|35|II(e) Unspecified lymphomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.4
30.8|33.2|32.0|2632|III CNS and misc intracranial and intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|30.6|33.0|31.8
2.2|2.9|2.5|209|III(a) Ependymomas and choroid plexus tumor|82749431|0-19|All Races|Male and Female|2007|2.2|2.9|2.5
15.2|17.0|16.1|1326|III(b) Astrocytomas|82749431|0-19|All Races|Male and Female|2007|15.2|16.9|16.0
5.9|7.1|6.5|532|III(c) Intracranial and intraspinal embryonal tumors|82749431|0-19|All Races|Male and Female|2007|5.9|7.0|6.4
5.2|6.3|5.7|469|III(d) Other gliomas|82749431|0-19|All Races|Male and Female|2007|5.2|6.2|5.7
0.5|0.9|0.7|58|III(e) Other specified intracranial & intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|0.5|0.9|0.7
0.3|0.6|0.5|38|III(f) Unspecified intracranial and intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.5
8.4|9.7|9.0|753|IV Neuroblastoma and other peripheral nervous cell tumors|82749431|0-19|All Races|Male and Female|2007|8.5|9.8|9.1
8.2|9.4|8.8|734|IV(a) Neuroblastoma and ganglioneuroblastoma|82749431|0-19|All Races|Male and Female|2007|8.2|9.5|8.9
0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|82749431|0-19|All Races|Male and Female|2007|0.1|0.4|0.2
11.8|13.3|12.6|1051|IX Soft tissue and other extraosseous sarcomas|82749431|0-19|All Races|Male and Female|2007|11.9|13.5|12.7
4.7|5.7|5.2|426|IX(a) Rhabdomyosarcomas|82749431|0-19|All Races|Male and Female|2007|4.7|5.7|5.1
1.1|1.7|1.4|117|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82749431|0-19|All Races|Male and Female|2007|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82749431|0-19|All Races|Male and Female|2007|~|~|~
4.3|5.3|4.8|404|IX(d) Other specified soft tissue sarcomas|82749431|0-19|All Races|Male and Female|2007|4.4|5.4|4.9
1.0|1.4|1.2|100|IX(e) Unspecified soft tissue sarcomas|82749431|0-19|All Races|Male and Female|2007|1.0|1.5|1.2
0.1|0.3|0.2|18|Not classified by ICCC|82749431|0-19|All Races|Male and Female|2007|0.1|0.3|0.2
2.9|3.7|3.2|273|V Retinoblastoma|82749431|0-19|All Races|Male and Female|2007|2.9|3.7|3.3
6.4|7.5|6.9|570|VI Renal tumors|82749431|0-19|All Races|Male and Female|2007|6.3|7.5|6.9
5.7|6.8|6.2|514|VI(a) Nephroblastoma and other nonepithelial renal tumors|82749431|0-19|All Races|Male and Female|2007|5.7|6.8|6.2
0.5|0.8|0.6|54|VI(b) Renal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82749431|0-19|All Races|Male and Female|2007|~|~|~
2.0|2.6|2.3|193|VII Hepatic tumors|82749431|0-19|All Races|Male and Female|2007|2.0|2.7|2.3
1.4|2.0|1.7|142|VII(a) Hepatoblastoma|82749431|0-19|All Races|Male and Female|2007|1.4|2.0|1.7
0.4|0.8|0.6|51|VII(b) Hepatic carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82749431|0-19|All Races|Male and Female|2007|~|~|~
8.2|9.5|8.8|736|VIII Malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|8.3|9.6|8.9
4.3|5.2|4.7|394|VIII(a) Osteosarcomas|82749431|0-19|All Races|Male and Female|2007|4.3|5.3|4.8
0.2|0.5|0.4|31|VIII(b) Chondrosarcomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.5|0.4
2.7|3.5|3.1|256|VIII(c) Ewing tumor and related sarcomas of bone|82749431|0-19|All Races|Male and Female|2007|2.7|3.5|3.1
0.3|0.6|0.4|34|VIII(d) Other specified malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.4
0.2|0.4|0.3|21|VIII(e) Unspecified malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.4|0.3
10.5|11.9|11.2|957|X Germ cell, trophoblastic tumors & neoplasms of gonads|82749431|0-19|All Races|Male and Female|2007|10.8|12.3|11.6
1.4|1.9|1.6|135|X(a) Intracranial & intraspinal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|1.4|1.9|1.6
1.1|1.7|1.4|118|X(b) Malignant extracranial & extragonadal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|1.2|1.7|1.4
6.9|8.1|7.5|646|X(c) Malignant gonadal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|7.2|8.4|7.8
0.3|0.5|0.4|32|X(d) Gonadal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.5|0.4
0.2|0.4|0.3|26|X(e) Other and unspecified malignant gonadal tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.5|0.3
16.8|18.6|17.7|1518|XI Other malignant epithelial neoplasms and malignant melanomas|82749431|0-19|All Races|Male and Female|2007|17.4|19.3|18.3
~|~|~|~|XI(a) Adrenocortical carcinomas|82749431|0-19|All Races|Male and Female|2007|~|~|~
6.8|7.9|7.3|632|XI(b) Thyroid carcinomas|82749431|0-19|All Races|Male and Female|2007|7.1|8.3|7.6
0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.8|0.6
4.9|5.9|5.4|460|XI(d) Malignant melanomas|82749431|0-19|All Races|Male and Female|2007|5.1|6.1|5.6
~|~|~|~|XI(e) Skin carcinomas|82749431|0-19|All Races|Male and Female|2007|~|~|~
3.7|4.6|4.1|352|XI(f) Other and unspecified carcinomas|82749431|0-19|All Races|Male and Female|2007|3.8|4.7|4.3
0.6|1.0|0.8|69|XII Other and unspecified malignant neoplasms|82749431|0-19|All Races|Male and Female|2007|0.6|1.1|0.8
0.2|0.5|0.3|29|XII(a) Other specified malignant tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.5|0.4
0.3|0.6|0.5|40|XII(b) Other unspecified malignant tumors|82749431|0-19|All Races|Male and Female|2007|0.3|0.7|0.5
176.3|182.1|179.2|15039|All ICCC Groups Combined|83118264|0-19|All Races|Male and Female|2008|178.1|183.9|180.9
47.4|50.4|48.9|4065|I Leukemias, myeloproliferative & myelodysplastic diseases|83118264|0-19|All Races|Male and Female|2008|47.4|50.4|48.9
33.9|36.5|35.2|2909|I(a) Lymphoid leukemias|83118264|0-19|All Races|Male and Female|2008|33.7|36.3|35.0
7.7|9.0|8.3|700|I(b) Acute myeloid leukemias|83118264|0-19|All Races|Male and Female|2008|7.8|9.1|8.4
2.4|3.1|2.7|232|I(c) Chronic myeloproliferative diseases|83118264|0-19|All Races|Male and Female|2008|2.4|3.2|2.8
1.3|1.9|1.6|132|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83118264|0-19|All Races|Male and Female|2008|1.3|1.9|1.6
0.9|1.3|1.1|92|I(e) Unspecified and other specified leukemias|83118264|0-19|All Races|Male and Female|2008|0.9|1.4|1.1
24.5|26.6|25.5|2161|II Lymphomas and reticuloendothelial neoplasms|83118264|0-19|All Races|Male and Female|2008|24.9|27.1|26.0
12.2|13.7|12.9|1106|II(a) Hodgkin lymphomas|83118264|0-19|All Races|Male and Female|2008|12.5|14.1|13.3
8.2|9.5|8.8|740|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83118264|0-19|All Races|Male and Female|2008|8.3|9.6|8.9
2.2|2.9|2.6|211|II(c) Burkitt lymphoma|83118264|0-19|All Races|Male and Female|2008|2.2|2.9|2.5
0.7|1.2|0.9|78|II(d) Miscellaneous lymphoreticular neoplasms|83118264|0-19|All Races|Male and Female|2008|0.7|1.2|0.9
0.2|0.5|0.3|26|II(e) Unspecified lymphomas|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
31.2|33.6|32.4|2680|III CNS and misc intracranial and intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|31.0|33.5|32.2
2.0|2.7|2.4|196|III(a) Ependymomas and choroid plexus tumor|83118264|0-19|All Races|Male and Female|2008|2.0|2.7|2.4
15.5|17.3|16.4|1356|III(b) Astrocytomas|83118264|0-19|All Races|Male and Female|2008|15.5|17.2|16.3
6.2|7.3|6.7|556|III(c) Intracranial and intraspinal embryonal tumors|83118264|0-19|All Races|Male and Female|2008|6.1|7.3|6.7
5.3|6.4|5.8|482|III(d) Other gliomas|83118264|0-19|All Races|Male and Female|2008|5.3|6.3|5.8
0.5|0.9|0.7|58|III(e) Other specified intracranial & intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|0.5|0.9|0.7
0.3|0.5|0.4|32|III(f) Unspecified intracranial and intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|0.3|0.5|0.4
7.8|9.1|8.4|705|IV Neuroblastoma and other peripheral nervous cell tumors|83118264|0-19|All Races|Male and Female|2008|7.9|9.1|8.5
7.5|8.7|8.1|677|IV(a) Neuroblastoma and ganglioneuroblastoma|83118264|0-19|All Races|Male and Female|2008|7.5|8.8|8.1
0.2|0.5|0.3|28|IV(b) Other peripheral nervous cell tumors|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
11.5|13.1|12.3|1031|IX Soft tissue and other extraosseous sarcomas|83118264|0-19|All Races|Male and Female|2008|11.7|13.2|12.4
4.6|5.6|5.1|425|IX(a) Rhabdomyosarcomas|83118264|0-19|All Races|Male and Female|2008|4.6|5.6|5.1
0.9|1.4|1.1|94|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83118264|0-19|All Races|Male and Female|2008|0.9|1.4|1.1
~|~|~|~|IX(c) Kaposi sarcoma|83118264|0-19|All Races|Male and Female|2008|~|~|~
4.1|5.0|4.5|384|IX(d) Other specified soft tissue sarcomas|83118264|0-19|All Races|Male and Female|2008|4.2|5.1|4.6
1.2|1.8|1.5|126|IX(e) Unspecified soft tissue sarcomas|83118264|0-19|All Races|Male and Female|2008|1.3|1.8|1.5
0.2|0.4|0.3|23|Not classified by ICCC|83118264|0-19|All Races|Male and Female|2008|0.2|0.4|0.3
2.8|3.6|3.2|268|V Retinoblastoma|83118264|0-19|All Races|Male and Female|2008|2.8|3.6|3.2
6.7|7.8|7.2|601|VI Renal tumors|83118264|0-19|All Races|Male and Female|2008|6.7|7.8|7.2
5.9|7.0|6.5|537|VI(a) Nephroblastoma and other nonepithelial renal tumors|83118264|0-19|All Races|Male and Female|2008|5.9|7.0|6.5
0.5|0.9|0.7|61|VI(b) Renal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.6|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
1.9|2.6|2.3|190|VII Hepatic tumors|83118264|0-19|All Races|Male and Female|2008|2.0|2.6|2.3
1.4|2.0|1.7|142|VII(a) Hepatoblastoma|83118264|0-19|All Races|Male and Female|2008|1.4|2.0|1.7
0.4|0.7|0.6|47|VII(b) Hepatic carcinomas|83118264|0-19|All Races|Male and Female|2008|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
8.2|9.5|8.8|738|VIII Malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|8.2|9.5|8.9
4.5|5.5|5.0|415|VIII(a) Osteosarcomas|83118264|0-19|All Races|Male and Female|2008|4.5|5.5|5.0
0.3|0.6|0.4|34|VIII(b) Chondrosarcomas|83118264|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
2.4|3.2|2.8|232|VIII(c) Ewing tumor and related sarcomas of bone|83118264|0-19|All Races|Male and Female|2008|2.4|3.2|2.8
0.3|0.6|0.4|34|VIII(d) Other specified malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
0.2|0.4|0.3|23|VIII(e) Unspecified malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|0.2|0.4|0.3
10.3|11.7|11.0|944|X Germ cell, trophoblastic tumors & neoplasms of gonads|83118264|0-19|All Races|Male and Female|2008|10.6|12.1|11.4
1.5|2.1|1.8|147|X(a) Intracranial & intraspinal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|1.5|2.1|1.8
1.2|1.7|1.4|123|X(b) Malignant extracranial & extragonadal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|1.2|1.8|1.5
6.7|7.8|7.3|630|X(c) Malignant gonadal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|7.0|8.2|7.6
0.2|0.5|0.3|29|X(d) Gonadal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
17.3|19.1|18.2|1569|XI Other malignant epithelial neoplasms and malignant melanomas|83118264|0-19|All Races|Male and Female|2008|18.0|19.8|18.9
0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|83118264|0-19|All Races|Male and Female|2008|0.1|0.4|0.2
7.5|8.7|8.1|703|XI(b) Thyroid carcinomas|83118264|0-19|All Races|Male and Female|2008|7.8|9.1|8.5
0.4|0.7|0.5|46|XI(c) Nasopharyngeal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.4|0.7|0.6
4.5|5.4|4.9|422|XI(d) Malignant melanomas|83118264|0-19|All Races|Male and Female|2008|4.6|5.6|5.1
~|~|~|~|XI(e) Skin carcinomas|83118264|0-19|All Races|Male and Female|2008|~|~|~
3.9|4.8|4.3|373|XI(f) Other and unspecified carcinomas|83118264|0-19|All Races|Male and Female|2008|4.0|5.0|4.5
0.6|1.0|0.8|64|XII Other and unspecified malignant neoplasms|83118264|0-19|All Races|Male and Female|2008|0.6|1.0|0.8
0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.5|0.4
0.3|0.5|0.4|32|XII(b) Other unspecified malignant tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.5|0.4
175.4|181.1|178.3|14975|All ICCC Groups Combined|83280391|0-19|All Races|Male and Female|2009|176.9|182.7|179.8
46.0|49.0|47.5|3955|I Leukemias, myeloproliferative & myelodysplastic diseases|83280391|0-19|All Races|Male and Female|2009|46.0|49.0|47.5
33.5|36.1|34.8|2889|I(a) Lymphoid leukemias|83280391|0-19|All Races|Male and Female|2009|33.4|36.0|34.7
7.1|8.3|7.6|642|I(b) Acute myeloid leukemias|83280391|0-19|All Races|Male and Female|2009|7.1|8.3|7.7
2.0|2.7|2.3|199|I(c) Chronic myeloproliferative diseases|83280391|0-19|All Races|Male and Female|2009|2.1|2.7|2.4
1.3|1.8|1.5|128|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83280391|0-19|All Races|Male and Female|2009|1.3|1.8|1.5
0.9|1.4|1.2|97|I(e) Unspecified and other specified leukemias|83280391|0-19|All Races|Male and Female|2009|0.9|1.4|1.2
24.3|26.4|25.3|2148|II Lymphomas and reticuloendothelial neoplasms|83280391|0-19|All Races|Male and Female|2009|24.7|26.9|25.8
11.9|13.4|12.6|1082|II(a) Hodgkin lymphomas|83280391|0-19|All Races|Male and Female|2009|12.2|13.8|13.0
8.2|9.5|8.9|745|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83280391|0-19|All Races|Male and Female|2009|8.3|9.6|8.9
1.9|2.6|2.2|184|II(c) Burkitt lymphoma|83280391|0-19|All Races|Male and Female|2009|1.9|2.6|2.2
1.1|1.6|1.3|111|II(d) Miscellaneous lymphoreticular neoplasms|83280391|0-19|All Races|Male and Female|2009|1.1|1.6|1.3
0.2|0.5|0.3|26|II(e) Unspecified lymphomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
30.9|33.4|32.1|2665|III CNS and misc intracranial and intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|30.8|33.2|32.0
2.1|2.8|2.4|204|III(a) Ependymomas and choroid plexus tumor|83280391|0-19|All Races|Male and Female|2009|2.1|2.8|2.4
15.4|17.2|16.3|1350|III(b) Astrocytomas|83280391|0-19|All Races|Male and Female|2009|15.4|17.1|16.2
5.8|6.9|6.4|526|III(c) Intracranial and intraspinal embryonal tumors|83280391|0-19|All Races|Male and Female|2009|5.8|6.9|6.3
5.5|6.6|6.0|499|III(d) Other gliomas|83280391|0-19|All Races|Male and Female|2009|5.5|6.5|6.0
0.4|0.8|0.6|49|III(e) Other specified intracranial & intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|0.4|0.8|0.6
0.3|0.6|0.4|37|III(f) Unspecified intracranial and intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|0.3|0.6|0.4
7.7|8.9|8.3|690|IV Neuroblastoma and other peripheral nervous cell tumors|83280391|0-19|All Races|Male and Female|2009|7.7|8.9|8.3
7.4|8.7|8.0|668|IV(a) Neuroblastoma and ganglioneuroblastoma|83280391|0-19|All Races|Male and Female|2009|7.4|8.7|8.0
0.2|0.4|0.3|22|IV(b) Other peripheral nervous cell tumors|83280391|0-19|All Races|Male and Female|2009|0.2|0.4|0.3
11.4|12.9|12.2|1021|IX Soft tissue and other extraosseous sarcomas|83280391|0-19|All Races|Male and Female|2009|11.5|13.0|12.3
3.8|4.7|4.2|354|IX(a) Rhabdomyosarcomas|83280391|0-19|All Races|Male and Female|2009|3.8|4.7|4.3
1.3|1.8|1.5|130|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83280391|0-19|All Races|Male and Female|2009|1.3|1.9|1.6
~|~|~|~|IX(c) Kaposi sarcoma|83280391|0-19|All Races|Male and Female|2009|~|~|~
4.5|5.4|4.9|417|IX(d) Other specified soft tissue sarcomas|83280391|0-19|All Races|Male and Female|2009|4.5|5.5|5.0
1.1|1.6|1.3|113|IX(e) Unspecified soft tissue sarcomas|83280391|0-19|All Races|Male and Female|2009|1.1|1.6|1.4
0.2|0.5|0.3|28|Not classified by ICCC|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
3.0|3.8|3.4|284|V Retinoblastoma|83280391|0-19|All Races|Male and Female|2009|3.0|3.8|3.4
6.8|8.0|7.4|616|VI Renal tumors|83280391|0-19|All Races|Male and Female|2009|6.8|8.0|7.4
6.0|7.1|6.6|546|VI(a) Nephroblastoma and other nonepithelial renal tumors|83280391|0-19|All Races|Male and Female|2009|6.0|7.1|6.6
0.6|1.0|0.8|68|VI(b) Renal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.6|1.0|0.8
~|~|~|~|VI(c) Unspecified malignant renal tumors|83280391|0-19|All Races|Male and Female|2009|~|~|~
1.7|2.3|2.0|167|VII Hepatic tumors|83280391|0-19|All Races|Male and Female|2009|1.7|2.3|2.0
1.1|1.7|1.4|116|VII(a) Hepatoblastoma|83280391|0-19|All Races|Male and Female|2009|1.2|1.7|1.4
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|83280391|0-19|All Races|Male and Female|2009|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83280391|0-19|All Races|Male and Female|2009|~|~|~
8.4|9.7|9.0|758|VIII Malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|8.5|9.8|9.1
4.6|5.6|5.1|425|VIII(a) Osteosarcomas|83280391|0-19|All Races|Male and Female|2009|4.6|5.6|5.1
0.2|0.5|0.3|27|VIII(b) Chondrosarcomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
2.6|3.3|2.9|247|VIII(c) Ewing tumor and related sarcomas of bone|83280391|0-19|All Races|Male and Female|2009|2.6|3.4|3.0
0.4|0.7|0.5|42|VIII(d) Other specified malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|0.4|0.7|0.5
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|0.1|0.3|0.2
10.8|12.3|11.6|993|X Germ cell, trophoblastic tumors & neoplasms of gonads|83280391|0-19|All Races|Male and Female|2009|11.2|12.7|11.9
1.4|2.0|1.7|142|X(a) Intracranial & intraspinal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|1.4|2.0|1.7
1.1|1.6|1.4|116|X(b) Malignant extracranial & extragonadal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|1.2|1.7|1.4
7.0|8.2|7.6|654|X(c) Malignant gonadal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|7.3|8.5|7.9
0.5|0.8|0.6|53|X(d) Gonadal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.5|0.8|0.6
0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
17.4|19.2|18.3|1574|XI Other malignant epithelial neoplasms and malignant melanomas|83280391|0-19|All Races|Male and Female|2009|18.0|19.9|18.9
0.2|0.4|0.2|21|XI(a) Adrenocortical carcinomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.4|0.3
7.7|9.0|8.3|718|XI(b) Thyroid carcinomas|83280391|0-19|All Races|Male and Female|2009|8.0|9.3|8.6
0.5|0.9|0.7|59|XI(c) Nasopharyngeal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.5|0.9|0.7
4.0|4.9|4.4|382|XI(d) Malignant melanomas|83280391|0-19|All Races|Male and Female|2009|4.1|5.1|4.6
~|~|~|~|XI(e) Skin carcinomas|83280391|0-19|All Races|Male and Female|2009|~|~|~
4.0|5.0|4.5|385|XI(f) Other and unspecified carcinomas|83280391|0-19|All Races|Male and Female|2009|4.2|5.1|4.6
0.7|1.1|0.9|76|XII Other and unspecified malignant neoplasms|83280391|0-19|All Races|Male and Female|2009|0.7|1.1|0.9
0.2|0.5|0.4|31|XII(a) Other specified malignant tumors|83280391|0-19|All Races|Male and Female|2009|0.3|0.5|0.4
0.4|0.7|0.5|45|XII(b) Other unspecified malignant tumors|83280391|0-19|All Races|Male and Female|2009|0.4|0.7|0.5
179.2|185.0|182.1|15243|All ICCC Groups Combined|83181903|0-19|All Races|Male and Female|2010|180.4|186.2|183.2
47.6|50.6|49.1|4084|I Leukemias, myeloproliferative & myelodysplastic diseases|83181903|0-19|All Races|Male and Female|2010|47.6|50.6|49.1
33.4|35.9|34.6|2874|I(a) Lymphoid leukemias|83181903|0-19|All Races|Male and Female|2010|33.3|35.8|34.6
7.7|9.0|8.4|700|I(b) Acute myeloid leukemias|83181903|0-19|All Races|Male and Female|2010|7.8|9.1|8.4
2.3|3.0|2.7|225|I(c) Chronic myeloproliferative diseases|83181903|0-19|All Races|Male and Female|2010|2.4|3.1|2.7
1.5|2.1|1.8|150|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83181903|0-19|All Races|Male and Female|2010|1.5|2.1|1.8
1.4|1.9|1.6|135|I(e) Unspecified and other specified leukemias|83181903|0-19|All Races|Male and Female|2010|1.4|1.9|1.6
26.4|28.7|27.5|2319|II Lymphomas and reticuloendothelial neoplasms|83181903|0-19|All Races|Male and Female|2010|26.8|29.0|27.9
11.4|12.9|12.1|1032|II(a) Hodgkin lymphomas|83181903|0-19|All Races|Male and Female|2010|11.7|13.2|12.4
8.0|9.3|8.7|725|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83181903|0-19|All Races|Male and Female|2010|8.1|9.4|8.7
2.1|2.8|2.4|202|II(c) Burkitt lymphoma|83181903|0-19|All Races|Male and Female|2010|2.1|2.8|2.4
3.6|4.5|4.0|331|II(d) Miscellaneous lymphoreticular neoplasms|83181903|0-19|All Races|Male and Female|2010|3.6|4.4|4.0
0.2|0.5|0.3|29|II(e) Unspecified lymphomas|83181903|0-19|All Races|Male and Female|2010|0.2|0.5|0.3
31.4|33.8|32.6|2700|III CNS and misc intracranial and intraspinal neoplasms|83181903|0-19|All Races|Male and Female|2010|31.2|33.7|32.5
2.5|3.3|2.9|239|III(a) Ependymomas and choroid plexus tumor|83181903|0-19|All Races|Male and Female|2010|2.5|3.3|2.9
16.2|18.0|17.0|1413|III(b) Astrocytomas|83181903|0-19|All Races|Male and Female|2010|16.1|17.9|17.0
5.6|6.6|6.1|502|III(c) Intracranial and intraspinal embryonal tumors|83181903|0-19|All Races|Male and Female|2010|5.5|6.6|6.0
5.2|6.2|5.7|468|III(d) Other gliomas|83181903|0-19|All Races|Male and Female|2010|5.1|6.2|5.6
0.5|0.8|0.6|51|III(e) Other specified intracranial & intraspinal neoplasms|83181903|0-19|All Races|Male and Female|2010|0.5|0.8|0.6
0.2|0.5|0.3|27|III(f) Unspecified intracranial and intraspinal neoplasms|83181903|0-19|All Races|Male and Female|2010|0.2|0.5|0.3
8.0|9.2|8.6|712|IV Neuroblastoma and other peripheral nervous cell tumors|83181903|0-19|All Races|Male and Female|2010|7.9|9.2|8.6
7.8|9.0|8.4|695|IV(a) Neuroblastoma and ganglioneuroblastoma|83181903|0-19|All Races|Male and Female|2010|7.7|9.0|8.4
0.1|0.3|0.2|17|IV(b) Other peripheral nervous cell tumors|83181903|0-19|All Races|Male and Female|2010|0.1|0.3|0.2
12.1|13.6|12.8|1071|IX Soft tissue and other extraosseous sarcomas|83181903|0-19|All Races|Male and Female|2010|12.1|13.7|12.9
4.8|5.8|5.3|438|IX(a) Rhabdomyosarcomas|83181903|0-19|All Races|Male and Female|2010|4.8|5.8|5.3
0.8|1.3|1.0|88|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83181903|0-19|All Races|Male and Female|2010|0.8|1.3|1.1
~|~|~|~|IX(c) Kaposi sarcoma|83181903|0-19|All Races|Male and Female|2010|~|~|~
4.3|5.2|4.7|397|IX(d) Other specified soft tissue sarcomas|83181903|0-19|All Races|Male and Female|2010|4.3|5.3|4.8
1.4|2.0|1.7|144|IX(e) Unspecified soft tissue sarcomas|83181903|0-19|All Races|Male and Female|2010|1.5|2.0|1.7
0.1|0.4|0.2|20|Not classified by ICCC|83181903|0-19|All Races|Male and Female|2010|0.1|0.4|0.2
3.0|3.8|3.4|283|V Retinoblastoma|83181903|0-19|All Races|Male and Female|2010|3.0|3.8|3.4
6.1|7.3|6.7|556|VI Renal tumors|83181903|0-19|All Races|Male and Female|2010|6.1|7.3|6.7
5.6|6.7|6.2|513|VI(a) Nephroblastoma and other nonepithelial renal tumors|83181903|0-19|All Races|Male and Female|2010|5.6|6.7|6.2
0.3|0.7|0.5|41|VI(b) Renal carcinomas|83181903|0-19|All Races|Male and Female|2010|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|83181903|0-19|All Races|Male and Female|2010|~|~|~
2.3|3.0|2.6|221|VII Hepatic tumors|83181903|0-19|All Races|Male and Female|2010|2.3|3.0|2.7
1.6|2.2|1.9|160|VII(a) Hepatoblastoma|83181903|0-19|All Races|Male and Female|2010|1.6|2.2|1.9
0.5|0.9|0.7|59|VII(b) Hepatic carcinomas|83181903|0-19|All Races|Male and Female|2010|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83181903|0-19|All Races|Male and Female|2010|~|~|~
7.7|9.0|8.4|699|VIII Malignant bone tumors|83181903|0-19|All Races|Male and Female|2010|7.8|9.1|8.4
4.3|5.2|4.7|397|VIII(a) Osteosarcomas|83181903|0-19|All Races|Male and Female|2010|4.3|5.3|4.8
0.3|0.5|0.4|32|VIII(b) Chondrosarcomas|83181903|0-19|All Races|Male and Female|2010|0.3|0.5|0.4
2.3|3.0|2.6|219|VIII(c) Ewing tumor and related sarcomas of bone|83181903|0-19|All Races|Male and Female|2010|2.3|3.0|2.6
0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|83181903|0-19|All Races|Male and Female|2010|0.3|0.6|0.4
~|~|~|~|VIII(e) Unspecified malignant bone tumors|83181903|0-19|All Races|Male and Female|2010|~|~|~
10.8|12.3|11.5|980|X Germ cell, trophoblastic tumors & neoplasms of gonads|83181903|0-19|All Races|Male and Female|2010|11.1|12.5|11.8
1.7|2.3|2.0|166|X(a) Intracranial & intraspinal germ cell tumors|83181903|0-19|All Races|Male and Female|2010|1.7|2.3|2.0
1.1|1.6|1.3|112|X(b) Malignant extracranial & extragonadal germ cell tumors|83181903|0-19|All Races|Male and Female|2010|1.1|1.6|1.3
6.7|7.9|7.3|625|X(c) Malignant gonadal germ cell tumors|83181903|0-19|All Races|Male and Female|2010|6.9|8.1|7.5
0.4|0.7|0.5|43|X(d) Gonadal carcinomas|83181903|0-19|All Races|Male and Female|2010|0.4|0.7|0.5
0.3|0.6|0.4|34|X(e) Other and unspecified malignant gonadal tumors|83181903|0-19|All Races|Male and Female|2010|0.3|0.6|0.4
17.1|18.9|18.0|1540|XI Other malignant epithelial neoplasms and malignant melanomas|83181903|0-19|All Races|Male and Female|2010|17.6|19.5|18.5
0.2|0.4|0.3|21|XI(a) Adrenocortical carcinomas|83181903|0-19|All Races|Male and Female|2010|0.2|0.4|0.3
8.0|9.2|8.6|737|XI(b) Thyroid carcinomas|83181903|0-19|All Races|Male and Female|2010|8.2|9.5|8.9
0.4|0.8|0.6|49|XI(c) Nasopharyngeal carcinomas|83181903|0-19|All Races|Male and Female|2010|0.4|0.8|0.6
3.6|4.5|4.0|344|XI(d) Malignant melanomas|83181903|0-19|All Races|Male and Female|2010|3.7|4.6|4.1
~|~|~|~|XI(e) Skin carcinomas|83181903|0-19|All Races|Male and Female|2010|~|~|~
4.0|4.9|4.4|380|XI(f) Other and unspecified carcinomas|83181903|0-19|All Races|Male and Female|2010|4.1|5.1|4.6
0.5|0.9|0.7|58|XII Other and unspecified malignant neoplasms|83181903|0-19|All Races|Male and Female|2010|0.5|0.9|0.7
0.3|0.6|0.4|33|XII(a) Other specified malignant tumors|83181903|0-19|All Races|Male and Female|2010|0.3|0.6|0.4
0.2|0.4|0.3|25|XII(b) Other unspecified malignant tumors|83181903|0-19|All Races|Male and Female|2010|0.2|0.4|0.3
181.0|186.9|183.9|15321|All ICCC Groups Combined|82827710|0-19|All Races|Male and Female|2011|182.1|187.9|185.0
47.8|50.8|49.3|4084|I Leukemias, myeloproliferative & myelodysplastic diseases|82827710|0-19|All Races|Male and Female|2011|47.8|50.8|49.3
34.5|37.1|35.8|2964|I(a) Lymphoid leukemias|82827710|0-19|All Races|Male and Female|2011|34.5|37.1|35.8
7.7|9.0|8.3|695|I(b) Acute myeloid leukemias|82827710|0-19|All Races|Male and Female|2011|7.8|9.0|8.4
2.1|2.7|2.4|198|I(c) Chronic myeloproliferative diseases|82827710|0-19|All Races|Male and Female|2011|2.1|2.7|2.4
1.1|1.6|1.3|107|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82827710|0-19|All Races|Male and Female|2011|1.1|1.6|1.3
1.2|1.7|1.4|120|I(e) Unspecified and other specified leukemias|82827710|0-19|All Races|Male and Female|2011|1.2|1.7|1.4
26.8|29.1|28.0|2339|II Lymphomas and reticuloendothelial neoplasms|82827710|0-19|All Races|Male and Female|2011|27.1|29.4|28.2
11.1|12.6|11.8|1001|II(a) Hodgkin lymphomas|82827710|0-19|All Races|Male and Female|2011|11.3|12.9|12.1
7.8|9.1|8.5|706|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82827710|0-19|All Races|Male and Female|2011|7.9|9.2|8.5
2.2|2.9|2.5|208|II(c) Burkitt lymphoma|82827710|0-19|All Races|Male and Female|2011|2.2|2.9|2.5
4.3|5.3|4.8|395|II(d) Miscellaneous lymphoreticular neoplasms|82827710|0-19|All Races|Male and Female|2011|4.3|5.3|4.8
0.2|0.5|0.3|29|II(e) Unspecified lymphomas|82827710|0-19|All Races|Male and Female|2011|0.2|0.5|0.4
32.0|34.5|33.2|2749|III CNS and misc intracranial and intraspinal neoplasms|82827710|0-19|All Races|Male and Female|2011|32.0|34.5|33.2
2.5|3.3|2.9|239|III(a) Ependymomas and choroid plexus tumor|82827710|0-19|All Races|Male and Female|2011|2.5|3.3|2.9
16.4|18.2|17.3|1429|III(b) Astrocytomas|82827710|0-19|All Races|Male and Female|2011|16.4|18.2|17.3
5.6|6.7|6.1|507|III(c) Intracranial and intraspinal embryonal tumors|82827710|0-19|All Races|Male and Female|2011|5.6|6.7|6.1
5.4|6.5|6.0|492|III(d) Other gliomas|82827710|0-19|All Races|Male and Female|2011|5.4|6.5|5.9
0.4|0.8|0.6|47|III(e) Other specified intracranial & intraspinal neoplasms|82827710|0-19|All Races|Male and Female|2011|0.4|0.8|0.6
0.3|0.6|0.4|35|III(f) Unspecified intracranial and intraspinal neoplasms|82827710|0-19|All Races|Male and Female|2011|0.3|0.6|0.4
8.0|9.2|8.6|711|IV Neuroblastoma and other peripheral nervous cell tumors|82827710|0-19|All Races|Male and Female|2011|8.0|9.2|8.6
7.7|9.0|8.3|690|IV(a) Neuroblastoma and ganglioneuroblastoma|82827710|0-19|All Races|Male and Female|2011|7.7|9.0|8.3
0.2|0.4|0.3|21|IV(b) Other peripheral nervous cell tumors|82827710|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
11.5|13.0|12.2|1017|IX Soft tissue and other extraosseous sarcomas|82827710|0-19|All Races|Male and Female|2011|11.5|13.1|12.3
4.3|5.2|4.7|393|IX(a) Rhabdomyosarcomas|82827710|0-19|All Races|Male and Female|2011|4.3|5.2|4.7
1.1|1.6|1.3|109|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82827710|0-19|All Races|Male and Female|2011|1.1|1.6|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82827710|0-19|All Races|Male and Female|2011|~|~|~
4.4|5.3|4.8|402|IX(d) Other specified soft tissue sarcomas|82827710|0-19|All Races|Male and Female|2011|4.4|5.4|4.9
1.0|1.5|1.3|106|IX(e) Unspecified soft tissue sarcomas|82827710|0-19|All Races|Male and Female|2011|1.0|1.5|1.3
0.2|0.4|0.3|23|Not classified by ICCC|82827710|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
2.8|3.6|3.2|262|V Retinoblastoma|82827710|0-19|All Races|Male and Female|2011|2.8|3.6|3.2
6.6|7.8|7.2|597|VI Renal tumors|82827710|0-19|All Races|Male and Female|2011|6.6|7.8|7.2
6.0|7.1|6.5|540|VI(a) Nephroblastoma and other nonepithelial renal tumors|82827710|0-19|All Races|Male and Female|2011|6.0|7.1|6.5
0.5|0.9|0.7|56|VI(b) Renal carcinomas|82827710|0-19|All Races|Male and Female|2011|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82827710|0-19|All Races|Male and Female|2011|~|~|~
2.3|3.0|2.6|216|VII Hepatic tumors|82827710|0-19|All Races|Male and Female|2011|2.3|3.0|2.6
1.7|2.4|2.0|168|VII(a) Hepatoblastoma|82827710|0-19|All Races|Male and Female|2011|1.7|2.4|2.0
0.4|0.7|0.5|44|VII(b) Hepatic carcinomas|82827710|0-19|All Races|Male and Female|2011|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82827710|0-19|All Races|Male and Female|2011|~|~|~
8.3|9.6|8.9|743|VIII Malignant bone tumors|82827710|0-19|All Races|Male and Female|2011|8.3|9.6|9.0
4.6|5.6|5.1|421|VIII(a) Osteosarcomas|82827710|0-19|All Races|Male and Female|2011|4.6|5.6|5.1
0.2|0.4|0.2|21|VIII(b) Chondrosarcomas|82827710|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
2.8|3.6|3.2|262|VIII(c) Ewing tumor and related sarcomas of bone|82827710|0-19|All Races|Male and Female|2011|2.8|3.6|3.2
0.2|0.5|0.3|26|VIII(d) Other specified malignant bone tumors|82827710|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82827710|0-19|All Races|Male and Female|2011|~|~|~
10.1|11.5|10.8|909|X Germ cell, trophoblastic tumors & neoplasms of gonads|82827710|0-19|All Races|Male and Female|2011|10.3|11.7|11.0
1.4|2.0|1.7|139|X(a) Intracranial & intraspinal germ cell tumors|82827710|0-19|All Races|Male and Female|2011|1.4|2.0|1.7
1.1|1.6|1.4|115|X(b) Malignant extracranial & extragonadal germ cell tumors|82827710|0-19|All Races|Male and Female|2011|1.1|1.7|1.4
6.6|7.7|7.1|608|X(c) Malignant gonadal germ cell tumors|82827710|0-19|All Races|Male and Female|2011|6.8|7.9|7.3
0.2|0.5|0.3|26|X(d) Gonadal carcinomas|82827710|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
0.2|0.4|0.2|21|X(e) Other and unspecified malignant gonadal tumors|82827710|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
18.1|20.0|19.1|1614|XI Other malignant epithelial neoplasms and malignant melanomas|82827710|0-19|All Races|Male and Female|2011|18.5|20.5|19.5
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|82827710|0-19|All Races|Male and Female|2011|0.1|0.4|0.2
8.7|10.0|9.3|792|XI(b) Thyroid carcinomas|82827710|0-19|All Races|Male and Female|2011|8.9|10.3|9.6
0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82827710|0-19|All Races|Male and Female|2011|0.5|0.8|0.6
3.9|4.8|4.3|364|XI(d) Malignant melanomas|82827710|0-19|All Races|Male and Female|2011|4.0|4.9|4.4
~|~|~|~|XI(e) Skin carcinomas|82827710|0-19|All Races|Male and Female|2011|~|~|~
4.0|5.0|4.5|380|XI(f) Other and unspecified carcinomas|82827710|0-19|All Races|Male and Female|2011|4.1|5.1|4.6
0.5|0.9|0.7|57|XII Other and unspecified malignant neoplasms|82827710|0-19|All Races|Male and Female|2011|0.5|0.9|0.7
0.2|0.5|0.3|27|XII(a) Other specified malignant tumors|82827710|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
0.2|0.5|0.4|30|XII(b) Other unspecified malignant tumors|82827710|0-19|All Races|Male and Female|2011|0.2|0.5|0.4
182.4|188.3|185.3|15357|All ICCC Groups Combined|82483581|0-19|All Races|Male and Female|2012|183.2|189.2|186.2
46.2|49.2|47.7|3939|I Leukemias, myeloproliferative & myelodysplastic diseases|82483581|0-19|All Races|Male and Female|2012|46.3|49.3|47.8
32.8|35.3|34.1|2809|I(a) Lymphoid leukemias|82483581|0-19|All Races|Male and Female|2012|32.8|35.3|34.1
7.3|8.5|7.9|651|I(b) Acute myeloid leukemias|82483581|0-19|All Races|Male and Female|2012|7.3|8.5|7.9
2.2|2.9|2.5|209|I(c) Chronic myeloproliferative diseases|82483581|0-19|All Races|Male and Female|2012|2.2|2.9|2.5
1.3|1.8|1.5|124|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82483581|0-19|All Races|Male and Female|2012|1.3|1.8|1.5
1.5|2.1|1.8|146|I(e) Unspecified and other specified leukemias|82483581|0-19|All Races|Male and Female|2012|1.5|2.1|1.8
28.8|31.2|30.0|2493|II Lymphomas and reticuloendothelial neoplasms|82483581|0-19|All Races|Male and Female|2012|29.0|31.4|30.2
11.8|13.3|12.6|1051|II(a) Hodgkin lymphomas|82483581|0-19|All Races|Male and Female|2012|12.0|13.5|12.7
9.2|10.5|9.8|816|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82483581|0-19|All Races|Male and Female|2012|9.2|10.6|9.9
2.0|2.7|2.3|191|II(c) Burkitt lymphoma|82483581|0-19|All Races|Male and Female|2012|2.0|2.7|2.3
4.3|5.3|4.8|395|II(d) Miscellaneous lymphoreticular neoplasms|82483581|0-19|All Races|Male and Female|2012|4.3|5.3|4.8
0.3|0.7|0.5|40|II(e) Unspecified lymphomas|82483581|0-19|All Races|Male and Female|2012|0.3|0.7|0.5
31.1|33.5|32.3|2659|III CNS and misc intracranial and intraspinal neoplasms|82483581|0-19|All Races|Male and Female|2012|31.0|33.5|32.2
2.3|3.1|2.7|222|III(a) Ependymomas and choroid plexus tumor|82483581|0-19|All Races|Male and Female|2012|2.3|3.1|2.7
16.5|18.3|17.4|1432|III(b) Astrocytomas|82483581|0-19|All Races|Male and Female|2012|16.5|18.3|17.4
5.3|6.4|5.8|478|III(c) Intracranial and intraspinal embryonal tumors|82483581|0-19|All Races|Male and Female|2012|5.3|6.3|5.8
4.7|5.7|5.2|428|III(d) Other gliomas|82483581|0-19|All Races|Male and Female|2012|4.7|5.7|5.2
0.4|0.7|0.6|46|III(e) Other specified intracranial & intraspinal neoplasms|82483581|0-19|All Races|Male and Female|2012|0.4|0.7|0.6
0.5|0.8|0.6|53|III(f) Unspecified intracranial and intraspinal neoplasms|82483581|0-19|All Races|Male and Female|2012|0.5|0.8|0.6
8.1|9.4|8.8|723|IV Neuroblastoma and other peripheral nervous cell tumors|82483581|0-19|All Races|Male and Female|2012|8.1|9.4|8.8
7.9|9.2|8.5|703|IV(a) Neuroblastoma and ganglioneuroblastoma|82483581|0-19|All Races|Male and Female|2012|7.9|9.2|8.5
0.1|0.4|0.2|20|IV(b) Other peripheral nervous cell tumors|82483581|0-19|All Races|Male and Female|2012|0.1|0.4|0.2
11.1|12.6|11.8|977|IX Soft tissue and other extraosseous sarcomas|82483581|0-19|All Races|Male and Female|2012|11.1|12.6|11.8
4.1|5.0|4.6|376|IX(a) Rhabdomyosarcomas|82483581|0-19|All Races|Male and Female|2012|4.1|5.0|4.6
1.0|1.5|1.3|104|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82483581|0-19|All Races|Male and Female|2012|1.0|1.5|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82483581|0-19|All Races|Male and Female|2012|~|~|~
4.1|5.0|4.5|376|IX(d) Other specified soft tissue sarcomas|82483581|0-19|All Races|Male and Female|2012|4.1|5.0|4.6
1.2|1.7|1.4|116|IX(e) Unspecified soft tissue sarcomas|82483581|0-19|All Races|Male and Female|2012|1.2|1.7|1.4
0.1|0.4|0.2|19|Not classified by ICCC|82483581|0-19|All Races|Male and Female|2012|0.1|0.4|0.2
2.9|3.7|3.3|273|V Retinoblastoma|82483581|0-19|All Races|Male and Female|2012|2.9|3.7|3.3
6.5|7.6|7.0|582|VI Renal tumors|82483581|0-19|All Races|Male and Female|2012|6.5|7.7|7.1
5.7|6.8|6.3|516|VI(a) Nephroblastoma and other nonepithelial renal tumors|82483581|0-19|All Races|Male and Female|2012|5.7|6.8|6.3
0.6|0.9|0.7|61|VI(b) Renal carcinomas|82483581|0-19|All Races|Male and Female|2012|0.6|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82483581|0-19|All Races|Male and Female|2012|~|~|~
2.4|3.2|2.8|230|VII Hepatic tumors|82483581|0-19|All Races|Male and Female|2012|2.4|3.2|2.8
1.8|2.5|2.1|176|VII(a) Hepatoblastoma|82483581|0-19|All Races|Male and Female|2012|1.8|2.5|2.1
0.5|0.8|0.6|52|VII(b) Hepatic carcinomas|82483581|0-19|All Races|Male and Female|2012|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82483581|0-19|All Races|Male and Female|2012|~|~|~
8.4|9.7|9.1|750|VIII Malignant bone tumors|82483581|0-19|All Races|Male and Female|2012|8.5|9.8|9.1
4.8|5.8|5.2|432|VIII(a) Osteosarcomas|82483581|0-19|All Races|Male and Female|2012|4.8|5.8|5.2
0.2|0.5|0.3|28|VIII(b) Chondrosarcomas|82483581|0-19|All Races|Male and Female|2012|0.2|0.5|0.3
2.5|3.2|2.8|236|VIII(c) Ewing tumor and related sarcomas of bone|82483581|0-19|All Races|Male and Female|2012|2.5|3.3|2.9
0.3|0.6|0.4|35|VIII(d) Other specified malignant bone tumors|82483581|0-19|All Races|Male and Female|2012|0.3|0.6|0.4
0.1|0.4|0.2|19|VIII(e) Unspecified malignant bone tumors|82483581|0-19|All Races|Male and Female|2012|0.1|0.4|0.2
10.9|12.4|11.7|977|X Germ cell, trophoblastic tumors & neoplasms of gonads|82483581|0-19|All Races|Male and Female|2012|11.1|12.6|11.8
1.3|1.9|1.6|131|X(a) Intracranial & intraspinal germ cell tumors|82483581|0-19|All Races|Male and Female|2012|1.3|1.9|1.6
1.4|2.0|1.7|141|X(b) Malignant extracranial & extragonadal germ cell tumors|82483581|0-19|All Races|Male and Female|2012|1.4|2.0|1.7
7.1|8.2|7.6|643|X(c) Malignant gonadal germ cell tumors|82483581|0-19|All Races|Male and Female|2012|7.2|8.4|7.8
0.3|0.6|0.4|35|X(d) Gonadal carcinomas|82483581|0-19|All Races|Male and Female|2012|0.3|0.6|0.4
0.2|0.5|0.3|27|X(e) Other and unspecified malignant gonadal tumors|82483581|0-19|All Races|Male and Female|2012|0.2|0.5|0.3
18.8|20.7|19.7|1653|XI Other malignant epithelial neoplasms and malignant melanomas|82483581|0-19|All Races|Male and Female|2012|19.1|21.0|20.0
0.2|0.4|0.3|22|XI(a) Adrenocortical carcinomas|82483581|0-19|All Races|Male and Female|2012|0.2|0.4|0.3
9.1|10.4|9.7|817|XI(b) Thyroid carcinomas|82483581|0-19|All Races|Male and Female|2012|9.2|10.6|9.9
0.3|0.6|0.5|38|XI(c) Nasopharyngeal carcinomas|82483581|0-19|All Races|Male and Female|2012|0.3|0.6|0.5
3.8|4.7|4.3|356|XI(d) Malignant melanomas|82483581|0-19|All Races|Male and Female|2012|3.9|4.8|4.3
~|~|~|~|XI(e) Skin carcinomas|82483581|0-19|All Races|Male and Female|2012|~|~|~
4.5|5.4|4.9|412|XI(f) Other and unspecified carcinomas|82483581|0-19|All Races|Male and Female|2012|4.5|5.5|5.0
0.8|1.2|1.0|82|XII Other and unspecified malignant neoplasms|82483581|0-19|All Races|Male and Female|2012|0.8|1.2|1.0
0.3|0.6|0.4|36|XII(a) Other specified malignant tumors|82483581|0-19|All Races|Male and Female|2012|0.3|0.6|0.4
0.4|0.7|0.6|46|XII(b) Other unspecified malignant tumors|82483581|0-19|All Races|Male and Female|2012|0.4|0.7|0.6
181.8|187.7|184.7|15232|All ICCC Groups Combined|82246791|0-19|All Races|Male and Female|2013|182.3|188.2|185.2
45.4|48.4|46.9|3859|I Leukemias, myeloproliferative & myelodysplastic diseases|82246791|0-19|All Races|Male and Female|2013|45.5|48.4|46.9
31.3|33.8|32.6|2676|I(a) Lymphoid leukemias|82246791|0-19|All Races|Male and Female|2013|31.3|33.8|32.5
7.7|8.9|8.3|681|I(b) Acute myeloid leukemias|82246791|0-19|All Races|Male and Female|2013|7.7|8.9|8.3
2.1|2.8|2.5|203|I(c) Chronic myeloproliferative diseases|82246791|0-19|All Races|Male and Female|2013|2.1|2.8|2.5
1.4|1.9|1.6|135|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82246791|0-19|All Races|Male and Female|2013|1.4|1.9|1.6
1.7|2.3|2.0|164|I(e) Unspecified and other specified leukemias|82246791|0-19|All Races|Male and Female|2013|1.7|2.3|2.0
27.2|29.6|28.4|2346|II Lymphomas and reticuloendothelial neoplasms|82246791|0-19|All Races|Male and Female|2013|27.4|29.7|28.5
10.9|12.3|11.6|963|II(a) Hodgkin lymphomas|82246791|0-19|All Races|Male and Female|2013|11.0|12.5|11.7
8.4|9.8|9.1|750|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82246791|0-19|All Races|Male and Female|2013|8.5|9.8|9.1
2.0|2.6|2.3|188|II(c) Burkitt lymphoma|82246791|0-19|All Races|Male and Female|2013|2.0|2.6|2.3
4.6|5.6|5.1|415|II(d) Miscellaneous lymphoreticular neoplasms|82246791|0-19|All Races|Male and Female|2013|4.6|5.6|5.0
0.2|0.5|0.4|30|II(e) Unspecified lymphomas|82246791|0-19|All Races|Male and Female|2013|0.2|0.5|0.4
32.0|34.5|33.2|2727|III CNS and misc intracranial and intraspinal neoplasms|82246791|0-19|All Races|Male and Female|2013|31.9|34.4|33.2
2.4|3.1|2.7|222|III(a) Ependymomas and choroid plexus tumor|82246791|0-19|All Races|Male and Female|2013|2.4|3.1|2.7
17.0|18.8|17.9|1468|III(b) Astrocytomas|82246791|0-19|All Races|Male and Female|2013|16.9|18.8|17.8
5.2|6.2|5.7|467|III(c) Intracranial and intraspinal embryonal tumors|82246791|0-19|All Races|Male and Female|2013|5.2|6.2|5.7
5.2|6.3|5.7|471|III(d) Other gliomas|82246791|0-19|All Races|Male and Female|2013|5.2|6.3|5.7
0.5|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|82246791|0-19|All Races|Male and Female|2013|0.5|0.9|0.7
0.3|0.7|0.5|40|III(f) Unspecified intracranial and intraspinal neoplasms|82246791|0-19|All Races|Male and Female|2013|0.3|0.7|0.5
8.7|10.0|9.3|764|IV Neuroblastoma and other peripheral nervous cell tumors|82246791|0-19|All Races|Male and Female|2013|8.6|10.0|9.3
8.4|9.7|9.0|739|IV(a) Neuroblastoma and ganglioneuroblastoma|82246791|0-19|All Races|Male and Female|2013|8.3|9.7|9.0
0.2|0.4|0.3|25|IV(b) Other peripheral nervous cell tumors|82246791|0-19|All Races|Male and Female|2013|0.2|0.4|0.3
11.2|12.7|11.9|979|IX Soft tissue and other extraosseous sarcomas|82246791|0-19|All Races|Male and Female|2013|11.2|12.7|11.9
4.4|5.3|4.8|397|IX(a) Rhabdomyosarcomas|82246791|0-19|All Races|Male and Female|2013|4.4|5.3|4.8
1.0|1.5|1.3|105|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82246791|0-19|All Races|Male and Female|2013|1.0|1.5|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82246791|0-19|All Races|Male and Female|2013|~|~|~
4.1|5.0|4.5|373|IX(d) Other specified soft tissue sarcomas|82246791|0-19|All Races|Male and Female|2013|4.1|5.0|4.5
1.0|1.5|1.2|103|IX(e) Unspecified soft tissue sarcomas|82246791|0-19|All Races|Male and Female|2013|1.0|1.5|1.3
0.2|0.4|0.3|23|Not classified by ICCC|82246791|0-19|All Races|Male and Female|2013|0.2|0.4|0.3
2.9|3.7|3.2|266|V Retinoblastoma|82246791|0-19|All Races|Male and Female|2013|2.9|3.6|3.2
6.8|8.0|7.4|605|VI Renal tumors|82246791|0-19|All Races|Male and Female|2013|6.8|8.0|7.4
5.9|7.0|6.5|531|VI(a) Nephroblastoma and other nonepithelial renal tumors|82246791|0-19|All Races|Male and Female|2013|5.9|7.0|6.5
0.7|1.1|0.9|71|VI(b) Renal carcinomas|82246791|0-19|All Races|Male and Female|2013|0.7|1.1|0.9
~|~|~|~|VI(c) Unspecified malignant renal tumors|82246791|0-19|All Races|Male and Female|2013|~|~|~
2.2|2.8|2.5|204|VII Hepatic tumors|82246791|0-19|All Races|Male and Female|2013|2.2|2.8|2.5
1.5|2.1|1.8|149|VII(a) Hepatoblastoma|82246791|0-19|All Races|Male and Female|2013|1.5|2.1|1.8
0.5|0.8|0.6|53|VII(b) Hepatic carcinomas|82246791|0-19|All Races|Male and Female|2013|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82246791|0-19|All Races|Male and Female|2013|~|~|~
8.5|9.9|9.2|757|VIII Malignant bone tumors|82246791|0-19|All Races|Male and Female|2013|8.6|9.9|9.2
4.5|5.5|5.0|409|VIII(a) Osteosarcomas|82246791|0-19|All Races|Male and Female|2013|4.5|5.5|5.0
0.2|0.5|0.3|29|VIII(b) Chondrosarcomas|82246791|0-19|All Races|Male and Female|2013|0.2|0.5|0.4
2.8|3.6|3.2|260|VIII(c) Ewing tumor and related sarcomas of bone|82246791|0-19|All Races|Male and Female|2013|2.8|3.6|3.2
0.4|0.7|0.5|45|VIII(d) Other specified malignant bone tumors|82246791|0-19|All Races|Male and Female|2013|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82246791|0-19|All Races|Male and Female|2013|~|~|~
11.2|12.7|11.9|990|X Germ cell, trophoblastic tumors & neoplasms of gonads|82246791|0-19|All Races|Male and Female|2013|11.3|12.8|12.0
1.6|2.3|1.9|159|X(a) Intracranial & intraspinal germ cell tumors|82246791|0-19|All Races|Male and Female|2013|1.6|2.3|1.9
1.1|1.7|1.4|114|X(b) Malignant extracranial & extragonadal germ cell tumors|82246791|0-19|All Races|Male and Female|2013|1.1|1.7|1.4
7.0|8.2|7.6|636|X(c) Malignant gonadal germ cell tumors|82246791|0-19|All Races|Male and Female|2013|7.1|8.4|7.7
0.4|0.7|0.6|47|X(d) Gonadal carcinomas|82246791|0-19|All Races|Male and Female|2013|0.4|0.8|0.6
0.3|0.6|0.4|34|X(e) Other and unspecified malignant gonadal tumors|82246791|0-19|All Races|Male and Female|2013|0.3|0.6|0.4
18.8|20.7|19.7|1642|XI Other malignant epithelial neoplasms and malignant melanomas|82246791|0-19|All Races|Male and Female|2013|19.0|21.0|20.0
~|~|~|~|XI(a) Adrenocortical carcinomas|82246791|0-19|All Races|Male and Female|2013|~|~|~
8.8|10.1|9.4|787|XI(b) Thyroid carcinomas|82246791|0-19|All Races|Male and Female|2013|8.9|10.3|9.6
0.5|0.8|0.6|53|XI(c) Nasopharyngeal carcinomas|82246791|0-19|All Races|Male and Female|2013|0.5|0.8|0.6
3.8|4.7|4.2|352|XI(d) Malignant melanomas|82246791|0-19|All Races|Male and Female|2013|3.8|4.8|4.3
~|~|~|~|XI(e) Skin carcinomas|82246791|0-19|All Races|Male and Female|2013|~|~|~
4.7|5.7|5.2|434|XI(f) Other and unspecified carcinomas|82246791|0-19|All Races|Male and Female|2013|4.8|5.8|5.3
0.7|1.1|0.8|70|XII Other and unspecified malignant neoplasms|82246791|0-19|All Races|Male and Female|2013|0.7|1.1|0.9
0.3|0.6|0.4|36|XII(a) Other specified malignant tumors|82246791|0-19|All Races|Male and Female|2013|0.3|0.6|0.4
0.3|0.6|0.4|34|XII(b) Other unspecified malignant tumors|82246791|0-19|All Races|Male and Female|2013|0.3|0.6|0.4
187.7|190.3|189.0|77854|All ICCC Groups Combined|410614782|0-19|All Races|Male and Female|2013-2017|188.3|190.9|189.6
47.5|48.9|48.2|19801|I Leukemias, myeloproliferative & myelodysplastic diseases|410614782|0-19|All Races|Male and Female|2013-2017|47.6|48.9|48.2
33.4|34.5|34.0|13942|I(a) Lymphoid leukemias|410614782|0-19|All Races|Male and Female|2013-2017|33.4|34.5|34.0
8.0|8.6|8.3|3407|I(b) Acute myeloid leukemias|410614782|0-19|All Races|Male and Female|2013-2017|8.0|8.6|8.3
2.4|2.7|2.6|1058|I(c) Chronic myeloproliferative diseases|410614782|0-19|All Races|Male and Female|2013-2017|2.4|2.7|2.6
1.3|1.6|1.4|593|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|410614782|0-19|All Races|Male and Female|2013-2017|1.3|1.6|1.4
1.8|2.1|2.0|801|I(e) Unspecified and other specified leukemias|410614782|0-19|All Races|Male and Female|2013-2017|1.8|2.1|2.0
29.5|30.5|30.0|12373|II Lymphomas and reticuloendothelial neoplasms|410614782|0-19|All Races|Male and Female|2013-2017|29.6|30.7|30.1
11.7|12.4|12.1|5003|II(a) Hodgkin lymphomas|410614782|0-19|All Races|Male and Female|2013-2017|11.8|12.5|12.2
9.6|10.2|9.9|4079|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|410614782|0-19|All Races|Male and Female|2013-2017|9.6|10.2|9.9
2.3|2.6|2.5|1011|II(c) Burkitt lymphoma|410614782|0-19|All Races|Male and Female|2013-2017|2.3|2.6|2.5
5.0|5.4|5.2|2125|II(d) Miscellaneous lymphoreticular neoplasms|410614782|0-19|All Races|Male and Female|2013-2017|5.0|5.4|5.2
0.3|0.4|0.4|155|II(e) Unspecified lymphomas|410614782|0-19|All Races|Male and Female|2013-2017|0.3|0.4|0.4
31.8|32.9|32.4|13282|III CNS and misc intracranial and intraspinal neoplasms|410614782|0-19|All Races|Male and Female|2013-2017|31.8|32.9|32.3
2.6|2.9|2.7|1115|III(a) Ependymomas and choroid plexus tumor|410614782|0-19|All Races|Male and Female|2013-2017|2.6|2.9|2.7
16.4|17.1|16.7|6870|III(b) Astrocytomas|410614782|0-19|All Races|Male and Female|2013-2017|16.3|17.1|16.7
5.6|6.0|5.8|2379|III(c) Intracranial and intraspinal embryonal tumors|410614782|0-19|All Races|Male and Female|2013-2017|5.6|6.0|5.8
5.6|6.1|5.8|2389|III(d) Other gliomas|410614782|0-19|All Races|Male and Female|2013-2017|5.6|6.1|5.8
0.7|0.8|0.8|310|III(e) Other specified intracranial & intraspinal neoplasms|410614782|0-19|All Races|Male and Female|2013-2017|0.7|0.8|0.8
0.5|0.6|0.5|219|III(f) Unspecified intracranial and intraspinal neoplasms|410614782|0-19|All Races|Male and Female|2013-2017|0.5|0.6|0.5
8.7|9.2|8.9|3673|IV Neuroblastoma and other peripheral nervous cell tumors|410614782|0-19|All Races|Male and Female|2013-2017|8.7|9.2|8.9
8.4|9.0|8.7|3568|IV(a) Neuroblastoma and ganglioneuroblastoma|410614782|0-19|All Races|Male and Female|2013-2017|8.4|9.0|8.7
0.2|0.3|0.3|105|IV(b) Other peripheral nervous cell tumors|410614782|0-19|All Races|Male and Female|2013-2017|0.2|0.3|0.3
11.9|12.6|12.2|5042|IX Soft tissue and other extraosseous sarcomas|410614782|0-19|All Races|Male and Female|2013-2017|11.9|12.6|12.3
4.6|5.0|4.8|1974|IX(a) Rhabdomyosarcomas|410614782|0-19|All Races|Male and Female|2013-2017|4.6|5.0|4.8
1.2|1.4|1.3|522|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|410614782|0-19|All Races|Male and Female|2013-2017|1.2|1.4|1.3
~|~|~|~|IX(c) Kaposi sarcoma|410614782|0-19|All Races|Male and Female|2013-2017|~|~|~
4.5|4.9|4.7|1935|IX(d) Other specified soft tissue sarcomas|410614782|0-19|All Races|Male and Female|2013-2017|4.5|4.9|4.7
1.3|1.6|1.4|597|IX(e) Unspecified soft tissue sarcomas|410614782|0-19|All Races|Male and Female|2013-2017|1.3|1.6|1.5
0.2|0.3|0.3|109|Not classified by ICCC|410614782|0-19|All Races|Male and Female|2013-2017|0.2|0.3|0.3
3.1|3.4|3.3|1343|V Retinoblastoma|410614782|0-19|All Races|Male and Female|2013-2017|3.1|3.5|3.3
6.9|7.5|7.2|2960|VI Renal tumors|410614782|0-19|All Races|Male and Female|2013-2017|7.0|7.5|7.2
6.2|6.7|6.4|2631|VI(a) Nephroblastoma and other nonepithelial renal tumors|410614782|0-19|All Races|Male and Female|2013-2017|6.2|6.7|6.4
0.7|0.9|0.8|316|VI(b) Renal carcinomas|410614782|0-19|All Races|Male and Female|2013-2017|0.7|0.9|0.8
~|~|~|~|VI(c) Unspecified malignant renal tumors|410614782|0-19|All Races|Male and Female|2013-2017|~|~|~
2.4|2.7|2.6|1058|VII Hepatic tumors|410614782|0-19|All Races|Male and Female|2013-2017|2.4|2.7|2.6
1.8|2.1|2.0|809|VII(a) Hepatoblastoma|410614782|0-19|All Races|Male and Female|2013-2017|1.8|2.1|2.0
0.5|0.7|0.6|239|VII(b) Hepatic carcinomas|410614782|0-19|All Races|Male and Female|2013-2017|0.5|0.7|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|410614782|0-19|All Races|Male and Female|2013-2017|~|~|~
9.1|9.7|9.4|3848|VIII Malignant bone tumors|410614782|0-19|All Races|Male and Female|2013-2017|9.1|9.7|9.4
4.9|5.3|5.1|2107|VIII(a) Osteosarcomas|410614782|0-19|All Races|Male and Female|2013-2017|4.9|5.4|5.1
0.3|0.4|0.3|139|VIII(b) Chondrosarcomas|410614782|0-19|All Races|Male and Female|2013-2017|0.3|0.4|0.3
3.0|3.3|3.1|1286|VIII(c) Ewing tumor and related sarcomas of bone|410614782|0-19|All Races|Male and Female|2013-2017|3.0|3.3|3.1
0.5|0.6|0.6|227|VIII(d) Other specified malignant bone tumors|410614782|0-19|All Races|Male and Female|2013-2017|0.5|0.6|0.6
0.2|0.3|0.2|89|VIII(e) Unspecified malignant bone tumors|410614782|0-19|All Races|Male and Female|2013-2017|0.2|0.3|0.2
11.1|11.7|11.4|4730|X Germ cell, trophoblastic tumors & neoplasms of gonads|410614782|0-19|All Races|Male and Female|2013-2017|11.2|11.9|11.5
1.8|2.0|1.9|785|X(a) Intracranial & intraspinal germ cell tumors|410614782|0-19|All Races|Male and Female|2013-2017|1.8|2.1|1.9
1.3|1.5|1.4|580|X(b) Malignant extracranial & extragonadal germ cell tumors|410614782|0-19|All Races|Male and Female|2013-2017|1.3|1.5|1.4
6.9|7.5|7.2|2996|X(c) Malignant gonadal germ cell tumors|410614782|0-19|All Races|Male and Female|2013-2017|7.0|7.6|7.3
0.4|0.5|0.5|196|X(d) Gonadal carcinomas|410614782|0-19|All Races|Male and Female|2013-2017|0.4|0.5|0.5
0.4|0.5|0.4|173|X(e) Other and unspecified malignant gonadal tumors|410614782|0-19|All Races|Male and Female|2013-2017|0.4|0.5|0.4
21.9|22.8|22.3|9269|XI Other malignant epithelial neoplasms and malignant melanomas|410614782|0-19|All Races|Male and Female|2013-2017|22.1|23.0|22.6
0.1|0.2|0.2|73|XI(a) Adrenocortical carcinomas|410614782|0-19|All Races|Male and Female|2013-2017|0.1|0.2|0.2
10.1|10.7|10.4|4318|XI(b) Thyroid carcinomas|410614782|0-19|All Races|Male and Female|2013-2017|10.2|10.8|10.5
0.4|0.6|0.5|203|XI(c) Nasopharyngeal carcinomas|410614782|0-19|All Races|Male and Female|2013-2017|0.4|0.6|0.5
3.6|4.0|3.8|1586|XI(d) Malignant melanomas|410614782|0-19|All Races|Male and Female|2013-2017|3.7|4.1|3.9
0.1|0.1|0.1|35|XI(e) Skin carcinomas|410614782|0-19|All Races|Male and Female|2013-2017|0.1|0.1|0.1
7.1|7.6|7.4|3054|XI(f) Other and unspecified carcinomas|410614782|0-19|All Races|Male and Female|2013-2017|7.2|7.7|7.4
0.8|1.0|0.9|366|XII Other and unspecified malignant neoplasms|410614782|0-19|All Races|Male and Female|2013-2017|0.8|1.0|0.9
0.4|0.6|0.5|201|XII(a) Other specified malignant tumors|410614782|0-19|All Races|Male and Female|2013-2017|0.4|0.6|0.5
0.3|0.5|0.4|165|XII(b) Other unspecified malignant tumors|410614782|0-19|All Races|Male and Female|2013-2017|0.3|0.5|0.4
187.6|193.5|190.5|15686|All ICCC Groups Combined|82108087|0-19|All Races|Male and Female|2014|188.1|194.1|191.0
46.7|49.7|48.2|3958|I Leukemias, myeloproliferative & myelodysplastic diseases|82108087|0-19|All Races|Male and Female|2014|46.7|49.7|48.2
32.3|34.8|33.5|2754|I(a) Lymphoid leukemias|82108087|0-19|All Races|Male and Female|2014|32.3|34.8|33.5
7.9|9.2|8.6|705|I(b) Acute myeloid leukemias|82108087|0-19|All Races|Male and Female|2014|8.0|9.2|8.6
2.1|2.8|2.5|204|I(c) Chronic myeloproliferative diseases|82108087|0-19|All Races|Male and Female|2014|2.2|2.8|2.5
1.3|1.8|1.5|127|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82108087|0-19|All Races|Male and Female|2014|1.3|1.8|1.5
1.7|2.4|2.0|168|I(e) Unspecified and other specified leukemias|82108087|0-19|All Races|Male and Female|2014|1.7|2.4|2.0
30.1|32.5|31.3|2581|II Lymphomas and reticuloendothelial neoplasms|82108087|0-19|All Races|Male and Female|2014|30.2|32.7|31.4
11.2|12.7|12.0|990|II(a) Hodgkin lymphomas|82108087|0-19|All Races|Male and Female|2014|11.3|12.8|12.1
10.2|11.6|10.9|894|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82108087|0-19|All Races|Male and Female|2014|10.2|11.6|10.9
2.3|3.0|2.7|218|II(c) Burkitt lymphoma|82108087|0-19|All Races|Male and Female|2014|2.3|3.0|2.7
5.0|6.0|5.5|447|II(d) Miscellaneous lymphoreticular neoplasms|82108087|0-19|All Races|Male and Female|2014|5.0|6.0|5.4
0.3|0.5|0.4|32|II(e) Unspecified lymphomas|82108087|0-19|All Races|Male and Female|2014|0.3|0.6|0.4
32.0|34.5|33.3|2729|III CNS and misc intracranial and intraspinal neoplasms|82108087|0-19|All Races|Male and Female|2014|32.0|34.5|33.2
2.4|3.2|2.8|228|III(a) Ependymomas and choroid plexus tumor|82108087|0-19|All Races|Male and Female|2014|2.4|3.2|2.8
16.8|18.6|17.7|1450|III(b) Astrocytomas|82108087|0-19|All Races|Male and Female|2014|16.8|18.6|17.7
5.5|6.6|6.1|496|III(c) Intracranial and intraspinal embryonal tumors|82108087|0-19|All Races|Male and Female|2014|5.5|6.6|6.0
4.9|5.9|5.4|440|III(d) Other gliomas|82108087|0-19|All Races|Male and Female|2014|4.9|5.9|5.4
0.6|1.0|0.8|68|III(e) Other specified intracranial & intraspinal neoplasms|82108087|0-19|All Races|Male and Female|2014|0.6|1.0|0.8
0.4|0.8|0.6|47|III(f) Unspecified intracranial and intraspinal neoplasms|82108087|0-19|All Races|Male and Female|2014|0.4|0.8|0.6
8.6|9.9|9.3|761|IV Neuroblastoma and other peripheral nervous cell tumors|82108087|0-19|All Races|Male and Female|2014|8.6|10.0|9.3
8.3|9.6|8.9|733|IV(a) Neuroblastoma and ganglioneuroblastoma|82108087|0-19|All Races|Male and Female|2014|8.3|9.6|8.9
0.2|0.5|0.3|28|IV(b) Other peripheral nervous cell tumors|82108087|0-19|All Races|Male and Female|2014|0.2|0.5|0.3
11.6|13.1|12.3|1016|IX Soft tissue and other extraosseous sarcomas|82108087|0-19|All Races|Male and Female|2014|11.6|13.2|12.4
3.9|4.8|4.4|358|IX(a) Rhabdomyosarcomas|82108087|0-19|All Races|Male and Female|2014|3.9|4.8|4.4
1.3|1.8|1.5|125|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82108087|0-19|All Races|Male and Female|2014|1.3|1.8|1.5
~|~|~|~|IX(c) Kaposi sarcoma|82108087|0-19|All Races|Male and Female|2014|~|~|~
4.6|5.5|5.0|414|IX(d) Other specified soft tissue sarcomas|82108087|0-19|All Races|Male and Female|2014|4.6|5.6|5.0
1.1|1.7|1.4|114|IX(e) Unspecified soft tissue sarcomas|82108087|0-19|All Races|Male and Female|2014|1.1|1.7|1.4
0.2|0.5|0.3|26|Not classified by ICCC|82108087|0-19|All Races|Male and Female|2014|0.2|0.5|0.3
2.9|3.7|3.2|267|V Retinoblastoma|82108087|0-19|All Races|Male and Female|2014|2.9|3.7|3.3
6.7|7.9|7.3|601|VI Renal tumors|82108087|0-19|All Races|Male and Female|2014|6.7|7.9|7.3
6.1|7.2|6.6|546|VI(a) Nephroblastoma and other nonepithelial renal tumors|82108087|0-19|All Races|Male and Female|2014|6.1|7.2|6.6
0.5|0.8|0.6|53|VI(b) Renal carcinomas|82108087|0-19|All Races|Male and Female|2014|0.5|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|82108087|0-19|All Races|Male and Female|2014|~|~|~
2.2|2.9|2.5|209|VII Hepatic tumors|82108087|0-19|All Races|Male and Female|2014|2.2|2.9|2.5
1.7|2.3|2.0|161|VII(a) Hepatoblastoma|82108087|0-19|All Races|Male and Female|2014|1.7|2.3|2.0
0.4|0.8|0.6|47|VII(b) Hepatic carcinomas|82108087|0-19|All Races|Male and Female|2014|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82108087|0-19|All Races|Male and Female|2014|~|~|~
8.8|10.1|9.4|775|VIII Malignant bone tumors|82108087|0-19|All Races|Male and Female|2014|8.8|10.1|9.4
4.8|5.8|5.2|430|VIII(a) Osteosarcomas|82108087|0-19|All Races|Male and Female|2014|4.8|5.8|5.2
0.2|0.5|0.4|29|VIII(b) Chondrosarcomas|82108087|0-19|All Races|Male and Female|2014|0.2|0.5|0.4
2.7|3.4|3.0|250|VIII(c) Ewing tumor and related sarcomas of bone|82108087|0-19|All Races|Male and Female|2014|2.7|3.4|3.0
0.4|0.7|0.5|45|VIII(d) Other specified malignant bone tumors|82108087|0-19|All Races|Male and Female|2014|0.4|0.7|0.5
0.2|0.4|0.3|21|VIII(e) Unspecified malignant bone tumors|82108087|0-19|All Races|Male and Female|2014|0.2|0.4|0.3
10.5|12.0|11.2|931|X Germ cell, trophoblastic tumors & neoplasms of gonads|82108087|0-19|All Races|Male and Female|2014|10.6|12.1|11.3
1.4|2.0|1.7|136|X(a) Intracranial & intraspinal germ cell tumors|82108087|0-19|All Races|Male and Female|2014|1.4|2.0|1.7
1.4|2.0|1.7|138|X(b) Malignant extracranial & extragonadal germ cell tumors|82108087|0-19|All Races|Male and Female|2014|1.4|2.0|1.7
6.4|7.6|7.0|582|X(c) Malignant gonadal germ cell tumors|82108087|0-19|All Races|Male and Female|2014|6.5|7.7|7.1
0.3|0.7|0.5|40|X(d) Gonadal carcinomas|82108087|0-19|All Races|Male and Female|2014|0.3|0.7|0.5
0.3|0.6|0.4|35|X(e) Other and unspecified malignant gonadal tumors|82108087|0-19|All Races|Male and Female|2014|0.3|0.6|0.4
20.5|22.5|21.5|1780|XI Other malignant epithelial neoplasms and malignant melanomas|82108087|0-19|All Races|Male and Female|2014|20.7|22.7|21.7
0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|82108087|0-19|All Races|Male and Female|2014|0.1|0.4|0.2
9.9|11.3|10.6|881|XI(b) Thyroid carcinomas|82108087|0-19|All Races|Male and Female|2014|10.0|11.5|10.7
0.2|0.5|0.4|30|XI(c) Nasopharyngeal carcinomas|82108087|0-19|All Races|Male and Female|2014|0.2|0.5|0.4
3.7|4.6|4.2|344|XI(d) Malignant melanomas|82108087|0-19|All Races|Male and Female|2014|3.8|4.7|4.2
~|~|~|~|XI(e) Skin carcinomas|82108087|0-19|All Races|Male and Female|2014|~|~|~
5.5|6.6|6.0|499|XI(f) Other and unspecified carcinomas|82108087|0-19|All Races|Male and Female|2014|5.6|6.6|6.1
0.5|0.8|0.6|52|XII Other and unspecified malignant neoplasms|82108087|0-19|All Races|Male and Female|2014|0.5|0.8|0.6
0.2|0.5|0.3|28|XII(a) Other specified malignant tumors|82108087|0-19|All Races|Male and Female|2014|0.2|0.5|0.3
0.2|0.4|0.3|24|XII(b) Other unspecified malignant tumors|82108087|0-19|All Races|Male and Female|2014|0.2|0.4|0.3
192.4|198.5|195.4|16101|All ICCC Groups Combined|82082905|0-19|All Races|Male and Female|2015|193.1|199.2|196.2
48.8|51.9|50.4|4140|I Leukemias, myeloproliferative & myelodysplastic diseases|82082905|0-19|All Races|Male and Female|2015|48.9|52.0|50.4
34.5|37.1|35.8|2940|I(a) Lymphoid leukemias|82082905|0-19|All Races|Male and Female|2015|34.5|37.1|35.8
7.8|9.0|8.4|692|I(b) Acute myeloid leukemias|82082905|0-19|All Races|Male and Female|2015|7.8|9.1|8.4
2.4|3.1|2.7|224|I(c) Chronic myeloproliferative diseases|82082905|0-19|All Races|Male and Female|2015|2.4|3.1|2.7
1.2|1.8|1.5|121|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82082905|0-19|All Races|Male and Female|2015|1.2|1.8|1.5
1.7|2.3|2.0|163|I(e) Unspecified and other specified leukemias|82082905|0-19|All Races|Male and Female|2015|1.7|2.3|2.0
29.7|32.1|30.9|2544|II Lymphomas and reticuloendothelial neoplasms|82082905|0-19|All Races|Male and Female|2015|29.8|32.2|31.0
11.7|13.2|12.4|1029|II(a) Hodgkin lymphomas|82082905|0-19|All Races|Male and Female|2015|11.8|13.3|12.5
9.2|10.6|9.9|815|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82082905|0-19|All Races|Male and Female|2015|9.3|10.6|9.9
2.1|2.8|2.5|202|II(c) Burkitt lymphoma|82082905|0-19|All Races|Male and Female|2015|2.1|2.8|2.5
5.1|6.2|5.6|463|II(d) Miscellaneous lymphoreticular neoplasms|82082905|0-19|All Races|Male and Female|2015|5.1|6.2|5.6
0.3|0.6|0.4|35|II(e) Unspecified lymphomas|82082905|0-19|All Races|Male and Female|2015|0.3|0.6|0.4
31.2|33.7|32.4|2657|III CNS and misc intracranial and intraspinal neoplasms|82082905|0-19|All Races|Male and Female|2015|31.2|33.6|32.4
2.4|3.2|2.8|228|III(a) Ependymomas and choroid plexus tumor|82082905|0-19|All Races|Male and Female|2015|2.4|3.2|2.8
15.6|17.4|16.5|1354|III(b) Astrocytomas|82082905|0-19|All Races|Male and Female|2015|15.6|17.4|16.5
5.6|6.6|6.1|498|III(c) Intracranial and intraspinal embryonal tumors|82082905|0-19|All Races|Male and Female|2015|5.5|6.6|6.1
5.3|6.4|5.8|476|III(d) Other gliomas|82082905|0-19|All Races|Male and Female|2015|5.3|6.3|5.8
0.6|1.0|0.8|66|III(e) Other specified intracranial & intraspinal neoplasms|82082905|0-19|All Races|Male and Female|2015|0.6|1.0|0.8
0.3|0.6|0.4|35|III(f) Unspecified intracranial and intraspinal neoplasms|82082905|0-19|All Races|Male and Female|2015|0.3|0.6|0.4
8.8|10.2|9.5|781|IV Neuroblastoma and other peripheral nervous cell tumors|82082905|0-19|All Races|Male and Female|2015|8.9|10.2|9.5
8.5|9.8|9.2|756|IV(a) Neuroblastoma and ganglioneuroblastoma|82082905|0-19|All Races|Male and Female|2015|8.6|9.9|9.2
0.2|0.4|0.3|25|IV(b) Other peripheral nervous cell tumors|82082905|0-19|All Races|Male and Female|2015|0.2|0.4|0.3
11.8|13.3|12.5|1030|IX Soft tissue and other extraosseous sarcomas|82082905|0-19|All Races|Male and Female|2015|11.8|13.3|12.5
4.4|5.3|4.8|398|IX(a) Rhabdomyosarcomas|82082905|0-19|All Races|Male and Female|2015|4.4|5.3|4.8
1.2|1.7|1.4|116|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82082905|0-19|All Races|Male and Female|2015|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82082905|0-19|All Races|Male and Female|2015|~|~|~
4.3|5.3|4.8|392|IX(d) Other specified soft tissue sarcomas|82082905|0-19|All Races|Male and Female|2015|4.3|5.3|4.8
1.2|1.7|1.5|120|IX(e) Unspecified soft tissue sarcomas|82082905|0-19|All Races|Male and Female|2015|1.2|1.7|1.5
0.1|0.3|0.2|16|Not classified by ICCC|82082905|0-19|All Races|Male and Female|2015|0.1|0.3|0.2
3.3|4.1|3.7|303|V Retinoblastoma|82082905|0-19|All Races|Male and Female|2015|3.3|4.1|3.7
7.3|8.5|7.9|649|VI Renal tumors|82082905|0-19|All Races|Male and Female|2015|7.3|8.5|7.9
6.5|7.7|7.1|580|VI(a) Nephroblastoma and other nonepithelial renal tumors|82082905|0-19|All Races|Male and Female|2015|6.5|7.7|7.1
0.6|1.0|0.8|67|VI(b) Renal carcinomas|82082905|0-19|All Races|Male and Female|2015|0.6|1.0|0.8
~|~|~|~|VI(c) Unspecified malignant renal tumors|82082905|0-19|All Races|Male and Female|2015|~|~|~
2.4|3.2|2.8|231|VII Hepatic tumors|82082905|0-19|All Races|Male and Female|2015|2.5|3.2|2.8
1.8|2.4|2.1|173|VII(a) Hepatoblastoma|82082905|0-19|All Races|Male and Female|2015|1.8|2.4|2.1
0.5|0.9|0.7|56|VII(b) Hepatic carcinomas|82082905|0-19|All Races|Male and Female|2015|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82082905|0-19|All Races|Male and Female|2015|~|~|~
8.5|9.8|9.2|753|VIII Malignant bone tumors|82082905|0-19|All Races|Male and Female|2015|8.5|9.9|9.2
4.5|5.4|4.9|405|VIII(a) Osteosarcomas|82082905|0-19|All Races|Male and Female|2015|4.5|5.4|4.9
0.2|0.5|0.4|30|VIII(b) Chondrosarcomas|82082905|0-19|All Races|Male and Female|2015|0.2|0.5|0.4
2.7|3.5|3.1|255|VIII(c) Ewing tumor and related sarcomas of bone|82082905|0-19|All Races|Male and Female|2015|2.7|3.5|3.1
0.4|0.7|0.5|44|VIII(d) Other specified malignant bone tumors|82082905|0-19|All Races|Male and Female|2015|0.4|0.7|0.5
0.1|0.4|0.2|19|VIII(e) Unspecified malignant bone tumors|82082905|0-19|All Races|Male and Female|2015|0.1|0.4|0.2
10.9|12.4|11.7|968|X Germ cell, trophoblastic tumors & neoplasms of gonads|82082905|0-19|All Races|Male and Female|2015|11.1|12.6|11.8
1.6|2.2|1.9|152|X(a) Intracranial & intraspinal germ cell tumors|82082905|0-19|All Races|Male and Female|2015|1.6|2.2|1.9
1.1|1.7|1.4|114|X(b) Malignant extracranial & extragonadal germ cell tumors|82082905|0-19|All Races|Male and Female|2015|1.1|1.7|1.4
7.0|8.2|7.6|631|X(c) Malignant gonadal germ cell tumors|82082905|0-19|All Races|Male and Female|2015|7.1|8.3|7.7
0.3|0.7|0.5|40|X(d) Gonadal carcinomas|82082905|0-19|All Races|Male and Female|2015|0.3|0.7|0.5
0.3|0.5|0.4|31|X(e) Other and unspecified malignant gonadal tumors|82082905|0-19|All Races|Male and Female|2015|0.3|0.5|0.4
22.6|24.7|23.6|1961|XI Other malignant epithelial neoplasms and malignant melanomas|82082905|0-19|All Races|Male and Female|2015|22.8|25.0|23.9
~|~|~|~|XI(a) Adrenocortical carcinomas|82082905|0-19|All Races|Male and Female|2015|~|~|~
10.1|11.5|10.8|899|XI(b) Thyroid carcinomas|82082905|0-19|All Races|Male and Female|2015|10.2|11.7|11.0
0.4|0.8|0.6|50|XI(c) Nasopharyngeal carcinomas|82082905|0-19|All Races|Male and Female|2015|0.5|0.8|0.6
3.5|4.4|3.9|325|XI(d) Malignant melanomas|82082905|0-19|All Races|Male and Female|2015|3.5|4.4|4.0
~|~|~|~|XI(e) Skin carcinomas|82082905|0-19|All Races|Male and Female|2015|~|~|~
7.5|8.7|8.1|670|XI(f) Other and unspecified carcinomas|82082905|0-19|All Races|Male and Female|2015|7.6|8.8|8.2
0.6|1.0|0.8|68|XII Other and unspecified malignant neoplasms|82082905|0-19|All Races|Male and Female|2015|0.6|1.1|0.8
0.4|0.7|0.5|44|XII(a) Other specified malignant tumors|82082905|0-19|All Races|Male and Female|2015|0.4|0.7|0.5
0.2|0.4|0.3|24|XII(b) Other unspecified malignant tumors|82082905|0-19|All Races|Male and Female|2015|0.2|0.4|0.3
189.0|195.0|192.0|15822|All ICCC Groups Combined|82110969|0-19|All Races|Male and Female|2016|189.7|195.7|192.7
48.3|51.4|49.8|4096|I Leukemias, myeloproliferative & myelodysplastic diseases|82110969|0-19|All Races|Male and Female|2016|48.4|51.4|49.9
34.1|36.7|35.4|2906|I(a) Lymphoid leukemias|82110969|0-19|All Races|Male and Female|2016|34.1|36.7|35.4
7.8|9.0|8.4|691|I(b) Acute myeloid leukemias|82110969|0-19|All Races|Male and Female|2016|7.8|9.1|8.4
2.4|3.1|2.7|225|I(c) Chronic myeloproliferative diseases|82110969|0-19|All Races|Male and Female|2016|2.4|3.1|2.7
1.2|1.7|1.4|117|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82110969|0-19|All Races|Male and Female|2016|1.2|1.7|1.4
1.6|2.2|1.9|157|I(e) Unspecified and other specified leukemias|82110969|0-19|All Races|Male and Female|2016|1.6|2.2|1.9
29.0|31.4|30.2|2490|II Lymphomas and reticuloendothelial neoplasms|82110969|0-19|All Races|Male and Female|2016|29.1|31.5|30.3
11.7|13.2|12.4|1032|II(a) Hodgkin lymphomas|82110969|0-19|All Races|Male and Female|2016|11.8|13.4|12.6
9.6|11.0|10.3|849|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82110969|0-19|All Races|Male and Female|2016|9.7|11.1|10.3
2.2|2.9|2.5|206|II(c) Burkitt lymphoma|82110969|0-19|All Races|Male and Female|2016|2.2|2.9|2.5
4.1|5.0|4.5|372|II(d) Miscellaneous lymphoreticular neoplasms|82110969|0-19|All Races|Male and Female|2016|4.1|5.0|4.5
0.3|0.5|0.4|31|II(e) Unspecified lymphomas|82110969|0-19|All Races|Male and Female|2016|0.3|0.5|0.4
29.8|32.3|31.0|2545|III CNS and misc intracranial and intraspinal neoplasms|82110969|0-19|All Races|Male and Female|2016|29.8|32.2|31.0
2.2|2.8|2.5|204|III(a) Ependymomas and choroid plexus tumor|82110969|0-19|All Races|Male and Female|2016|2.2|2.8|2.5
14.4|16.1|15.3|1252|III(b) Astrocytomas|82110969|0-19|All Races|Male and Female|2016|14.4|16.1|15.2
5.1|6.2|5.6|461|III(c) Intracranial and intraspinal embryonal tumors|82110969|0-19|All Races|Male and Female|2016|5.1|6.2|5.6
5.7|6.8|6.2|509|III(d) Other gliomas|82110969|0-19|All Races|Male and Female|2016|5.7|6.8|6.2
0.7|1.1|0.9|72|III(e) Other specified intracranial & intraspinal neoplasms|82110969|0-19|All Races|Male and Female|2016|0.7|1.1|0.9
0.4|0.8|0.6|47|III(f) Unspecified intracranial and intraspinal neoplasms|82110969|0-19|All Races|Male and Female|2016|0.4|0.8|0.6
8.0|9.3|8.6|711|IV Neuroblastoma and other peripheral nervous cell tumors|82110969|0-19|All Races|Male and Female|2016|8.0|9.3|8.7
7.9|9.2|8.5|699|IV(a) Neuroblastoma and ganglioneuroblastoma|82110969|0-19|All Races|Male and Female|2016|7.9|9.2|8.5
~|~|~|~|IV(b) Other peripheral nervous cell tumors|82110969|0-19|All Races|Male and Female|2016|~|~|~
11.7|13.2|12.4|1024|IX Soft tissue and other extraosseous sarcomas|82110969|0-19|All Races|Male and Female|2016|11.7|13.3|12.5
4.6|5.6|5.1|420|IX(a) Rhabdomyosarcomas|82110969|0-19|All Races|Male and Female|2016|4.6|5.6|5.1
0.9|1.3|1.1|89|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82110969|0-19|All Races|Male and Female|2016|0.9|1.3|1.1
~|~|~|~|IX(c) Kaposi sarcoma|82110969|0-19|All Races|Male and Female|2016|~|~|~
4.3|5.3|4.8|393|IX(d) Other specified soft tissue sarcomas|82110969|0-19|All Races|Male and Female|2016|4.3|5.3|4.8
1.2|1.7|1.5|120|IX(e) Unspecified soft tissue sarcomas|82110969|0-19|All Races|Male and Female|2016|1.2|1.7|1.5
0.2|0.5|0.3|26|Not classified by ICCC|82110969|0-19|All Races|Male and Female|2016|0.2|0.5|0.3
2.8|3.6|3.2|263|V Retinoblastoma|82110969|0-19|All Races|Male and Female|2016|2.8|3.6|3.2
6.4|7.5|6.9|569|VI Renal tumors|82110969|0-19|All Races|Male and Female|2016|6.4|7.5|6.9
5.5|6.6|6.0|496|VI(a) Nephroblastoma and other nonepithelial renal tumors|82110969|0-19|All Races|Male and Female|2016|5.5|6.6|6.0
0.7|1.1|0.8|70|VI(b) Renal carcinomas|82110969|0-19|All Races|Male and Female|2016|0.7|1.1|0.9
~|~|~|~|VI(c) Unspecified malignant renal tumors|82110969|0-19|All Races|Male and Female|2016|~|~|~
2.3|3.0|2.6|216|VII Hepatic tumors|82110969|0-19|All Races|Male and Female|2016|2.3|3.0|2.6
1.8|2.5|2.2|177|VII(a) Hepatoblastoma|82110969|0-19|All Races|Male and Female|2016|1.8|2.5|2.2
0.3|0.6|0.4|37|VII(b) Hepatic carcinomas|82110969|0-19|All Races|Male and Female|2016|0.3|0.6|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82110969|0-19|All Races|Male and Female|2016|~|~|~
9.2|10.5|9.8|809|VIII Malignant bone tumors|82110969|0-19|All Races|Male and Female|2016|9.2|10.6|9.9
4.8|5.8|5.2|431|VIII(a) Osteosarcomas|82110969|0-19|All Races|Male and Female|2016|4.8|5.8|5.2
0.2|0.4|0.3|25|VIII(b) Chondrosarcomas|82110969|0-19|All Races|Male and Female|2016|0.2|0.4|0.3
3.1|3.9|3.5|286|VIII(c) Ewing tumor and related sarcomas of bone|82110969|0-19|All Races|Male and Female|2016|3.1|3.9|3.5
0.5|0.9|0.7|54|VIII(d) Other specified malignant bone tumors|82110969|0-19|All Races|Male and Female|2016|0.5|0.9|0.7
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82110969|0-19|All Races|Male and Female|2016|~|~|~
10.5|12.0|11.3|935|X Germ cell, trophoblastic tumors & neoplasms of gonads|82110969|0-19|All Races|Male and Female|2016|10.7|12.1|11.4
1.7|2.4|2.0|166|X(a) Intracranial & intraspinal germ cell tumors|82110969|0-19|All Races|Male and Female|2016|1.7|2.4|2.0
1.1|1.6|1.3|109|X(b) Malignant extracranial & extragonadal germ cell tumors|82110969|0-19|All Races|Male and Female|2016|1.1|1.6|1.3
6.5|7.7|7.1|592|X(c) Malignant gonadal germ cell tumors|82110969|0-19|All Races|Male and Female|2016|6.6|7.8|7.2
0.3|0.6|0.5|38|X(d) Gonadal carcinomas|82110969|0-19|All Races|Male and Female|2016|0.3|0.6|0.5
0.2|0.5|0.4|30|X(e) Other and unspecified malignant gonadal tumors|82110969|0-19|All Races|Male and Female|2016|0.2|0.5|0.4
23.6|25.8|24.7|2054|XI Other malignant epithelial neoplasms and malignant melanomas|82110969|0-19|All Races|Male and Female|2016|23.9|26.1|25.0
~|~|~|~|XI(a) Adrenocortical carcinomas|82110969|0-19|All Races|Male and Female|2016|~|~|~
10.4|11.8|11.1|922|XI(b) Thyroid carcinomas|82110969|0-19|All Races|Male and Female|2016|10.5|12.0|11.2
0.2|0.5|0.3|28|XI(c) Nasopharyngeal carcinomas|82110969|0-19|All Races|Male and Female|2016|0.2|0.5|0.3
3.5|4.3|3.9|322|XI(d) Malignant melanomas|82110969|0-19|All Races|Male and Female|2016|3.5|4.4|3.9
~|~|~|~|XI(e) Skin carcinomas|82110969|0-19|All Races|Male and Female|2016|~|~|~
8.5|9.8|9.1|756|XI(f) Other and unspecified carcinomas|82110969|0-19|All Races|Male and Female|2016|8.6|9.9|9.2
0.8|1.3|1.0|84|XII Other and unspecified malignant neoplasms|82110969|0-19|All Races|Male and Female|2016|0.8|1.3|1.0
0.4|0.7|0.6|46|XII(a) Other specified malignant tumors|82110969|0-19|All Races|Male and Female|2016|0.4|0.7|0.6
0.3|0.6|0.5|38|XII(b) Other unspecified malignant tumors|82110969|0-19|All Races|Male and Female|2016|0.3|0.6|0.5
179.4|185.2|182.3|15013|All ICCC Groups Combined|82066030|0-19|All Races|Male and Female|2017|180.0|185.9|182.9
44.2|47.1|45.6|3748|I Leukemias, myeloproliferative & myelodysplastic diseases|82066030|0-19|All Races|Male and Female|2017|44.2|47.2|45.7
31.2|33.7|32.5|2666|I(a) Lymphoid leukemias|82066030|0-19|All Races|Male and Female|2017|31.3|33.7|32.5
7.2|8.4|7.8|638|I(b) Acute myeloid leukemias|82066030|0-19|All Races|Male and Female|2017|7.2|8.4|7.8
2.1|2.8|2.4|202|I(c) Chronic myeloproliferative diseases|82066030|0-19|All Races|Male and Female|2017|2.1|2.8|2.5
0.9|1.4|1.1|93|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82066030|0-19|All Races|Male and Female|2017|0.9|1.4|1.1
1.5|2.1|1.8|149|I(e) Unspecified and other specified leukemias|82066030|0-19|All Races|Male and Female|2017|1.5|2.1|1.8
28.1|30.4|29.2|2412|II Lymphomas and reticuloendothelial neoplasms|82066030|0-19|All Races|Male and Female|2017|28.2|30.6|29.4
11.2|12.7|11.9|989|II(a) Hodgkin lymphomas|82066030|0-19|All Races|Male and Female|2017|11.3|12.8|12.1
8.7|10.0|9.4|771|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82066030|0-19|All Races|Male and Female|2017|8.7|10.1|9.4
2.1|2.8|2.4|197|II(c) Burkitt lymphoma|82066030|0-19|All Races|Male and Female|2017|2.1|2.8|2.4
4.7|5.8|5.2|428|II(d) Miscellaneous lymphoreticular neoplasms|82066030|0-19|All Races|Male and Female|2017|4.7|5.7|5.2
0.2|0.5|0.3|27|II(e) Unspecified lymphomas|82066030|0-19|All Races|Male and Female|2017|0.2|0.5|0.3
30.8|33.3|32.0|2624|III CNS and misc intracranial and intraspinal neoplasms|82066030|0-19|All Races|Male and Female|2017|30.8|33.2|32.0
2.5|3.2|2.8|233|III(a) Ependymomas and choroid plexus tumor|82066030|0-19|All Races|Male and Female|2017|2.5|3.2|2.8
15.5|17.3|16.4|1346|III(b) Astrocytomas|82066030|0-19|All Races|Male and Female|2017|15.5|17.3|16.4
5.1|6.1|5.6|457|III(c) Intracranial and intraspinal embryonal tumors|82066030|0-19|All Races|Male and Female|2017|5.1|6.1|5.6
5.5|6.6|6.0|493|III(d) Other gliomas|82066030|0-19|All Races|Male and Female|2017|5.5|6.6|6.0
0.4|0.7|0.5|45|III(e) Other specified intracranial & intraspinal neoplasms|82066030|0-19|All Races|Male and Female|2017|0.4|0.7|0.5
0.5|0.8|0.6|50|III(f) Unspecified intracranial and intraspinal neoplasms|82066030|0-19|All Races|Male and Female|2017|0.5|0.8|0.6
7.4|8.6|8.0|656|IV Neuroblastoma and other peripheral nervous cell tumors|82066030|0-19|All Races|Male and Female|2017|7.4|8.6|8.0
7.2|8.5|7.8|641|IV(a) Neuroblastoma and ganglioneuroblastoma|82066030|0-19|All Races|Male and Female|2017|7.2|8.4|7.8
~|~|~|~|IV(b) Other peripheral nervous cell tumors|82066030|0-19|All Races|Male and Female|2017|~|~|~
11.3|12.8|12.1|993|IX Soft tissue and other extraosseous sarcomas|82066030|0-19|All Races|Male and Female|2017|11.4|12.9|12.1
4.4|5.4|4.9|401|IX(a) Rhabdomyosarcomas|82066030|0-19|All Races|Male and Female|2017|4.4|5.4|4.9
0.8|1.3|1.1|87|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82066030|0-19|All Races|Male and Female|2017|0.8|1.3|1.1
~|~|~|~|IX(c) Kaposi sarcoma|82066030|0-19|All Races|Male and Female|2017|~|~|~
4.0|4.9|4.4|363|IX(d) Other specified soft tissue sarcomas|82066030|0-19|All Races|Male and Female|2017|4.0|4.9|4.4
1.4|2.0|1.7|140|IX(e) Unspecified soft tissue sarcomas|82066030|0-19|All Races|Male and Female|2017|1.4|2.0|1.7
0.1|0.3|0.2|18|Not classified by ICCC|82066030|0-19|All Races|Male and Female|2017|0.1|0.3|0.2
2.6|3.4|3.0|244|V Retinoblastoma|82066030|0-19|All Races|Male and Female|2017|2.6|3.4|3.0
6.0|7.1|6.5|536|VI Renal tumors|82066030|0-19|All Races|Male and Female|2017|6.0|7.1|6.5
5.3|6.4|5.8|478|VI(a) Nephroblastoma and other nonepithelial renal tumors|82066030|0-19|All Races|Male and Female|2017|5.3|6.4|5.8
0.5|0.9|0.7|55|VI(b) Renal carcinomas|82066030|0-19|All Races|Male and Female|2017|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82066030|0-19|All Races|Male and Female|2017|~|~|~
2.1|2.8|2.4|198|VII Hepatic tumors|82066030|0-19|All Races|Male and Female|2017|2.1|2.8|2.4
1.5|2.1|1.8|149|VII(a) Hepatoblastoma|82066030|0-19|All Races|Male and Female|2017|1.5|2.1|1.8
0.4|0.7|0.6|46|VII(b) Hepatic carcinomas|82066030|0-19|All Races|Male and Female|2017|0.4|0.7|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82066030|0-19|All Races|Male and Female|2017|~|~|~
8.5|9.8|9.2|754|VIII Malignant bone tumors|82066030|0-19|All Races|Male and Female|2017|8.5|9.9|9.2
4.8|5.8|5.2|432|VIII(a) Osteosarcomas|82066030|0-19|All Races|Male and Female|2017|4.8|5.8|5.3
0.2|0.5|0.3|26|VIII(b) Chondrosarcomas|82066030|0-19|All Races|Male and Female|2017|0.2|0.5|0.3
2.5|3.2|2.9|235|VIII(c) Ewing tumor and related sarcomas of bone|82066030|0-19|All Races|Male and Female|2017|2.5|3.3|2.9
0.3|0.6|0.5|39|VIII(d) Other specified malignant bone tumors|82066030|0-19|All Races|Male and Female|2017|0.3|0.6|0.5
0.2|0.4|0.3|22|VIII(e) Unspecified malignant bone tumors|82066030|0-19|All Races|Male and Female|2017|0.2|0.4|0.3
10.2|11.7|10.9|906|X Germ cell, trophoblastic tumors & neoplasms of gonads|82066030|0-19|All Races|Male and Female|2017|10.3|11.8|11.0
1.8|2.4|2.1|172|X(a) Intracranial & intraspinal germ cell tumors|82066030|0-19|All Races|Male and Female|2017|1.8|2.4|2.1
1.0|1.5|1.3|105|X(b) Malignant extracranial & extragonadal germ cell tumors|82066030|0-19|All Races|Male and Female|2017|1.0|1.5|1.3
6.1|7.2|6.7|555|X(c) Malignant gonadal germ cell tumors|82066030|0-19|All Races|Male and Female|2017|6.2|7.3|6.8
0.3|0.5|0.4|31|X(d) Gonadal carcinomas|82066030|0-19|All Races|Male and Female|2017|0.3|0.5|0.4
0.4|0.7|0.5|43|X(e) Other and unspecified malignant gonadal tumors|82066030|0-19|All Races|Male and Female|2017|0.4|0.7|0.5
21.0|23.1|22.0|1832|XI Other malignant epithelial neoplasms and malignant melanomas|82066030|0-19|All Races|Male and Female|2017|21.3|23.4|22.3
~|~|~|~|XI(a) Adrenocortical carcinomas|82066030|0-19|All Races|Male and Female|2017|~|~|~
9.3|10.7|10.0|829|XI(b) Thyroid carcinomas|82066030|0-19|All Races|Male and Female|2017|9.4|10.8|10.1
0.4|0.7|0.5|42|XI(c) Nasopharyngeal carcinomas|82066030|0-19|All Races|Male and Female|2017|0.4|0.7|0.5
2.6|3.3|2.9|243|XI(d) Malignant melanomas|82066030|0-19|All Races|Male and Female|2017|2.6|3.4|3.0
~|~|~|~|XI(e) Skin carcinomas|82066030|0-19|All Races|Male and Female|2017|~|~|~
7.8|9.0|8.4|695|XI(f) Other and unspecified carcinomas|82066030|0-19|All Races|Male and Female|2017|7.9|9.1|8.5
0.9|1.4|1.1|92|XII Other and unspecified malignant neoplasms|82066030|0-19|All Races|Male and Female|2017|0.9|1.4|1.1
0.4|0.8|0.6|47|XII(a) Other specified malignant tumors|82066030|0-19|All Races|Male and Female|2017|0.4|0.8|0.6
0.4|0.7|0.5|45|XII(b) Other unspecified malignant tumors|82066030|0-19|All Races|Male and Female|2017|0.4|0.7|0.5
